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ABSTRACT 
 
The endo-membrane system of eukaryotic cells is a dynamic network of membrane-
bound organelles that exists in a constant state of flux as they exchange membrane 
and protein cargoes. Understanding how these organelles retain their unique protein 
and lipid compositions in the face of this enormous inward/outward flow is one of the 
central problems in cell biology and has implications for the fields of biotechnology, 
virology, immunity and cancer biology. 
 
All protein trafficking can be reduced to a problem of regulated membrane fission 
events that couple cargo selection with the formation of transport vesicles, followed 
by selective membrane fusion with the target organelle. The same fusion and fission 
events are thought to underlie the changes in organelle size and shape that can occur 
during stress or when organelles divide (e.g. during cytokinesis). 
 
The yeast vacuole is a highly dynamic organelle that receives membrane and cargo 
from a number of different pathways. This organelle also changes shape in response to 
both hypo and hyper-osmotic stresses and so has been used to study both membrane 
fusion and fission. Fusion is relatively well characterized but fission is not well 
understood. 
 
This work focuses on the molecular events that co-ordinate vacuole fission during 
hyper-osmotic stress. One polyphosphoinositide pathway was known to regulate 
vacuole fission before this work began: the Fab1p pathway. Polyphosphoinositides are 
a group of lipid signals that are rapidly formed in cells and modulate the activity of 
  
                                                                                                                                                                                 
protein effectors. The Fab1p pathway is activated during hyper-osmotic stress and 
causes the vacuole to fragment into many tiny sub-compartments by a process of 
membrane fission. I characterized a number of the components of this pathway to 
learn how they work together, including Vac7p, Vac14p, Fig4p and Ymr1p. The 
specificity and localisation of several of these proteins were characterized and a 
greater understanding of this protein network emerges from this work. 
 
I then focused on understanding how fission of the vacuole is maintained and fusion 
inhibited in hyper-osmotic media. It was previously reported that Yck3p, a vacuolar 
protein casein kinase, was activated by hyper-osmotic stress to phosphorylate Vps41p, 
a component of the vacuole fusion machinery. The effect of this phosphorylation and 
the upstream signaling pathway controlling Yck3p were unknown. 
 
I started by looking if any known signalling systems might control Yck3p and ruled 
out both the Fab1p and Hog1p osmotic stress response pathways as upstream 
activators. I then found that another polyphosphoinositide signalling system controls 
Yck3p: namely the Plc1p phospholipase pathway that produces a series of water 
soluble inositol polyphosphate second messengers. I further found that deletion of any 
of the inositol polyphosphate kinases in the Plc1p pathway prevented Yck3p 
signalling, suggesting that the inositol pyrophosphates control Yck3p activity in some 
fashion. 
 
I also identified the Yck3p phosphorylation sites on Vps41p by FT-ICR mass 
spectrometry and showed that phosphorylation of these sites was required to block 
vacuole fusion during hyper-osmotic stress. vps41 mutants lacking these sites showed 
  
                                                                                                                                                                                 
aberrant behavior: their vacuoles underwent normal fission in response to hyper-
osmotic stress but then immediately re-fused in an apparent “futile cycle”. 
 
Thus Plc1p controls a novel signalling pathway mediated by Yck3p that prevents 
vacuole fusion by phosphorylating thus inhibiting a vital component of the fusion 
machinery: Vps41p. 
  
 
 
 
 
 
  
                                                                                                                                                                                 
DEDICATION 
 
I would like to dedicate this thesis to my beloved parents and my wife, who will be 
proud of me obtaining a Ph.D. degree, and also to my lovely new-born son, I hope 
that he might one day “follow in my footsteps” and attempt to solve a few “insoluble” 
lipid problems of his own. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
                                                                                                                                                                                 
ACKNOWLEDGEMENTS 
 
Throughout the years of Ph.D. study, I have received invaluable support and 
encouragement from many people. First and foremost, I would like to express my 
sincere appreciation to Dr. Stephen Dove, my Ph.D supervisor, who has guided me 
with enthusiasm and patience. I feel that in each lab meeting and personal talk, he 
helped me to understand much that was beyond me in the early days. Special thanks 
must also go to Professor Bob Michell: a pioneer in the field of inositol lipids. His 
insight always brought me out of confusion and into the light. Both in particular, 
helped me immeasurably during the writing of this thesis, discussing difficulties, 
reviewing my drafts and gaving me timely feedback.  
 
Next, I would like to express my gratitude to all previous and current members of Dr 
Dove’s lab, and also to all the people on the sixth floor. I am very happy to have 
known and spent time with you all over the past few years. Many thanks for your help 
with experiments and bringing me a lot of funs every day.  In addition, many thanks 
must also be given to Dr. Cleidiane Zampronio for her assistance on the mass 
spectrometry data analysis.  
 
I must acknowledge my beloved family whose emotional support, particularly 
understanding my need to focus on my studying, was a precious gift. 
 
Finally but importantly, I greatly appreciate the financial support of the Dorothy 
Hodgkin Postgraduate Award (DHPA) that has funded my studies and my life over 
last three years in Birmingham, U.K.  
  
                                                                                                                                                                                 
ABBREVIATIONS  
 
CK1 & 2 
CORVET 
DAG 
DIC 
DTT 
E. coli 
ER 
GFP 
HA 
HOPS 
HPLC                      
IPs 
IP3              
IP4              
IP5              
IP6               
IP7                       
IP8         
MAPK 
MTMR 
MVB 
ORF 
PLC 
PM 
PPIn 
PtdIns 
PtdIns3P 
PtdIns4P 
PtdIns5P 
PtdIns(3,5)P2 
PtdIns(4,5)P2 
Casein kinase 1 & 2 
Class C core vacuole/endosome tethering           
Diacylglycerol                             
Differential interference contrast 
Dithiothreitol 
Escherichia coli 
Endoplasmic reticulum 
Green fluorescent protein 
Hemagglutinin 
Homotypic fusion and protein sorting 
High performance liquid chromatography 
Inositol polyphosphates 
Inositol 1,4,5-trisphosphate 
Inositol 1,4,5,6-tetrakisphosphate 
Inositol 1,3,4,5,6-pentakisphosphate 
Inositol 1,2,3,4,5,6-hexakisphosphate 
Diphosphoinositol pentakisphosphate (“PP-IP5 ”) 
Bis-diphosphoinositol tetrakisphosphate (PP)2-IP4 
Mitogen-activated protein kinase 
Myotubularin related protein   
Multivesicular body 
Open reading frame 
Phospholipase C 
Plasma membrane 
Polyphosphoinositide 
Phosphatidylinositol 
Phosphatidylinositol 3-monophosphate 
Phosphatidylinositol 4-monophosphate 
Phosphatidylinositol 5-monophosphate 
Phosphatidylinositol 3,5-bisphosphate 
Phosphatidylinositol 4,5-bisphosphate 
  
                                                                                                                                                                                 
PtdIns(3,4,5)P3 Phosphatidylinositol 3,4,5-trisphosphate 
PTEN 
 
S. cerevisiae 
SNARE 
 
TGN 
ts 
Phosphatase and tensin homologue deleted on 
chromosome ten 
Saccharomyces cerevisiae 
Solube N-ethylmaledimide-sensitive factor 
attachment protein receptor                           
Trans-golgi network 
Temperature sensitive 
 
      
  
                                                                                                                                                                                 
CONTENTS 
 
Chapter 1: Introduction 
1.1 General introduction and history of PPIns.............................................1 
1.2 PPIns: synthesis, degradation and interconversion………………….5 
1.3 PPIns in budding yeast……………………………………...........................8 
1.4 PPIn kinases (PIKs)………………………………………...........................10 
1.4.1 PtdIns 3-kinases (PI3Ks)……………………………………………………...11 
1.4.1.1 Class I PI3Ks (PI3KC1)……………………………………………………....11 
1.4.1.2 Class II PI3Ks (PI3KC2)……………………………………………………..13 
1.4.1.3 Class III PI3Ks (PI3KC3) and Vps34p…………………………………….....13 
1.4.2 PtdIns 4-kinases (PI4Ks)……………………………………………………...16 
1.4.2.1 Type II PI4Ks (PI4KIIs) and Lsb6p…………………………………………..16 
1.4.2.2 Type III PI4Ks (PI4KIIIs)…………………………………………………….18 
1.4.2.2.1 PI4KIIIα and Stt4p………………………………………………………….18 
1.4.2.2.2 PI4KIIIβ and Pik1p………………………………………………………....19 
1.4.3 PtdInsP kinases (PIPKs)……………………………………………………...21 
1.4.3.1 Type I PIP5K and Mss4p……………………………………………………..22 
1.4.3.2 Type III PIP5Ks and Fab1p…………………………………………………..23 
1.5 PPIn phosphatases………………………………………………………….23 
1.5.1 Type II PPIn 5-phosphatases………………………………………………....24 
1.5.2. PPIn 3-phosphatases…………………………………………………………27 
1.5.3. PPIn 4-phosphatases…………………………………………………………29 
i  
                                                                                                                                                                                 
1.5.4 Sac domain phosphatases…………………………………………………….29 
1.6 General introduction of individual PPIn……………………………...31 
1.6.1 PtdIns3P, a key component in endosomal membrane trafficking………....31 
1.6.2 PtdIns4P, the main PPIn player in Golgi complex………………………….34 
1.6.3 PtdIns5P, the orphan in the PPIns family………………………………...…36  
1.6.4 PtdIns(3,4)P2, lipid second messenger or downstream metabolite?………..37 
1.6.5 PtdIns(4,5)P2, has roles in a myriad of cellular activities…………………..38 
1.6.6 PtdIns(3,5)P2, functions in the endo-lysosomal system……………………..39 
1.6.7 PtdIns(3,4,5)P3, the most phosphorylated and fundamentally important 
PPIn………………………………………………………………………………….40 
1.7 Inositol Polyphosphates (IPs)…………………………………………….41 
1.8 Vacuole fusion and its regulation………………………………………..43 
1.9 PtdIns(3,5)P2 and vacuole fission………………………………………..51 
1.10 Project aims……………………………………………………….58 
 
Chapter 2: Materials and methods 
2.1 Strains, Media and Reagents……………………………………………..60 
2.2 Media composition and solutions………………………………………..64 
2.2.1 Luria Broth (LB) (1L)………………………………………………………....64 
2.2.2 LB + 100 μg/ml Ampicillin or 34 μg/ml chloramphenicol (1L) …………….64 
2.2.3 LB agar (1L)…………………………………………………………………...64 
2.2.4 LB agar + 100 μg/ml Ampicillin or 34 μg/ml chloramphenicol (1L).............64 
2.2.5 SOC medium (1L) …………………………………………………………….64 
2.2.6 Yeast Extract Peptone Dextrose (YPD) (1L) ………………………………...64 
ii  
                                                                                                                                                                                 
2.2.7 YPD + 0.9 M NaCl  or 0.4 M NaCl…………………………………………...64 
2.2.8 YPD agar (1L) ………………………………………………………………...64 
2.2.9 Amino-acid stock powder……………………………………………………..64 
2.2.10 Synthetic complement (SC) + Glucose (1L) ………………………………..64 
2.2.11 50x Tris-Acetate-EDTA buffer (TAE) ……………………………………....65 
2.2.12 6x DNA gel electrophoresis sample buffer………………………………….65 
2.2.13 2x SDS-PAGE sample buffer………………………………………………..65 
2.2.14 10x SDS-PAGE running buffer……………………………………………..65 
2.2.15 10x blot transferring buffer…………………………………………………65 
2.2.16 Phosphate buffered saline (PBS) …………………………………………...65 
2.3 Polymerase chain reaction (PCR) ……………………………………....66 
2.4 DNA sequencing……………………………………………………………..67 
2.5 Plasmid construction and yeast knock-in/out fragment……….…..67 
2.5.1 pET-15b-FIG4 & pGEX-6P-1-FIG4…………………………........................67 
2.5.2 pGEX-6P-1-YMR1……………….....................................................................68 
2.5.3 pEGKT-FIG4………………………….............................................................68 
2.5.4 VAC14-GFP  fragment and pUG36-VAC7…………………………………..68 
2.5.5 pEGKT-FAB1 and pEGKT-FAB1 with mutation in four distinct functional 
domains individually………………………………………………………………..69 
2.6 Transformation of E. coli (Hanahan 1983) …………………………...71 
2.7 Construction of BL21 star (DE3)-CodonPlus-RIL…………….…....71 
2.8 Recombinant Protein expression and purification……………….....72 
2.8.1 Expression and purification of GST-Ymr1p fusion protein…………….….72 
2.8.2 Expression and purification of GST-Fig4 fusion protein……………...……73 
iii  
                                                                                                                                                                                 
2.8.3 Expression and purification of GST-SKIP fusion protein…………………..73 
2.8.4 Expression and purification of His-Fig4p fusion protein...………………....73 
2.8.5 Expression and purification of GST-Fig4p fusion protein from budding 
yeast S. cerevisiae……………………………………………………………...…….74 
2.9 SDS-PAGE (Sodium Dodecyl Sulphate-polyacrylamide Gel 
Electrophoresis)………………………………………………………………….75 
2.10 Western blotting…………………………………………………………....75 
2.11 Immunochemical protein detection by Enhanced 
Chemiluminescence (ECL)……………………………………………………76 
2.12 High efficiency transformation of budding yeast …………………77 
2.13 Genomic DNA purification from budding yeast…………………...78 
2.14 Disruption (Knock-out) and Epitope tagging (Knock-in) of 
budding yeast strains…………………………………………………………...78 
2.15 Site-specific mutagenesis by overlap extension ……………………79 
2.16 Detection of phosphorylated Vps41-3HA by immunobloting…..81 
2.17 Quantification of immunoblot bands using ImageJ 1.42………...82 
2.18 Immuno-purification of Vps41p-3HA from budding yeast ….…83 
2.19 Analysis of Vps41p phosphorylation sites by LC-CID-FT-ICR-
MS…………………………………………………………………….……………..84 
2.20 Staining of cells with the lipophilic dye FM4-64 ………………......85 
2.21 Fluorescence microscopy…………………………………………….…..86 
2.22 HPLC analysis of inositol lipids …………………………………….…86 
iv  
                                                                                                                                                                                 
Chapter 3: Regulation of PtdIns(3,5)P2 mebabolism 
3.1 Introduction………………………………………………………………….87 
3.2 Results…………………………………………………………………………89 
3.2.1 Vac14p fails to localise on the vacuole membrane in fab1Δ, fig4Δ and vps34Δ 
cells…………………………………………………………………………………...89 
3.2.2 Both the CCT-like and PIPKIII-unique domains of Fab1p are required for 
Vac14p to localise to the vacuole membrane……………………………………....92 
3.2.3 Vac7p traffics to the vacuole membrane via the AP-3 pathway…………... 95 
3.2.4 PtdIns5P is present in live yeast……………………………………………...96 
3.2.5 Purification of yeast Ymr1p and Fig4p from E.coli ………………………..98 
3.3 Discussion……………………………………………………………………100 
3.3.1 Involvement of Vac14p and Vac7p in the synthesis of PtdIns(3,5)P2 by 
Fab1p……………………………………………………………………………….100 
3.3.2 Myotubularin type 3-phosphatases of Ymr1p……………………………...101 
 
Chapter 4: A Novel Osmotic Stress Pathway Mediated by 
Inositol Polyphosphates and Vps41p in S. cerevisiae 
4.1 Introduction…………………………………………………………………105 
4.2 Results………………………………………………………………………...107 
4.2.1 Vps41p is phosphorylated by Yck3p upon hyper-osmotic stress………….107  
4.2.2 Hypertonically induced Vps41p phosphorylation is independent of 
PtdIns(3,5)P2 synthesis by Fab1p and of activation of the Hog1p pathway….. .111 
4.2.3 Synthesis of inositol ‘pyrophosphates’ is required for stimulation of Vps41p 
phosphorylation…………………………………………………………………….117 
v  
                                                                                                                                                                                 
4.2.4 Vps41p localisation is correlated to its phosphorylation………….……….119 
4.2.5 Identification of the Vps41 phosphorylation sites…………………………123 
4.3 Discussion……………………………………………………………………133 
4.3.1 Detection of hyper-osmotic induced Vps41p phosphorylation by two distinct 
methods……………………………………………………………………………..133 
4.3.2 Regulation of hyper-osmotic induced Vps41p phosphorylation………......134 
4.3.3 Identification of hyper-osmotically induced Vps41p phosphorylation 
sites………………………………………………………………………………….140 
4.3.4 Three hyper-osmotic pathways in the budding yeast……………………...143 
 
Chapter 5: General discussion and future work 
5.1 Myotubularins: what is their real function ?……………………….146 
5.2 Vac7p localisation………………………………………………………….151 
5.3 The yeast endosomal system…………………………………………….152 
5.4 Why does the yeast vacuole respond to osmotic stress?.................155 
5.5 Are most higher inositol polyphosphates acting as true signals or 
are they just allosteric regulators ?………………………….…………......158 
References……………………………………………………………………....161 
vi  
                                                                                                                                    Introduction 
Chapter 1    Introduction 
 
1.1 General introduction and history of PPIns 
The inositols are a group of nine isomers of cyclohexanehexol. Myo-inositol (referred 
to simply as inositol in this work) is the most abundant in nature and the isomer most 
often incorporated into biological molecules. It was first identified as a component of 
muscle tissue by the German chemist Josef Scherer and named after this original 
source (Greek for muscle) (Scherer, 1850). Myo-inositol is the isomer of 1,2,3,4,5,6-
hexahydroxycyclohexane that has one axial hydroxyl at the 2-position and the other 
five hydroxyls equatorial to the six-carbon ring. 
 
The synthesis of inositol is catalyzed by two enzymes: an NAD+-dependent myo-
inositol-3-phosphate synthase (MIPS, called Ino1p in yeast) that takes glucose-6-
phosphate from glycolysis, and converts it to D-myo inositol-3-phosphate (Ins3P). 
Ins3P is then the substrate for an inositol monophosphatase (InsPase) that releases 
free inositol (see Michell, 2008) (see Fig. 1.1).  
 
The inositides constitute a diverse family of membrane and soluble cell components: 
phosphatidylinositol (PtdIns), phosphorylated derivatives of PtdIns known as the 
polyphosphoinositides (PPIns) and a variety of soluble inositol polyphosphates (IPs). 
Both of the latter groups are interesting as they play roles in the regulation of diverse 
cellular events. They have been intensively investigated over the past six decades and 
particularly since the early 1980s (Downes et al., 1982; Creva et al., 1983; Streb et al., 
1983; Berridge, 1983). The common structural unit of all PPIn is phosphatidyl-1-D-
myo-inositol (PtdIns) which is synthesized by the route depicted in Fig. 1.1.   
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Figure 1.1: Route of synthesis of phosphatidylinositol 
DAG, diacylglycerol; ATP, adenosine triphosphate; ADP, adenosine diphosphate; PtdA, phosphatidic 
acid or phosphatidate; CTP, cytidine triphosphate; CDP, cytidine diphosphate; CMP, cytidine 
monophosphate; PtdIns, phosphatidylinositol 
 
The history of research on PPIns is complex and first involved pioneering work by a 
number of chemists in the US. Studies on PPIn can be traced back to 1942 when Jordi 
Folch-Pi isolated “inositol phosphatide” as a natural component of bovine brain 
phospholipids in Boston (Folch-Pi and Woolley, 1942; Folch-Pi, 1942; Strahl and 
Thorner, 2007). More than ten years later, Mabel and Lowell Hokin observed that the 
32P labelling of ‘RNA’ rapidly increased in some tissue preparations in response to 
external stimuli of carbamylcholine or acetylcholine (with eserine), but then showed – 
using new lipid analysis techniques developed by Rex Dawson – that the extra 32P 
was incorporated into PtdIns and phosphatidate rather than RNA (Hokin and Hokin, 
1953; Dawson, 1954; Hokin and Hokin, 1955). This phenomenon then became known 
as ‘the Hokin effect’.  
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Agranoff and Kennedy independently defined the route of PtdIns biosynthesis in the 
late 1950s (see Agranoff, 2009). Unfortunately, none of these early US-based research 
groups continued to investigate ‘the Hokin effect’. Instead, it captured the imagination 
of two groups of researchers in the UK: one at the University of Birmingham, led by 
Tim Hawthorne and later by Bob Michell and the other at The Babraham Institute, 
headed by Rex Dawson and then Robin Irvine.  
 
The field then moved slowly for a number of years, as researchers investigated the 
idea that hydrolysis of PtdIns by a phosphoinositide-specific phospholipase C (PLC), 
was the metabolic event that underlay the Hokin effect. The groups remained divided 
as to the function of this hydrolysis but a PLC activity had been detected by several 
groups. It was partially purified and characterized as a “PtdIns-specific PLC” by 
Dawson and his colleagues in 1959, and by Hawthorne’s lab in 1961 and 1968 
(Dawson, 1959; Kemp et al., 1961; Atherton and Hawthorne, 1968). 
 
A crucial shift in thinking occurred during the 1970s, when Bob Michell and his 
colleagues published a body of evidence suggesting a direct link between cell surface 
receptor signalling and phospholipase C-catalyzed PtdIns hydrolysis. Michell 
proposed in his seminal review of 1975 (Michell, 1975) that PtdIns hydrolysis by 
PLC might be a step in receptor-controlled Ca2+ mobilization. At about the same time, 
in Babraham, Rex Dawson and Robin Irvine were using methods pioneered by 
Clinton Ballou’s laboratory (Tomlinson and Ballou, 1961) to produce high quality 
preparations of PtdIns4P and PtdIns(4,5)P2: two minor lipids that were initially 
thought to occur only in brain and other nervous tissues.  
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Judith Creba and Peter Downes in Michell’s lab then provided another important 
observation: that receptor-activated PLCs might act on PtdIns(4,5)P2 and PtdIns4P 
rather than PtdIns (Creba et al., 1983). Peter Downes also identified an enzyme that 
could 5-dephosphorylate IP3, the product of PtdIns(4,5)P2 cleavage (Downes et al., 
1982). 
 
Michell’s ideas that PPIn hydrolysis might be linked to Ca2+-signalling and that 
PtdIns(4,5)P2 could be the true physiological substrate of PLCs, stimulated a three-
way collaboration between the laboratories of Robin Irvine, Mike Berridge and Irene 
Shultz. They realized that if Michell was right, then IP3 might be an intracellular 
second messenger. Using IP3 made from Irvine’s high quality PtdIns(4,5)P2 and the 
Shultz lab’s rat pancreatic acinar cell preparation, they provided the first direct 
evidence that IP3 is indeed a Ca2+-mobilizing agent (Streb et al., 1983).  
 
It had taken 30 years from the discovery of the ‘the Hokin effect’ to the elucidation of 
its function: the stimulated release of internal Ca2+. It is now established that IP3 binds 
to a family of intracellular calcium channels, known as ‘IP3 receptors’, and that this 
interaction promotes the release of Ca2+ from intracellular stores, thus triggering Ca2+-
dependent responses such as secretion and smooth muscle contraction (Strahl and 
Thorner, 2007). The other product of PtdIns(4,5)P2 breakdown, DAG, was also found 
to have signalling functions. Yasutomi Nishizuka’s laboratory had already shown that 
it was a potent activator of a novel protein kinase (Takai et al., 1979), and it is now 
generally accepted that DAG can activate certain isoforms of protein kinase C (PKC), 
ultimately leading to changes in gene expression (Nishizuka, 1984) (Fig. 1.2). 
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Figure 1.2: The updated version of the classical “Hokin effect” (from Balla, 2006) 
Plasma membrane PtdIns(4,5)P2 is hydrolyzed by PLC enzymes upon receptor stimulation to generate 
two second messengers: IP3 and DAG. IP3 can mobilize intracellular Ca2+ from intracellular stores 
whereas DAG activates PKC enzymes 
 
Research on the ‘Hokin effect’ dominated work on the inositol lipids from the 1960s 
until the 1980s. Much of the focus has since shifted, following the discovery of the 
novel inositol lipids PtdIns3P and PtdIns(3,4,5)P3 in 1988 (Whitman et al., 1988; 
Traynor-Kaplan et al., 1988), and of PtdIns5P and PtdIns(3,5)P2 in 1997 (Rameh et 
al., 1997; Dove et al., 1997). Early experiments established that none of the lipids that 
include a 3-phosphate are substrates for PLCs, so it became clear that any regulatory 
actions of these lipids would have to involve hitherto unknown mechanisms. 
 
1.2 PPIns: synthesis, degradation and interconversion 
PPIns, the phosphorylated derivatives of phosphatidylinositol, include seven distinct 
species that are distinguished by the presence of phosphate groups on various 
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permutations of the D3-, 4- and 5-hydroxy positions on the myo-inositol headgroup 
(Fig. 1.3). 
 
 
 
Figure 1.3: The eight ‘simple’ glycerophosphoinositol lipids of eukaryotic cells 
The fatty acid profiles of S. cerevisiae are usually dominated by 1-palmitoleoyl, 2-oleoyl lipids 
 
PPIns reside at the cytoplasmic faces of cellular and/or organellar membranes and 
exert their effects on cell physiology by regulating a suite of downstream effector 
proteins that gain or lose a function when complexed with their particular lipid(s). 
Hence, by binding to or recruiting their effectors, PPIns play key regulatory roles in a 
diverse range of cellular events. For example, PtdIns(3,4,5)P3 plays important roles in 
regulating growth, proliferation, differentiation, survival, cancer progression and 
responses to extracellular environmental changes (Simonsen et al., 2001; 
Vanhaesebroeck et al., 2001; Katso et al., 2001; Wishart and Dixon, 2002; Deane and 
Fruman, 2004). Other PPIns have specific biological functions in, for example, 
cytoskeletal organization, cytokinesis, membrane trafficking, endoplasmic reticulum 
ATP transport, and sub-cellular compartmentalization (Dove et al., 1997; Maehama et  
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al., 2000; Dove et al., 2002; Yin and Janmey, 2003; Roth, 2004; Raftopoulou et al., 
2004; Di Paolo and De Camilli, 2006; Coronas et al., 2007). 
 
PPIns are interconverted by the action of a suite of exquisitely controlled lipid kinases 
and lipid phosphatases (Fig. 1.4). Usually, each of these enzymes will only 
phosphorylate or dephosphorylate a PPIn at a particular hydroxyl or 
phosphomonoester at the D-3-, 4-, or 5-position of the inositol ring. As alluded to 
earlier, PLC can only hydrolyze PPIns that lack a D3 phosphate. Given the 
importance of the various PPIns to multiple aspects of cell regulation, it was to be 
expected that these lipid kinases and phosphatases would be controlled by upstream 
regulators, with the activity state of some of these linked to cell surface receptors.  
 
The control of levels of PPIns in a cell is critical for regulation of their physiological 
functions. For instance, the levels of PtdIns(3,4,5)P3 regulate cell survival in 
mammalian cells via activation of PKB/Akt (Hawkins et al., 2006). If too much 
PtdIns(3,4,5)P3 is persistently present in a cell, it will not respond to pro-apoptotic 
stimuli such as Fas ligand. This can contribute to inappropriate cell survival, e.g. in 
cancer (Stephens et al., 2005; Engelman et al., 2006).  
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Figure 1.4: The network of interconversion between PPIn (from Balla, 2006) 
PPIns are phosphorylated (red arrows) by PPIn kinases and are dephosphorylated (blue arrows) by 
PPIn phosphatases. Most (but not all) of the kinases are quite specific whereas the substrate specificity 
of most (but not all) phosphatases is less stringent in vitro 
 
1.3 PPIns in budding yeast  
The budding yeast Saccharomyces cerevisiae possesses the essential elements of most 
inositol lipid signalling pathways which, with the exception of the PtdIns(3,4,5)P3 
pathway, appear to be conserved throughout eukaryotic phylogeny (Michell, 2008). 
The functions of these lipids can therefore be more readily elucidated by a 
combination of biochemistry, genetics and cell biology in yeast. Four PPIns 
(PtdIns3P, PtdIns4P, PtdIns(3,5)P2 and PtdIns(4,5)P2) have been identified and 
investigated in S. cerevisiae, showing that they are involved in regulating numerous 
processes, including membrane trafficking, cytoskeletal rearrangements and responses 
  8 
                                                                                                                                    Introduction 
to extra-cellular environmental changes (see review of Strahl and Thorner, 2007).  
 
All PPIn kinases that have been identified in yeast exhibit specificity for a single 
substrate (Fig. 1.5A). Three different enzymes, namely Lsb6p, Pik1p and Stt4p, can 
catalyse the phosphorylation of PtdIns to PtdIns4P, and each of the other reactions is 
catalysed by one kinase (see Section 1.4). In contrast to the PPIn kinases, the PPIn 
phosphatases of S. cerevisiae show a high degree of redundancy, as several of them 
can dephosphorylate a number of substrates with relatively little specificity (Fig. 1.5B 
and Section 1.5). Fig4p, Inp51p/Sjl1p and Inp54p are highly selective for a single 
substrate, whereas Inp52p/Sjl2p and Inp53p/Sjl3p can convert most yeast PPIns to 
PtdIns. 
 
 
 
Figure 1.5: Interconversion of PPIns  in yeast (from Strahl and Thorner, 2007) 
A: PPIn kinase reactions in S. cerevisiae; B: PPIn phosphatase reactions S. cerevisiae 
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1.4 PPIn kinases (PIKs) 
Most PPIn kinases are conserved throughout evolution, so understanding the 
properties of PPIn kinases in unicellular model organisms such as yeast can inform 
investigations in more complex mammalian cells, and vice-versa. I will focus 
primarily on yeast, digressing to compare the situation in higher organisms (Fig. 1.6).  
 
Vps34p 
Lsb6p 
 
 
Figure 1.6: The schematic domain structures of six PPIn kinases in S. cerevisiae 
(adapted from Strahl and Thorner, 2007) 
C2, C2 domain; LKU, lipid kinase unique domain; PH, pleckstrin homology domain; NHD, novel 
homology domain; FYVE, Fab1, YGL023, Vps27, and EEA1; CCT, chaperonin containing T-complex 
homology region 
 
 
Stt4p 
Pik1p 
type I/III kinase domain C2  
PH 
LKU  
Mss4p 
0 
Fab1p 
200 (amino acids) 
Vps15p interaction site type II kinase domain 
PIPK kinase domain Frqlp interaction site NHD 
FYVE CCT Cys-rich domain 
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Inositol lipid kinases comprise three basic families: the Type I/III “PtdIns-kinases”, 
the type II “PtdIns-kinases” that share no sequence homology with the Type I/III 
enzymes and the PtdInsP kinases. The PPIn kinases were originally classified into 
three classes: I, II and III (Fruman et al., 1998) based upon the properties of impure 
enzymes: for example, such as KM for ATP, sensitivity to inhibitors (e.g. adenosine), 
activation by detergents (e.g. Triton X-100), inhibition by wortmannin and inhibition 
by a monoclonal antibody to the Type II “PtdIns-kinases”. Later it was found that 
these properties did separate these enzymes into meaningful groups. For example, the 
Type I and Type III ‘PtdIns-kinases’ share significant sequence homology, domain 
structure, and modes of regulation, and Type II ‘PtdIns-kinases’ have a disparate 
amino-acid sequence. Most of the inositol lipid kinases are specific, phosphorylating 
only one substrate lipid at one position of the inositol ring (Balla, 2006). In this 
context, they have alternatively – and more appropriately – been classified according 
to the reactions they catalyse: PtdIns 3-kinases (PI3Ks), PtdIns 4-kinases (PI4Ks) and 
three types of PtdInsP kinases (PIPKs) (Strahl and Thorner, 2007). I will mainly use 
this classification system.  
 
1.4.1 PtdIns 3-kinases (PI3Ks)  
Originally known as “Type I PtdIns-kinases”, these kinases are all specific for the D3 
position of the inositol ring. They have been reclassified based on their domain 
structures and their different substrate selectivities (Domin and Waterfield, 1997; 
Vanhaesebroeck et al., 2001).  
 
1.4.1.1 Class I PI3Ks (PI3KC1) 
Class I PI3Ks are heterodimers comprising of a ~110-kilodalton catalytic subunit 
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(p110) and an adaptor/regulatory subunit. PI3KC1s can phosphorylate PtdIns, 
PtdIns4P and PtdIns(4,5)P2 in vitro, but PtdIns(4,5)P2 is their preferred substrate in 
vivo. In cells they synthesise PtdIns(3,4,5)P3, the most heavily phosphorylated PPIn 
(Fruman, et al., 1998). PI3KC1s can further subdivided into class IA and class IB 
enzymes, which signal downstream of tyrosine kinases and heterotrimeric G protein-
coupled receptors (GPCRs), respectively (Vanhaesebroeck et al., 2001). A major 
signalling pathway downstream of PI3KC1s is through the sequential protein kinases 
PDK1 and Akt/PKB (Franke et al., 1997; Alessi et al., 1997). These two kinases 
regulate a wide variety of cellular events including glucose metabolism, protein 
synthesis and cell division, and also a major anti-apoptotic pathway in animal cells 
(Balla, 2006).  
 
The class IA PI3Ks are composed of a catalytic p110 subunit and a regulatory subunit. 
In mammalian cells, three Class IA p110 isoforms (p110α, β and δ) and at least seven 
regulatory subunits have been identified (Vanhaesebroeck et al., 1997). Class IA 
PI3Ks are mainly cytosolic but can be recruited to the membrane by their regulatory 
subunit binding to phosphorylated tyrosine residues that are generated by activated 
tyrosine kinase receptors. The class IB PI3K includes a p110γ catalytic subunit and a 
p101 regulatory subunit. The p110γ/p101 heterodimers are activated, downstream of 
activated G-protein-coupled receptors, by βγ-complexes released from heterotrimeric 
G proteins. No PI3KC1s have been found in yeast or plants, consistent with the lack 
of PtdIns(3,4,5)P3 detected in either group of organisms. This is likely to be because 
of the loss of these machineries from plants and yeast somewhere during the course of 
evolution since slime moulds still have PI3KC1s despite being thought to be 
evolutionary more distant from animals than fungi. This assertion is strengthened by 
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the finding that both plants and fungi have PTEN homologues (Mitra et al., 2004). 
 
1.4.1.2 Class II PI3Ks (PI3KC2) 
Class II PI3Ks are larger than PI3KC1s, at ~170 kilodaltons.  A C-terminal C2 domain 
is a defining feature, through which they interact with their lipid substrates in vitro in 
a Ca2+-independent manner. Deletion of the C2 domain does not compromise their 
predominant membrane localisation (Arcaro et al., 1998), which suggests that there 
must be other mechanism(s) targeting class II PI3Ks to membranes. The Class II 
PI3K-C2α isoform has been found in clathrin-coated pits at the plasma membrane and 
on the Golgi (Domin et al., 2000), so it may play a role in membrane traffic (Gaidarov 
et al., 2001). No class II PI3Ks are found in yeast or plants.  
 
Like Class I PI3Ks, Class II PI3Ks can phosphorylate PtdIns, PtdIns4P or 
PtdIns(4,5)P2) in vitro, with the order of preference PtdIns>PtdIns4P>PtdIns(4,5)P2, 
but their substrate specificity in vivo remains uncertain. In vitro, the class II PI3K-C2α 
isoform showed an elevated lipid kinase activity towards phosphorylated PPIns upon 
binding clathrin (Gaidarov et al., 2001), suggesting that the substrate preferences of 
class II PI3Ks in vivo may be modulated by its binding partners.   
 
1.4.1.3 Class III PI3Ks (PI3KC3) and Vps34p 
Class III PI3Ks, typified by the yeast protein Vps34p, are responsible for most 
PtdIns3P synthesis in cells. Both in vitro and in vivo, Class III PI3Ks only 
phosphorylate PtdIns to PtdIns3P, so they should be more properly called 
“PtdIns3Ks”. The activity of the catalytic subunit of PI3KC3 is regulated by a Ser/Thr 
protein kinase: Vps15p in yeast and p150 in mammals. Vps15p and p150 are post-
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translationally modified to contain an N-terminal myristoyl moiety that helps to tether 
the Vps34p/Vps15p complex to membranes. All eukaryotes seem to possess Vps34p 
and Vps15p homologues. Since the cellular PtdIns3P levels change little during 
extracellular stimulation, it seems that PI3KC3 enzymes play little or no role in signal 
transduction. Instead, they have more constitutive cellular functions in a number of 
membrane trafficking pathways which are nicely exemplified by considering their 
roles in yeast.        
 
Vps34p was first identified as a protein required for the sorting of vacuolar enzymes 
from the Golgi to the vacuole in S. cerevisiae (Herman and Emr, 1990) and was then 
shown to be the sole PI3K responsible for PtdIns3P synthesis in budding yeast (Hiles 
et al., 1992; Schu et al., 1993). Vps34p is cytosolic but can be recruited to endosomal 
membranes by activated membrane-bound Vps15p (Stack et al., 1993). Mutating the 
kinase domain of vps15 resulted in a substantial decrease of PtdIns3P level and 
vacuolar protein sorting defects that phenocopy those of a vps34 mutant (Stack et al., 
1993), indicating that this interaction requires the kinase activity of Vps15p.  
 
A vps34ts mutant also displays very acute and pronounced defects in protein sorting to 
the vacuole when grown at the restrictive temperature (Stack et al., 1995). In parallel, 
Vps34pts loses lipid kinase activity when incubated at 37ºC and levels of PtdIns3P in 
the cell plummet upon temperature upshift, suggesting that Vps34p and/or PtdIns3P 
have a direct role in vesicular transport from the Golgi to the vacuole. The key to the 
role of Vps34p in TGN-to-Golgi trafficking is almost certainly that proteins of the 
Sortin Nexin (SNX) family (see Section 1.6.1) require PtdIns3P for membrane 
localisation. The SNXs Vps5p and Vps17p are required for recycling of Vps10p, a 
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protein needed for the transport of soluble vacuolar cargoes from the TGN to the 
vacuole. In the absence of active Vps34p, vacuolar proteins are secreted instead of 
being correctly targeted (Horazdovsky et al., 1997; Burda et al., 2002). 
 
In budding yeast, the Vps34p/Vps15p heterodimer can form at least two distinct 
multi-subunit complexes that modulate different pathways (Kihara et al., 2001). Both 
complexes share three proteins, Vps34p, Vps15p and Vps30p, but are distinguished 
by their fourth component, with Atg14p specific for Complex I and Vps38p 
diagnostic for Complex II (see Fig. 1.7). The N-terminal myristoyl moiety of Vps15p 
is necessary to direct Complex I to the pre-autophagosomal structure (PAS) and 
Complex II to the prevacuolar endosomal compartment (PVC). Atg14p is required for 
Complex I to interact with the PAS, but Vps38p is dispensable for the residency of 
Complex II on the PVC. Complex I regulates autophagy, a mechanism for degradation 
and subsequent recycling of a cell’s own components/organelles that allows starving 
cells to weather periods of nutrient limitation. In unstarved cells, there is a related 
process termed the Cvt pathway (Cytoplasm-to-vacuole targeting) that functions 
constitutively even under nutrient-rich conditions and delivers a vacuolar protease 
(API) to the vacuole, in which Complex I also participates. The more abundant 
complex II regulates the classical CPY sorting pathway (Vps pathway) described 
earlier in which PtdIns3P mediates recycling of Vps10p.    
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igure 1.7: Two Vps34-containing PtdIns 3-kinase complexes regulating two 
istinct pathways (from Strahl and Thorner, 2007)  
he yeast Vps34p forms two different multi-subunit complexes: Complex I and Complex II, which 
nction in distinct biological processes: the autophagy/cytoplasm-to-vacuole transport (Cvt) and 
vacuolar protein sorting (Vps) pathways respectively 
 
.4.2 PtdIns 4-kinases (PI4Ks) 
I4Ks synthesise cellular PtdIns4P by phosphorylating the D-4 position of the inositol 
ing. The Type II and Type III PIKs discussed earlier are both PtdIns 4-kinases.  
Lsb6p is the yeast ortholog of Type II PI4Ks, and the two yeast PI4Ks (Stt4p and 
ologous to mammalian Types IIIα and IIIβ, respectively.  
 kinase family (See Fig. 1.6 for Lsb6p). 
Lsb6p, the yeast PI4KII, is not essential for normal vegetative growth.  
 
F
d
T
fu
1
P
r
Pik1p) are hom
 
1.4.2.1 Type II PI4Ks (PI4KIIs) and Lsb6p 
The catalytic kinase domains of PI4KIIs exhibit very little sequence homology to 
PI4KIIIs or PI3Ks, and form a separate lipid
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In mammals, PI4KIIs exist as two isoforms: PI4KIIα and PI4KIIβ (Barylko et al., 
KIIα is mainly found on Golgi membranes where it 
r fraction of 
east PtdIns4P (< ~10%) (Audhya et al., 2000). Like its mammalian PI4KIIs 
embrane protein as a result of its C-
2001; Minogue et al., 2001). PI4
plays a role in membrane trafficking out of the Golgi (Wang et al., 2003). PI4KIIβ is a 
cytosolic protein that is recruited to the plasma membrane and activated by Rac1 upon 
growth factor stimulation (Wei et al., 2002). In mammals, PI4KIIs account for the 
majority of cellular PtdIns4P synthesis, but Lsb6p only produces a mino
y
homologue, Lsb6p behaves like an integral m
terminal S-palmitoylation (Han et al., 2002). This post-translational modification sets 
Lsb6p apart from the other yeast PIKs, which usually require accessory proteins for 
their membrane loading (Strahl and Thorner, 2007).  
 
In addition to its PM localisation, Lsb6p is the only yeast PI4K found on the vacuole. 
If it is assumed that Lsb6p supplies the PtdIns4P substrate for the PtdIns4P 5-kinase 
Mss4p in the vacuole, it might partially account for the PtdIns(4,5)P2 requirement for 
homotypic vacuole fusion (Mayer, et al., 2000),  
 
Lsb6p had been identified earlier in a two-hybrid screen as a binding partner of 
Las17p (Lsb6p is named Las17-binding). Las17p is the yeast ortholog of the human 
Wiskott-Aldrich Syndrome Protein (WASP), a promoter of actin filament 
polymerization (Madania et al., 1999). Lsb6p also has a kinase activity-independent 
function in endosome motility that involves its interaction with Las17p. The average 
eed of endosome movement was dramatically impeded in lsb6∆ cells, but was sp
normal in lsb6∆ expressing a catalytically-inactive form of Lsb6p (Chang et al., 
2005).  
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1.4.2.2 Type III PI4Ks (PI4KIIIs) 
PI4KIIIs are larger than PI4KIIs, and their catalytic domains show sequence 
omology with PI3Ks.  Mammals and yeast both express two PI4KIIIs: PI4KIIIα and 
 PI4KIIIα and Stt4p 
 to yeast Stt4p, was chiefly detected on the 
h
PI4KIIIβ in mammals, and Stt4p and Pik1p in yeast (Gehrmann and Heilmeyer, 
1998). In yeast, both enzymes are essential, suggesting distinct physiological roles. 
Stt4p principally functions at the plasma membrane to support regulation of the actin 
cytoskeleton and to maintain the integrity of the cell wall, whereas Pik1p has a major 
role in Golgi membrane trafficking, and the mammalian homologues fulfil generally 
similar functions.   
 
1.4.2.2.1
Mammalian PI4KIIIα, homologous
Endoplasmic reticulum (ER) but also contributes to the control of a PtdIns4P pool at 
the plasma membrane (Wong et al., 1997). This apparent paradox has been partially 
resolved by assuming that the PI4KIIIα-dependent generation of PtdIns4P may occur 
at ER-PM contact sites where there is close apposition between the ER and the PM 
(D’Angelo et al., 2008). 
 
Genetically, Stt4p (Staurosporine- and temperature-sensitive-4) was first recognized 
when stt4 mutants that were resistant to the protein-kinase inhibitor staurosporine 
ere isolated (Yoshida et al., 1994a). Stt4p, localised on the plasma membrane, 
urther converted to PtdIns(4,5)P2 by Mss4p, the sole 
w
produces the PtdIns4P that is f
yeast PtdIns4P 5-kinase (see Section 1.4.3.1). Their combined activity is necessary 
for activation of the Pkc1p-mediated MAP kinase cascade, a major cell wall integrity 
pathway (Audhya and Emr, 2002): both stt4 and mss4 mutants show synthetic defects 
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when combined with other mutants that impair the Pkc1p pathway. In addition, most 
PtdIns(4,5)P2 generation on the PM requires Stt4p rather than Pik1p (Levine and 
Munro, 2002; Perera et al., 2004).  
 
It appears that the isolated PH-like domain of Stt4p alone is not sufficient for plasma 
membrane targeting (Levine and Munro, 1998), and another protein Sfk1p 
(Suppressor of four kinase), a multicopy suppressor of the stt4-4ts allele, seems to be 
required for Stt4p to associate with the PM membrane (Audhya and Emr, 2002). In 
addition to its function, with Mss4p, in producing PtdIns(4,5)P2, some studies suggest 
that Stt4p-synthesised PtdIns4P may have independent roles in, for example, the 
intracellular aminophospholipid transport needed for phosphatidylethanolamine 
synthesis (Trotter et al., 1998), regulation of the actin cytoskeleton (Audhya et al., 
2000) and the polarized growth of budding cells (Wild et al., 2004). 
 
1.4.2.2.2 PI4KIIIβ and Pik1p 
ik1p was first characterized biochemically in yeast cell extracts, and the 
Mammalian PI4KIIIβ is a ~110KDa protein and its yeast homologue is designated 
Pik1p. It largely resides on the Golgi complex but some can be found in the nucleus 
(Wong et al., 1997; De Graaf et al., 2002). Maximal kinase activity of PI4KIIIβ 
requires two upstream activators, the GTP-bound form of Arf1p on the Golgi 
membrane (Godi et al., 1999), and neuronal calcium sensor-1 (NCS-1). Consistent 
with its location, the main roles of PI4KIIIβ are to support the TGN-to-PM transport 
of newly synthesized protein and to maintain the structural architecture of the Golgi 
complex (Godi et al., 1999; D’Angelo et al., 2008).  
 
P
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corresponding gene was cloned from a genomic library by using oligonucleotides 
 Arf1p, with the loss of Arf1p 
ading to a striking decrease of PtdIns4P levels (Audhya et al., 2000). 
phatase Sac1p 
ould reverse the growth and exocytosis defects in a sec14-3ts mutant. Both rescue 
deduced from the amino-acid sequence of the purified enzyme (Flanagan and Thorner, 
1992; Flanagan et al., 1993). Pik1p is an essential 125-KDa enzyme and behaves as a 
soluble protein. It is targeted to the TGN by binding to Frq1p, an essential 22-KDa 
EF-hand-type Ca2+-binding protein with a N-terminal myristoyl modification that is 
homologous to mammalian NCS-1 (Hendricks et al., 1999; Weisz et al., 2000). Both 
Ca2+-binding and N-terminal myristoylation are indispensable for the membrane 
association of Frq1p and for the targeting of Pik1p to the Golgi complex. Pik1p also 
displays genetic interactions with the small GTPase
le
 
In Golgi, the main function of Pik1p, through its product PtdIns4P, is to regulate the 
transit of secretory proteins from the Golgi to plasma membrane via the exocyst 
complex. This observation was first suggested by a study in the sec14-3ts mutant, 
which manifested a substantially reduced PtdIns4P level and a severe defect in protein 
secretion at the non-permissive temperature (Hama et al., 1999). Sec14p has PtdIns-
Transfer Protein (PITP) activity, is localised to the Golgi and seems to be responsible 
for PtdIns transport from ER to the Golgi complex (Bankaitis et al., 1990), where it 
can be phosphorylated to PtdIns4P by Pik1p. The link between PtdIns4P and the 
secretory pathway was further strengthened when it was found that over-expression of 
Pik1p – but not of Stt4p or Vps34p – or functional loss of the PPIn phos
c
methods partially restored cellular PtdIns4P levels.  
 
Pik1p has also been found in the nucleus (Garcia-Bustos et al., 1994) and undergoes 
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nucleocytoplasmic shuttling (Strahl et al., 2005). Although the nuclear function of 
Pik1p remains elusive, there are some hints that it may be involved in cytokinesis and 
in the production of nuclear PPIn and IPs (Walch-Solimena and Novick, 1999; Sciorra 
et al., 2005).  
 
Yeast requires active Pik1p to be present both at the Golgi and in the nucleus for 
viability. This was shown by the use of two catalytic active Pik1p variants, Pik1p-
CCAAX (which is restricted to the Golgi) and Pik1p∆10~192 (which is confined within 
the nucleus). Neither restored viability to pik1∆ cells, but co-expression of both did 
trahl et al., 2005).        
nenkov and Anderson, 1995). However, it was later realized that Type 
 PIPKs phosphorylate the D-4 position of the inositol headgroup, and so convert 
lassified as prototypic members of the type III PIPK family, 
sponsible for conversion of PtdIns3P to PtdIns(3,5)P2 in vivo. In summary, 
f mammalian PIPKs: Type I are PtdIns4P 5-kinases, 
(S
 
1.4.3 PtdInsP kinases (PIPKs) 
PIPKs, initially purified as PtdIns4P 5-kinases, were classified as Type I and Type II 
based on sequence relationships and sensitivities to phosphatidic acid (PA) (Moritz et 
al., 1992; Boro
II
PtdIns5P to PtdIns(4,5)P2 in vivo – and also PtdIns3P to PtdIns(3,4)P2 in vitro 
(Rameh et al., 1997; Lecompte et al., 2008) – so they should be named PIP4Ks. And 
then the putative yeast PIPK Fab1p was identified as a PtdIns3P 5-kinase (Cooke et 
al., 1998; Gary et al., 1998), followed by its mammalian orthologue, PIKfyve (Sbrissa 
et al., 1999).  Both were c
re
therefore, there are three types o
with the yeast homologue Mss4p; Type II are PtdIns5P/PtdIns3P 4-kinases, with no 
known yeast or plant examples; and Type III are PtdIns3P 5-kinases.   
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1.4.3.1 Type I PIP5K and Mss4p 
The three mammalian isoforms of Type I PIP5K (α, β and γ) are encoded by the same 
gene as a result of alternative splicing (Ishihara et al., 1998). The PIP5Ks are found at 
the PM and in the nucleus (Fruman et al., 1998), and their kinase activity can increase 
~10 fold upon stimulation with phosphatidic acid (Ishihara et al., 1998). Small G 
proteins of the Arf family are also activators of PIP5Ks and so influence the actin 
cytoskeleton at the PM (Roth, 2004). All mammalian PIP5Ks are stimulated by PtdIns 
to undergo auto-phosphorylation in vitro, and this auto-phosphorylation suppresses 
their PIP5K kinase activity (Itoh et al., 2000). 
 
In budding yeast, active Mss4p is essential for viability. It was first defined as a 
multicopy suppressor of the temperature-sensitive growth of the stt4-1ts mutant 
s): newly synthesized Mss4p does not 
ther to the PM in cells lacking functional CK1 (Robinson et al., 1993). A minor 
(MSS4) (Yoshida et al., 1994b), consistent with one of its main functions being to 
produce PtdIns(4,5)P2 from the PtdIns4P synthesized by Stt4p. PtdIns(4,5)P2 is very 
important for numerous cellular functions, including endocytosis, cytoskeletal re-
organization, polarized cell growth, secretory vesicle fusion with the PM and 
sphingolipid turnover (see review of Strahl and Thorner, 2007). All of these functions 
of Mss4p require its association with the PM. This is partially regulated by the 
phosphorylation of Mss4p by casein kinase I (CK1) (a plasma membrane-bound 
activity encoded by the YCK1 and YCK2 gene
te
fraction of Mss4p was also found in the nucleus (Audhya and Emr, 2003). Given the 
simultaneous presence of Pik1p in the nucleus, it is reasonable to assume that Pik1p 
and Mss4p are responsible for the supply of a pool of PtdIns(4,5)P2 in the nucleus. In 
this respect, it is interesting that Plc1p, the only phospholipase C in budding yeast, 
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also undergoes nucleo-cytoplasmic shuttling (Huynh, 1998). Plc1p can hydrolyse 
PtdIns(4,5)P2 to produce IP3 and thence a variety of inositol polyphosphates, and 
these are becoming a focus of interest because of their regulatory roles in various 
nuclear activities (York, 2006). One of the main functions of Pik1p/Mss4p-generated 
PtdIns(4,5)P2 in the nucleus may therefore be to provide the substrate of Plc1p.    
 
1.4.3.2 Type III PIP5Ks and Fab1p 
Mammalian cells express a single Type III PIP5K, PIKfyve, which synthesises 
PtdIns(3,5)P2 from PtdIns3P in vivo. It can also convert PtdIns to PtdIns5P in vitro 
(Sbrissa et al., 2000). PIKfyve is localised on the endosome by interacting with its 
PtdIns3P substrate via its FYVE domain, a diagnostic domain for the type III PIP5K 
(Sbrissa et al., 2002). PIKfyve has intrinsic protein kinase activity but the 
physiological function of this remains unknown (Sbrissa et al., 2000). The 
characterized functions of PIKfyve so far are related to the lysosome and late 
endosome: the orthologs of the yeast vacuole. Fab1p, the yeast PtdIns3P 5-kinase, 
was a major focus at the beginning of the current project, and it will be introduced in 
ore detail later (see Section 1.9). 
 
Inositol lipid phosphatases have been less well characterized than lipid kinases. 
However, several human genetic diseases have been traced to mutations in PPIn 
phosphatase genes (Wishart and Dixon, 2002; Pendaries et al., 2003; Decker and 
Saltiel, 2005; Sleeman et al., 2005; Hughes et al., 2000a; Srivastava et al., 2005), and 
the extra attention this has brought has accelerated progress in their identification and 
characterization (see Fig. 1.8). In addition, the virulence factors injected into cells by 
m
1.5 PPIn phosphatases 
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some bacterial pathogens are sometimes inositol lipid phosphatases. The PPIn 
phosphatases can be divided into four families based on their catalytic site sequence 
homologies and substrate specificities: Type II 5-phosphatases, 3-phosphatases, 4-
phosphatases and Sac domain phosphatases. 
 
 
Figure 1.8: PPIns metabolism and its implication in human diseases (from 
PTEN, phosphatase and tensin homologue deleted on
Pendaries et al., 2003) 
 chromosome ten; MTMR, myotubularin related 
protein; SHIP, Src homology 2-containing inositol-5-phosphatase; OCRL, phosphatase implicated in 
the oculocerebrorenal syndrome of Lowe; IpgD, entry-mediating invasion of S. flexneri 
 
1.5.1 Type II PPIn 5-phosphatases 
Type II 5-phosphatases share a highly conserved catalytic domain with type I 
phosphatases (type I only hydrolyze the water-soluble substrates IP3 and IP4), but 
contain an additional “Type II domain” located N-terminal to the catalytic domain 
(Majerus et al., 1999). The large Type II 5-phosphatase family can be further divided 
into five subgroups based on their domain organisation (Fig. 1.9).  
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SKIP 
GIP 
SCIP 
SHIP 
 
 
igure 1.9: Modular structure of the Type II 5-phosphatase subtypes (adapted from 
Van k et al., 2001) 
 
The si  are enzymes of the SKIP family (S
PIP 
Cx R catalytic signature 5
type II domain type II catalytic signature 
proline-rich domain 
GAP domain 
SH2 domain  SAC domain 
F
haesebroec
mplest keletal Muscle and kidney-Enriched 
inositol 5-phosphatase). These largely comprise the canonical catalytic domain and 
Type II domain and are abundantly expressed in skeletal muscle and kidney. 
PtdIns(4,5)P2 appears to be their preferred substrate (Ijuin et al., 2000).  
 
The second subgroup, the GIPs (GAP domain-Containing inositol 5-phosphatase), 
possess a C-terminal partial GAP (GTPase-activating protein) domain: these are 
OCRL and 5-phosphatase II. They can dephosphorylate PtdIns(4,5)P2 or 
PtdIns(3,4,5)P3, and the corresponding inositol polyphosphates (Jefferson and 
 et al., 1995; Suchy et al., 1995). 
he SCIPs (S
Majerus, 1995; Jackson
 
T AC domain-containing inositol 5-phosphatases) have an additional 
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catalytic SAC domain which confers dual 3-phosphatase and 4-phosphatase activities 
upon them (Guo et al., 1999). In principle, therefore, SCIPs could hydrolyze most 
PPIns all the way to PtdIns (Hughes et al., 2000b; Cremona et al., 1999). There are 
three putative S. cerevisiae SCIPs (Inp51p, Inp52p, Inp53p) and at least two 
ammalian enzymes: Synaptojanin I (Synapto I) and Synaptojanin II (Synapto II) 
nzymes have important roles 
 regulated exocytosis (Bauerfeind et al., 1997; Ramjaun et al., 1999; Nemoto and 
ular structure of SCIP family PPIn phosphatases (adapted from 
ughes et al., 2000a) 
 
m
(Hughes et al., 2000a) (Fig. 1.10). Except for Inp51p because its SAC domain is 
inactive due to mutations in the putative catalytic motif (Guo et al., 1999), the other 
four enzymes can all hydrolyze PtdIns(4,5)P2 to PtdIns. Synapto I is located in nerve 
terminals and associated with membranes coated with clathrin, and Synapto II seems 
to be present in all tissues. Both of these 5-phosphatase e
in
De Camilli, 1999) 
 
 
 
Figure 1.10:  Mod
Inp51p 
Inp53p 
Synapto I 
Inp52p 
5-phosphatase domain SAC domain proline-rich type II domain  
Synapto II 
0 100 (amino acids) 
H
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E f the SHIP (SHnzymes o 2 Domain-containing Inositol 5-phosphatases) subgroup 
include an N-terminal SH2 domain and a C-terminal proline-rich domain (Krystal et 
al., 1999; Rohrschneider et al., 2000). PtdIns(3,4,5)P3 appears to be the substrate of 
S o, and the 5-phosphatase function of SHIP complements the 3-phosphatase 
activity of PTEN on PtdIns(3,4,5)P3 (Taylor et al., 2000b).  PTEN appears to keep 
basal levels of PtdIns(3,4,5)P3 very low, and SHIP is thought to be responsible for the 
degradation of receptor-stimulated PtdIns(3,4,5)P3. The final subgroup, enzymes of 
the PIP (P
HIP in viv
roline-rich domain-containing Inositol 5-phosphatases) subgroup of the type 
II 5-phosphatases, has an N-terminal proline-rich domain. 
 
ses, an expanding inositol lipid phosphatase family, includes 
yotubularin-related proteins (MTMR) of 
3  
3  
3 
 defective gene in X-linked myotubular myopathy, a 
1.5.2. PPIn 3-phosphatases 
The PPIn 3-phosphata
PTEN, Myotubularin (MTM1) and the m
mammals and other organisms. The PTEN gene was originally identified as a 
candidate tumour suppressor gene and was regarded as belonging to the family of 
dual specificity protein tyrosine phosphatases (PTPs) (Steck et al., 1997; Myers et al., 
1997). However, it was proved later that PTEN utilizes PtdIns(3,4,5)P as its 
physiological substrate and so functions  as a negative regulator of the downstream 
signalling pathways mediated by PtdIns(3,4,5)P (Maehama and Dixon, 1999). PTEN 
is inactivated in up to 50% of human tumours (Li et al., 1997; Liaw et al., 1997; 
Engelman et al., 2006) indicating that its disruption and the concomitant rise in 
PtdIns(3,4,5)P levels may be the important contributors to carcinogenesis. 
 
MTM1 was identified as the
human genetic disease characterized by severe muscle degeneration (Sarnat, 1990). In 
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addition, thirteen human genes have been identified that encode MTMRs (Fig.1.11) 
(Laporte et al., 2003). MTMR2 inactivation is the cause of another human genetic 
disease, Charcot-Marie Tooth syndrome, a neuropathy characterized by improper 
nerve formation (Bolino et al., 2000).  
 
 
 
Figure 1.11: scaled representation of the protein domains of human 
myotubularins (adapted from Laporte et al., 2003) 
DENN, differentially expressed in neoplastic versus normal cells; GRAM, Glucosyltransferase, Rab-
like GTPase Activator and Myotubularins; RID, Rac-Induced recruitment Domain; PTP/DSP, 
tyrosine/dual-specificity phosphatase; SID, SET-interacting domain; PDZ, PSD-95/Dlg/ZO-1 
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Several of the myotubularin family of enzymes can dephosphorylate PtdIns3P and/or 
PtdIns(3 t not other PPIns that contain a 3-phosphate, and some contain a 
PtdIns3 g FYVE domain, so it is likely that they are involved in regulating 
membra mr1p (YJR110w) is the yeast myotubularin homologue, and 
its cata ivity had not been intensively investigated when my work began 
althoug y attack PtdIns3P in yeast (Parrish et al., 2004). Our in vitro 
colorim osphatase assay showed that Ymr1p can utilize PtdIns3P and 
PtdIns(3,5)  not PtdIns4P or PtdIns(4,5)P2 as substrates (see Section 3.2.5 for 
more detail)
 
1.5.3. PPIn 4-phosphatases 
Knowledge about PPIn 4-phosphatases is currently less complete. The two lipid 4-
phosphatases that have been cloned appear to prefer PtdIns(3,4)P2 as substrate 
(Munday et al., 1999; Norris and Majerus, 1994). There are no identified yeast 
homologues, which is not surprising since yeast does not produce much
tdIns(3,4)P2. 
f seven 
ighly conserved motifs that seem necessary for their phosphatase activity. The 
,5)P2 bu
P-bindin
ne trafficking. Y
lytic act
h it ma
etric ph
P2 but
. 
 
P
 
 
1.5.4 Sac domain phosphatases  
The Sac domain contains approximately 400 residues and is composed o
h
sequence RXNCLDCLDRTN within the sixth motif may well represent the catalytic 
core (Hughes et al., 2000a). Currently, the Sac domain phosphatase family includes 
the mammalian proteins KIAA0274, KIAA0966 and KIAA0851 and the yeast 
enzymes Sac1p and Fig4p (Fig. 1.12).  
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Fig4p 
 
KIAA0966 
KIAA0851 
KIAA0274
SAC domain 
 
 
Figure 1.12: M
Sac1p 
0 100 (amino acids) 
odular structures of Sac domain phosphatase (adapted from Hughes 
t al., 2000a). 
ny PPIn phosphatases, many of their physiological 
3,5)P2 in yeast in order to characterize these 
roteins enzymatically (see Chapter 3). My preliminary data suggests that yeast 
yotubularin-like Ymr1p can convert PtdIns(3,5)P2 to PtdIns5P. If this is true, then 
Ymr1p can be regarded as the off switch for the Fab1p pathway. 
 
 
 
e
 
Despite the identification of so ma
functions and the details of their regulation are still less than clear. Indeed, there is not 
even a general consensus as to the individual functions of each of these enzymes.  For 
example, some argue that the myotubularins act as effectors of inositol lipids and that 
they also happen to include an active site that switches off the signals (Schaletzky et 
al., 2003). One part of this thesis considers brief studies of a number of the enzymes 
involved in the metabolism of PtdIns(
p
m
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1.6 General introduction of individual PPIn 
1.6.1 PtdIns3  a key component in endosomal membrane trafficking 
 
PtdIns3P was discovered by Lew Cantley and his colleagues in 1988, as the product 
of a PtdIns kinase that was specifically activated in cells transformed by tyrosine 
k  Src or by the Middle T antigen of polyoma virus. Unexpectedly, this 
kinase produced the novel inositol phospholipid PtdIns3P when given PtdIns as a 
substrate (Whitman et al, 1988). It was later realized that PtdIns3P is constitutively 
generated from PtdIns by the class III PtdIns 3-kinase/Vps34p in mammalian cells. It
tdIns3P is highly enriched in early endosomal membranes and the internal vesicles 
that PtdIns3P plays a key role in regulating the membrane trafficking within the 
(Odorizzi et al., 2000). Specific depletion of PtdIns3P in endosomes results in an 
Several protein effectors of PtdIns3P have been identified, most of which possess 
FYVE and PX domains have revealed how they can selectively recognize PtdIns3P in 
embranes (Bravo et al., 2001; Dumas et  al., 2001, Misra et al., 2001) (Fig. 1.13). 
P,
inases such as
 
makes up approximately 1.8% of the total PPIns in yeast (Hughes et al., 2000a).  
 
P
of the multivesicular body (MVB), and is also found on vacuolar and endosomal 
membranes in yeast (Gillooly et al., 2000). Numerous lines of evidence have shown 
endosomal compartment (Corvera, 2001), and in Golgi-to-lysosome/vacuole sorting 
aberrant morphology of these organelles (Lemmon, 2003). 
 
either a FYVE or Phox (PX) domain that binds PtdIns3P. The crystal structures of 
m
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2
and (B) the p40phox PX domain bound to dibutanoyl-PtdIns3P (from Lemmon, 
2003) 
The FYVE domain comprises a ~60-70 amino acid sequence and was named for the 
first four proteins in which it was found: Fab1, YOTB, Vac1p and EEA1 (Stenmark et 
al., 2002). At least 38 mammalian FYVE domain-conta
Figure 1.13: Structures of: (A) the EEA1 FYVE domain dimer bound to Ins(1,3)P ; 
ining proteins have been 
entified so far, most of which have functional roles in endocytic membrane id
trafficking (Corvera, 2001). EEA1 (Early Endosome Autoantigen-1) and Hrs are two 
of the best-understood FYVE domain proteins. EEA1 is targeted to the early 
endosomal membrane by binding to PtdIns3P via its FYVE domain, but this 
membrane association also requires the GTPase Rab5 (Stenmark et al., 1996). EEA1 
functions as a Rab5 effector to promote vesicle fusion in concert with SNARE 
proteins (Lawe et al., 2000). Hrs is a mammalian homologue of yeast Vps27p protein 
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and interacts with clathrin as well as the ubiquitin-interacting molecules STAM1 and 
STAM2. The resulting Hrs-clathrin-STAM complex then recruits the ESCRT-I 
complex (Endosomal Sorting Complex Required for Transport-I) to the endosomal 
membrane, facilitating cargo concentration and MVB vesicle formation (Sasaki et al., 
2007). Consistent with their distinct functional roles in the endosomal sorting system, 
EEA1 and Hrs are located on different microdomains of the limiting membrane of 
endosomes (Gillooly et al., 2000). Clearly, PtdIns3P is not the only determinant for 
their association with membrane, other requirements include Rab5-binding domain of 
EEA1 and the coiled-coil domain of Hrs (Stenmark et al., 1996; Raiborg et al., 2001). 
 
The PX domain-containing proteins make up another large group of PtdIns3P
ffectors. The PX domain, a 130 amino-acid fold, was originally identified in two 
ain-containing proteins are involved in vesicular 
trafficking, protein sorting or lipid modification (Lemmon, 2003).  
 
SNXs comprise a large sub-family of this group of PtdIns3P effectors and function in 
the Golgi/endosomal axis (Roth, 2004). For example, SNX1, SNX2, SNX5 and SNX6 
have been suggested to complex with cargo selection components such as Vps35p to 
form the retromer complex, and this governs the recycling of cargo receptors such as 
CI-M6PR from endosomes to the trans-Golgi network (Clague et al., 2009). The full 
function of SNX1 requires not only its FYVE domain but also its carboxyl terminal 
BAR (B
 
e
subunits of the phagocyte NADPH oxidase (phox) complex – p40phox and p47phox. 
(Ponting, 1996). Most PX dom
in-Amphiphysin-Rvs) domain that facilitates SNX1 dimerization, senses 
membrane curvature and drives membrane tubulation (De matteis et al., 2005).  
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1.6.2 PtdIns4P, the main PPIn player in Golgi complex 
PtdIns4P is the most abundant monophosphorylated PPIn in mammalian cells 
(Lemmon, 2008). It constitutes ~2% of cellular PPIns in S. cerevisiae (Hughes et al., 
2000a).  
 
Most of the cell’s PtdIns4P is usually phosphorylated to PtdIns(4,5)P2, by PtdIns4P 5-
kinase, so PtdIns4P was until recently considered just as the precursor of 
PtdIns(4,5)P2. However, PtdIns4P has begun to capture more attention over the last 
decade as a PPIn that has its own functions in cellular processes. PtdIns4P is found in 
several cell compartments, but is particularly concentrated in the Golgi apparatus, 
especially in the TGN. Indeed, several putative PtdIns4P effectors are localised in the 
Golgi complex, strengthening the conclusion that PtdIns4P has important functions 
there (D’Angelo et al., 2008). These PtdIns4P effectors can be categorized into two 
classes: first is adaptor and coat components, such as AP-1 (adaptor protein-1), GGA 
protein (Golgi-localised, gamma adaptin ear-containing, ARF-binding protein) and 
Epsin R; second is lipid transfer proteins i.e. OSBP (oxysterol-binding protein), CERT 
(ceramide transfer) protein and the FAPP (four-phosphate-adaptor protein) (D’Angelo 
et al., 2008). AP-1, GGA and Epsin R participate in TGN-to-endosomal trafficking 
(De Matteis et al., 2005), FAPP1 and FAPP2 are involved in the TGN-to-plasma 
membrane transport, FAPP2 uses its glycolipid-transfer domain to facilitate 
sphingolipid transfer across the Golgi (De Matteis and D’Angelo, 2007), CERT 
operates for the transfer of ceramide from the ER to the Golgi (Hanada et al., 2003). 
 
At the TGN, PtdIns4P is recognized by the γ-adaptin subunit of the AP-1 complex 
and promotes AP-1-dependent formation of clathrin-coated vesicles. Decreasing the 
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PtdIns4P content of the Golgi by siRNA suppression of PtdIns4KIIα displaces AP-1 
of the Golgi complex and suppresses vesicular transport from the Golgi to 
e plasma membrane (Godi et al., 1999). Similarly, the loss of the PtdIns kinase 
 is intriguing that association of most PtdIns4P effectors (AP-1, GGAs, Epsin R, 
clathrin coats from Golgi membrane, and results in the Golgi fragmented (Mills et al., 
2003). Overexpression of a catalytically inactive mutant of PI4KIIIβ also perturbs the 
structure 
th
activity of Pik1p also results in strong defects in the secretory pathway in yeast 
(D’Angelo et al., 2008). 
 
Epsin R is an epsin that binds to PtdIns4P through its ENTH (Epsin N-terminal 
homology) domain. It also interacts with the ‘ear’ domain of the APs and with clathrin 
to induce cargo clustering and membrane curvature (Ford et al., 2002). Its association 
with the Golgi membrane is dependent on both PtdIns4P and a small GTPase Arf, but 
independent of AP-1 (Hirst et al., 2003).  
 
PtdIns4P’s role in the non-vesicular transport of membrane lipids is best exemplified 
by the characterization of CERT, one of its effectors. CERT is a glycosphingolipid 
transfer protein which mediates the transit of ceramide from ER to the Golgi for its 
conversion to sphingomyelin by sphingomyelin synthase-1 (Hanada et al., 2003). 
PtdIns4P functions as a Golgi membrane anchor to recruit the CERT through its PH 
domain, and the FFAT motif targets CERT to the ER membrane by interacting with 
the ER membrane protein VAP-A (D’Angelo et al., 2008).  
 
It
FAPP and OSBP1) with Golgi membrane involves interactions with both PtdIns4P 
and Arf1, in a way reminiscent of EEA1 binding to PtdIns3P and Rab5 at endosomes. 
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1.6.3 PtdIns5P, the orphan in the PPIns family   
Of the seven PPIns, PtdIns5P is the least characterized. It was identified in 
mammalian cells in 1997 and in plants in 2001 (Rameh et al., 1997; Meijer et al., 
2001). PtdIns5P had not so far been detected in yeast when my work started. PtdIns5P 
levels are regulated by agonist stimulation (see below), but its sub-cellular distribution 
and the mechanisms controlling its turnover are only beginning to be understood.  
 
Several routes of synthesis and metabolism have been proposed. Rather than being 
 
i is a PPIn 4-phosphatase 
at can make PtdIns5P by dephosphorylating PtdIns(4,5)P2. During the first step of 
synthesized from PtdIns by a phosphorylation, cellular PtdIns5P seems mainly to be 
formed by the action of PPIn phosphatases on PtdIns(3,5)P2 and/or PtdIns(4,5)P2 
(Roberts et al., 2005). No bona fide PI5K active in vivo has been identified, even 
though the Type I and Type III PIP kinases can phosphorylate PtdIns to PtdIns5P in 
vitro (Sbrissa et al., 1999; Tronchere et al., 2004). 
However, there is evidence that PtdIns5P may be a regulator in some cellular 
processes. The concentration of PtdIns5P is stable in resting or actively growing cells 
but can increase in thrombin-stimulated platelets (Morris et al., 2000) or insulin-
stimulated adipocytes (Sbrissa et al., 2004), and within the nucleus at G1 in the cell 
cycle (Roberts et al., 2005).  
 
The virulence factor IpgD of the bacterium Shigella flexner
th
infection, IpgD is injected into the target cell and the resulting PtdIns5P is 
concentrated at the entry foci of the bacteria, somehow activating the host cell 
PI3K/Akt pathway (Niebuhr et al., 2002; Pendaries et al., 2006). In mammalian cells, 
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the PPIn 3-phosphatase myotubularin (MTM1) can influence PtdIns5P. In L6 
here is also a possibility that PtdIns5P might be implicated in tumorigenesis. It can 
myotubes overexpressing MTM1, hyperosmotic shock triggered an elevation of 
PtdIns5P levels, and this increase was 50% smaller in the inactive MTM1D278A 
mutant, suggesting slower PtdIns(3,5)P2 conversion to PtdIns5P might be a factor in 
the etiology of myotubular myopathy (Tronchere et al., 2004).   
 
T
bind to the PHD domain of the tumour suppressor ING2 (inhibitor of growth protein-
2) to mediate apoptosis and cell death in response to DNA damage (Gozani et al., 
2003; Sasaki et al., 2007).  
     
1.6.4 PtdIns(3,4)P2: lipid second messenger or downstream metabolite? 
PtdIns(3,4)P2 is poorly understood so far and remains a target for future research. It 
accumulates transiently in the plasma membrane upon stimulation, but a substantial 
 (Vanhaesebroeck et al., 2001). Some PH domain-
ontaining PtdIns(3,4,5)P3 effectors like PKB (p
fraction is likely to be formed by Type II 5-phosphatase action on PtdIns(3,4,5)P3 
(Stephens et al., 1993a). However, a PtdIns(3,4,5)P3-independent route to 
PtdIns(3,4)P2 has been observed after induction of oxidative stress by H2O2 in 
mammalian cells or after integrin ligation on platelets, possibly as a result of PtdIns3P 
or PtdIns4P phosphorylation
c rorein kinase B) and DAPP1 (dual 
adapter of phosphotyrosine and 3-phosphoinositide protein) can also recognize 
PtdIns(3,4)P2 (Lemmon, 2003). The only proteins so far claimed to bind 
PtdIns(3,4)P2 selectively are the TAPP1 (tandem PH domain-containing protein-1) 
and TAPP2 (Dowler et al., 2000; Kimber et al., 2002), but the physiological functions 
of these lipid-protein specific interactions remain less than clear. 
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1.6.5 PtdIns(4,5)P2, has roles in a myriad of cellular activities 
PtdIns(4,5)P2 is normally the most abundant of the doubly phosphorylated PPIns 
(Vanhaesebroeck et al., 2001). It represents approximately ~1% of total cellular PPIns 
if PtdIns is included (Hughes et al., 2000b). PtdIns(4,5)P2 is predominantly 
concentrated at the plasma membrane, possibly enriched in raft-like structures (Di 
aolo and De Camilli, 2006), but is also present in the Golgi and the nucleus 
all cell pool of PtdIns5P by Type II PtdIns5P 4-kinase 
tarius et al., 2006). 
,
 in vitro homotypic 
P
(Halstead et al., 2005). The canonical pathway for PtdIns(4,5)P2 synthesis requires 
two consecutive phosphorylations of PtdIns by Type III PtdIns 4-kinase and Type I 
PtdIns4P 5-kinase (Hinchliffe et al., 1998), but a small fraction of PtdIns(4,5)P2 can 
also be made from the sm
(San
 
PtdIns(4,5)P2 is a substrate for signalling by the PLC family and by PI3KC1s, and can 
be metabolized by PtdIns(4,5)P2 phosphatases (Halstead et al., 2005). Although its 
overall concentration remains nearly invariant in many stimulated cells, local changes 
in PtdIns(4 5)P2 concentration are likely to occur within cells (Pendaries et al., 2003). 
In addition, there is now abundant evidence that, by serving as a binding or anchoring 
site for participating proteins, PtdIns(4,5)P2 regulates or is otherwise involved in a 
broad spectrum of cellular activities: these include actin cytoskeletal dynamics, ion 
channel gating, clathrin-mediated endocytosis, exocytosis, vesicle trafficking, focal 
adhesion formation (Downes et al., 2005; van Rheenen et al., 2005; Di Paolo and De 
Camilli, 2006; Santarius et al., 2006).  
 
There is clear evidence that PtdIns(4,5)P2 is required for vacuole fusion both in vitro 
and in vivo (Mayer et al., 2000; Wiradjaja et al., 2007). The
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vacuole fusion reaction is crippled following addition of antibodies to PtdIns(4,5)P2 
p. This result was interpreted as evidence that the vacuolar 
agmentation/fusion equilibrium depends on proper maintenance of the traffic of 
.6.6 PtdIns(3,5)P2, functions in the endo-lysosomal system 
or addition of PLC. In this system, PtdIns(4,5)P2 modulates two steps of vacuole 
fusion: first is the priming step during which SNARE protein complexes are 
dissociated; The second is after docking of the vesicle but prior to fusion (Mayer et 
al., 2000). However, an excess of PtdIns(4,5)P2 in vivo can limit vacuole fusion. In 
intact cells, probes detect PtdIns(4,5)P2 mainly at the plasma membrane, with little at 
the vacuole. When the two PtdIns(4,5)P2 phosphatases, Inp54p and Sac1p were 
inactivated,  PtdIns(4,5)P2  bioprobes exhibited loss of plasma membrane localisation 
and instead decorated a subset of fragmented vacuoles. Inactivation of the 
phosphatases also causes vacuole fusion defects that were rescued by inactivating the 
PtdIns4P 5-kinase Mss4
fr
plasma membrane-synthesised PtdIns(4,5)P2 between vacuolar and plasma 
membranes (Wiradjaja et al., 2007). 
 
A genetic analysis of deletion mutants showed that a Plc1p is required for vacuolar 
fusion (Seeley et al., 2002), and vacuole fusion in vitro was blocked by sequestration 
of DAG by the C1b domain from a mammalian PKCβII or by PLC inhibitors (Jun et 
al., 2004). These results suggest that PtdIns(4,5)P2 metabolites – DAG, IPs or both – 
might regulate vacuole fusion. In this thesis, I offer some evidence in support of this 
idea.   
 
1
PtdIns(3,5)P2 is one focus of this project and will be introduced in detail in Section 
1.9 and chapter 3. 
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1.6.7 PtdIns(3,4,5)P3, the most phosphorylated and fundamentally important 
PPIn 
Unlike its precursor, PtdIns(4,5)P2, PtdIns(3,4,5)P3 exists in very low concentrations 
in quiescent cells but its levels can be transiently and dramatically enhanced in 
response to the activation of Type I PI3Ks. The local generation of elevated levels of 
PtdIns(3,4,5)P3 results in the recruitment of its interacting proteins, whose activation 
mediates synergistic signalling cascades. Accordingly, PtdIns(3,4,5)P3 plays multi-
faceted roles in a repertoire of fundamental cellular activities: cell proliferation, 
differentiation, survival, motility, migration, chemotaxis, metabolism and immune 
responses (Di Paolo and De Camilli, 2006). PtdIns(3,4,5)P3 metabolic balance is thus 
the focus of intense research into novel drugs for the treatment of cancer, type II 
diabetes, cardiac failure, inflammatory diseases and problems involving auto/hyper-
immune response (Downes et al., 2005).  
 
One of the best-defined PtdIns(3,4,5)P3-mediated pathways is the activation of 
Akt/PKB, the cellular homologue of the retroviral oncogene v-Akt (Vivanco and 
Sawyers, 2002). Following PI 3-kinase activation, PtdIns(3,4,5)P3 recruits PDK 
(Phosphoinositide dependent kinase) and Akt at the plasma membrane, where Akt is 
phosphorylated and activated by PDK to integrate with important signalling pathways 
such as the Tor pathway (Nave et al., 1999). Because PTEN and SHIP-1 and 2 can 
negatively regulate the level of PtdIns(3,4,5)P3, both phosphatases are therefore 
mour suppressors and have a potential therapeutic function for cancer and type II tu
diabetes respectively (Cantley, 2002; Czech, 2003).   
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1.7 Inositol Polyphosphates (IPs) 
The growth of interest in the PPIns has been accompanied by an increased focus on 
 nature (Menniti et al., 1993; Hughes and 
ichell, 1993). The discovery of inositol pyrophosphates – in which one more 
d in mRNA export (York et al., 
999). The genes that were identified encoded Plc1p and the kinases necessary to 
atalyse a previously suggested pathway to synthesize IP6 from IP3 (Ongusaha et al., 
inositol polyphosphates (IPs), which are their soluble counterparts and metabolites 
thereof. In addition to IP3 functioning as a second messenger in intracellular Ca2+ 
release, as mentioned earlier, many IPs are now emerging as agents that regulate other 
cellular functions, including several nuclear processes, e.g. transcription, chromatin 
remodelling and mRNA editing and export (York, 2006; Alcazar-Roman and Wente, 
2008).  
 
IPs contain only an inositol core and various numbers of phosphomonoester groups 
attached to one or more of the six hydroxyl moieties. In theory, there could be 63 
simple myo-inositol phosphates isoforms (including isomers or stereoisomers), of 
which more than half have been found in
M
additional phosphate groups is added to an existing phosphomonoester group – 
expands the possible number of naturally occurring IPs indefinitely (Stephens et al., 
1993b; Shears, 1996, 2007; Burton et al., 2009).  
 
The synthesis of the various IPs and inositol pyrophosphates is achieved by a variety 
of IP kinases (IPK), IP phosphatases and inositol pyrophosphate synthases (IPS), 
almost always using as their starting material the IP3 liberated during hydrolysis of 
PtdIns(4,5)P2. The pathway for the synthesis of IPs from IP3 was built on a genetic 
screen aimed at finding yeast genes that are involve
1
c
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1998). One was an Ins(1,3,4,5,6)P5 2-kinase named Ipk1p, and the second was the 
y of an IP6 5-kinase Kcs1p (Saiardi et al., 1999) and the recently identified 
P6 1/3-kinase Vip1p (Mulugu et al., 2007; Lin et al., 2009) has extended this pathway 
tasis (Schneider et al., 1994). IP7 is 
quired for maintaining the Pho81p-dependent inactivation of this complex. The 
kinase: Arg82p/Ipk2p that can transform IP3 to Ins(1,3,4,5,6)P5 by sequentially adding 
phosphate groups on the 6- and 3- hydroxyls  (Odom et al., 2000; Saiardi et al., 1999, 
2000). This screen was also the first to indicate that production of IPs was linked to a 
nuclear function (mRNA export).  
 
The fully phosphorylated IP6 is not the end point of this synthetic route. The 
discover
I
to the conversion of IP6 to several inositol pyrophosphates that are loosely designated 
IP7 and IP8.  
 
The involvement of inositol pyrophosphates in nuclear regulation is well illustrated by 
the function of IP7 in the phosphate-responsive signalling (Pho) pathway. In budding 
yeast, inorganic phosphate limitation inactivates the Pho80p-Pho85p cyclin-cyclin 
dependant kinase (CDK) complex via the CDK inhibitor Pho81p, leading to 
expression of genes involved in nutrient homeos
re
genetic studies showed that this IP7 is made by Vip1p but not Kcs1p. In vitro assays 
strengthened this result because 4/6 PP-IP5 (the IP7 made by Vip1p) is more effective 
than 5PP-IP5 (made by Kcs1p) in inhibiting the Pho80p-Pho85p complex (Lee et al, 
2007). This is the first isomer-specific molecular action of an IP7 linked to a 
physiological response (Irvine, 2007). The story became more complete when it was 
found that IP7 interacts non-covalently with the Pho80p-Pho85p-Pho81p ternary 
complex and induces additional interactions between Pho81p and Pho80p-Pho85p 
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that prevent substrates from accessing the kinase active site (Lee et al., 2008). 
Alcazar-Roman and Wente (2008) suggest that IPs might modulate protein functions 
in a variety of ways: for example, by serving essential structural cofactors, by 
triggering allosteric or induced-fit structural changes in enzymes, or by direct 
competition with substrates. 
 
1.8 Vacuole fusion and its regulation 
Eukaryotic cells include multiple membrane-bound compartments, including ER, 
Golgi complex, endosomes and lysosomes, and their proteins must be targeted to the 
correct organelles. This protein trafficking is achieved by the movement of small 
membrane-bound vesicular transport intermediates between organelles. It involves: 
embrane vesicle budding from a “donor” compartment by a process that allows m
selective incorporation of cargo into the forming vesicles; vesicle transport between 
the “donor” compartment and the “acceptor” compartment; vesicle fusion with an 
appropriate “acceptor” compartment whereby the vesicle unloads its cargo into the 
surrounding membrane or lumen of the acceptor organelle. Such selective membrane 
fusion and fission events underlie both subcellular compartmentation and secretory 
processes (e.g. neurotransmission and hormone secretion).  Fig. 1.14 summarises 
major trafficking routes in eukaryote cells. It should be noted that progress on the 
molecular mechanisms of vesicle trafficking relied on two sets of seminal studies: the 
selection and characterization of secretion (sec) mutants of yeast by Schekman’s 
laboratory (Novick and Schekman, 1979); and the development of cell-free assays of 
compartment mixing by Rothman and colleagues (Balch et al., 1984).  
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Figure 1.14: Membrane-bound protein trafficking in Eukaryotic cells (from 
Raiborg et al., 2003) 
 (a) lytic granules in T lymphocytes, (b) MHC class II compartments and exosomes in antigen-
presenting cells, (c) melanosomes in melanocytes,  (d) late MVEs/lysosomes in most nucleated cells 
 
The vacuole of budding yeast is homologous to the mammalian lysosome or to a late 
endosome/lysosome hybrid structure. Several factors make the yeast vacuole an 
excellent model organelle with which to study membrane fusion and fission. In 
particular, a variety of genetic and biochemical tools are available for yeast, vacuoles 
can be easily isolated, and they can be visualised in vivo and in vitro by fluorescent 
in vitro assays for homotypic vacuole fusion have 
tablished recently (Haas et al., 1994). In vivo, the fusion of multiple vacuole 
techniques. Rapid and quantitative 
been es
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subcompartments and fission of vacuoles into multiple subcompartments occur in 
response, respectively, to hypo- and hyper-osmotic stress, and analysis of these 
processes allows genetic screens to identify novel components of fusion/fission 
pathways.  
 
The yeast vacuole is a highly dynamic organelle, and its biogenesis and functions are 
regulated by more than 70 proteins identified by several elegant mutant screens for 
defects in endocytosis (End), delivery of vacuolar peptidase (Pep), sorting of proteins 
to the vacuole (Vps), vacuole inheritance during budding (Vac) and vacuole 
morphology (Vam) in budding yeast (reviewed by Bowers and Stevens, 2005). 
Disruption of many of these genes leads to perturbed vacuole morphology.  These 
aberrant morphologies have been classified into six classes (Raymond et al., 1992):  
• Class A have wild-type vacuoles that comprise 3-5 clustered spherical 
compartments;  
  
n 
be recognized;  
• Class B mutants have  partly fragmented vacuoles, often with >10 small 
compartments;
• Class C mutants have highly fragmented vacuole, so that no true vacuole ca
• Class D mutants have a single large unlobed vacuole;  
• Class E vacuoles are enlarged and have an aberrant late endosome/MVB (the 
class E compartment) adjacent to the vacuoles; and 
• Class F mutants have one large vacuole surrounded by a number of small 
vacuolar subcompartments.  
To give rise to this multiplicity of vacuolar morphologies, vacuole membranes must 
be able to undergo homotypic fission and fusion in vivo (Wickner and Haas, 2000). 
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Experimental analysis of the fusion process has been facilitated by the establishment 
of an in vitro assay (Haas et al., 1994).  For this assay, vacuoles are isolated from two 
deletion strains: one lacks the PHO8 gene that encodes the proenzyme form of the 
vacuole alkaline phosphatase (pro-Pho8p); and the other lacks the PEP4 gene that 
ncodes a major intravacuolar protease that catalyses the maturation of vacuolar pro-
Pases, SNARE complexes, the HOPS (ho
e
proteins (including pro-Pho8p). Neither of two purified vacuole preparations harbors 
active Pho8p, but upon fusion of the vacuoles from the two mutants their lumenal 
contents mixing and Pep4p gains access to and activates pro-Pho8p, the activity of 
which is measured by the liberation of yellow p-nitrophenyl from p-
nitrophenylphosphate. The activity and rate of fusion can therefore be followed 
colorimetrically. 
 
Yeast vacuole fusion requires on the cooperative action of many proteins and lipids, 
including ATPases, GT motypic vacuole 
fusion and vacuole protein sorting) complex, PPIns, ergosterol, diacylglycerol, 
cholesterol and Ca2+ (reviewed by Wickner and Haas, 2000; Wickner, 2002; 
Ostrowicz et al., 2008). The SNARE (Soluble N-ethylmaleimide-sensitive factor 
attachment protein receptor) complex is the engine of fusion, with its functions 
 by their heptad-repeat 
osed membranes) (Sutton 
gion or a prenylated tail. Budding yeast 
regulated by other fusion factors. SNARE proteins are defined
“SNARE” motifs that assemble them into four-helical “coiled-coil” bundles in cis 
(anchored to same membrane) or in trans (anchored to app
et al., 1998; Fasshauer et al., 1998; Poirier et al., 1998). Most SNARE proteins are 
bound to membranes by a C-terminal apolar re
vacuoles have at least five abundant SNAREs: three Q-SNAREs (Vam3p, Vam7p, 
Vti1p) and two R-SNAREs (Nyv1p and Ykt6p) where the Q or R residues at the core 
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of the “SNARE” motif interact in helical bundles. Regulation of vacuole fusion can be  
seen primarily as the regulation of SNARE complex assembly and disassembly by 
distinct SNARE chaperones. Vacuole fusion can be experimentally separated into four 
sub-reactions termed priming, tethering, docking and fusion (Fig. 1.15).  
 
Priming Tethering Docking Fusion 
 
 
Figure 1.15: The four stages of yeast homotypic vacuole fusion (adapted from 
Wickner, 2002) 
 
The priming stage that starts a new round of fusion is characterized by disassembly – 
by the AAA-ATPase Sec18p/NSF (N-ethylmaleimide-sensitive factor) – of the cis-
SNARE complexes that catalysed the previous round of fusion. This leads to the 
release from vacuoles of Sec17p/αSNAP (soluble N-ethylmaleimide-sensitive factor 
attachment protein) and of Vam7p, establishing a pool of unpaired SNAREs that are 
in an active, fusion-competent state ready for subsequent pairing in trans (Söllner et 
al., 1993; Mayer et al., 1996; Ungermann et al., 1998). Upon priming by Sec18p and 
ATP, a hexameric complex, termed the HOPS complex, is also freed from pairing with 
the cis-SNAREs so that it can bind to Ypt7p and initiate the docking stage (Seals et 
al., 2000). The close association of primed vacuoles prior to fusion proceeds through 
two steps: first the reversible tethering of SNAREs between vacuoles in trans and 
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then their irreversible pairing or docking (Ungermann et al., 1998).  
 
Tethering is the first contact between vesicular and target vacuoles, in which the 
HOPS complex, SNAREs complex and Ypt7p become concentrated in a ring – the 
ertex ring – that encircles the apposed patches of membrane on the paired vacuoles. 
A rtex ring ha e R-SNARE f icle membran e- 
or v-SNARE) and three Q-SNAREs from the target membrane (target- or t-
SNARESs) bind each other to form a zipper-like 3Q:1R trans-SNARE complex 
(Stroupe et al., 2006) – but this formal vesicle/target distinction is, of course, 
irrelevant in homotypic vacuole fusion between identical membranes. Ypt7p is 
thought to orchestrate the association between the Q-SNAREs and the HOPS 
complex, facilitating the transition from transient tethering to formation of the 
-SNAREs complex. Docking triggers a brief release of calcium from 
e vacuole lumen (Peters and Mayer, 1998) and leads to the bilayer/bilayer fusion 
v
fter the ve s formed, on rom the ves e (vesicl
irreversible trans
th
and to the mixing of lumenal contents (Collins et al., 2005). 
 
In addition to the SNAREs complex, the HOPS complex is central to the fusion 
process. HOPS is a hexameric complex consisting of four Class C Vps proteins 
(Vps11p, Vps16p, Vps18p, Vps33p) and two Class B Vps proteins (Vps39p and 
Vps41p) (Fig. 1.16). The Class C proteins were first characterized as parts of a 65S 
SNARE-containing complex existing before priming (Rieder and Emr, 1997), and 
Vps39p and Vps41p were later found associated with the four SNARE proteins. 
Vps39p is a guanyl-nucleotide exchange factor (GEF) that regulates the activity of 
Ypt7p, the yeast Rab7 homologue (Wurmser et al., 2000). Vps33p, one of the HOPS 
complex subunit, belongs to the Sec1/Munc18 (SM) family of SNARE-binding 
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proteins (Banta et al., 1990), suggesting a potential role for the HOPS in regulating 
e assembly of SNAREs complexes.  th
 
 
 
complexes (from Nickerson et al., 2009) 
 a. Ribbon diagram depicting a folding model for Vps18; b. Summary of tertiary structure predictions 
indicated by color coding for Vps-C components; c. Working scheme for Vps-C complex function, in 
which interactions of CORVET and HOPS with endosomal and lysosomal Rabs regulate membrane 
fusion events at late endosomes and lysosomes, respectively. Hybrid complexes contain both HOPS 
 
 
Figure 1.16: Composition and domain structure of the HOPS and CORVET 
and CORVET subunits 
Upon priming, the HOPS complex dissociates from the SNARE complex as a 38S 
sub-complex which then “hops” to Ypt7p, activating this GTP-dependent Ypt/Rab 
switch to initiate docking by promoting and proofreading the formation of the trans-
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SNAREs complex at the docking step (Starai et al., 2008). Thus the HOPS complex 
facilitates the transition from ATP-dependent disassembly of the cis-SNARE complex 
ctive in priming to the assembly of the Ypt7p-dependent trans-SNARE complex for 
docking.  
 
Purification of the active HOPS complex later revealed its affinity for PPIn and the 
recognition of the PX domain of the SNARE Vam7p (Stroupe et al., 2006), leading to 
the proposal that HOPS is enriched at the vertex ring by directly interacting with 
Ypt7p, Vam7p and PtdIns(4,5)P2. In vitro fusion assays then demonstrated that 
vacuolar SNARE complexes bind either Sec17p or the HOPS complex, but not both. 
Thus, Sec17p may displace HOPS from SNAREs to allow the subsequent round of 
fusion (Collins et al., 2005).  
 
Functions have also been defined for other HOPS complex subunits. Vps11p and 
Vps18p contain C-terminal RING (R
a
eally interesting new gene) domains that are 
believed to mediate protein-protein interactions (Schultz et al., 1998) and so they may 
ave a role in HOPS complex assembly. Indeed, the C-terminal 148 amino acids of 
lex with vacuole contact sites and so may negatively regulate 
acuole fusion, and a YCK3 deletion mutant displays a strong accumulation of 
h
Vps39p were found to be necessary for the interaction between Vps39p and Vps11p 
(Wurmser et al., 2000). Vps16p remains the least well-defined HOPS subunit. The 
role of Vps41p in vacuole fusion has been characterized in some detail recently. The 
phosphorylation of Vps41p by the vacuole casein kinase Yck3p reduces association of 
the the HOPS comp
v
Vps41p at vacuole membrane micro-domains that are believed to be fusion docking 
sites (LaGrassa and Ungermann , 2005).  
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Regulation of Vps41p by Yck3p is a focus of one chapter of this thesis, so it will be 
discussed in more detail later. 
 
1.9 PtdIns(3,5)P2 and vacuole fission 
tdIns(3,5)P2 is one of the seven PPIns that is almost ubiquitous in eukaryotes 
(Michell et al., 2006). The existence of PtdIns(3,5)P2 in animal cells  was first 
suggested in 1989 (Auger et al., 1989), but it was not until 1997 that it was identified 
almost simultaneously in the budding yeast S. cerevisiae and in resting mouse 
fibroblasts (Dove et al., 1997; Whiteford et al., 1997). Dove at el. (1997) also showed 
that its cellular levels are strikingly elevated upon hyper-osmotic treatment, 
suggesting that this lipid might have a physiological function in yeast’s adaptation to 
hyper-osmotic stress.  
P
 
As mentioned earlier, PtdIns(3,5)P2 is synthesized from PtdIns by two consecutive 
phosphorylations of PtdIns, by the PtdIns 3-kinase Vps34p and the PtdIns3P 5-kinase 
Fab1p (Herman and Emr, 1990; Schu et al., 1993; Gary et al., 1998; Cooke et al., 
1998) (Fig. 1.17). Correct regulation of the kinase activity of Fab1p requires three 
additional proteins: Vac14p, Vac7p and Fig4p. Cells that lack any of these three 
proteins display deficient PtdIns(3,5)P2  synthesis and recapitulate most or all of the 
defects present in fab1Δ cells (Bonangelino et al., 1997; Dove et al., 2002; Duex et 
al., 2006a; Duex et al., 2006b), and Atg18p, one of the effectors of PtdIns(3,5)P2, 
modulates Fab1p activity in a negative fashion (Dove et al., 2004).   
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Vac7p 
Fig4p Vac14p 
 
 
 
Figure 1.17: PtdIns(3,5)P2 synthesis and degradation in S. cerevisiae  
Fig4p is a Sac1p-like PPI
 
n phosphatase that 5-dephosphorylates PtdIns(3,5)P2 to 
PtdIns3P (Gary et al.,  2002). In the one published study of recombinant Fig4p, 
y demonstrating 
at Fab1p, Vac14p and Fig4p form a large complex, with Vac14p acting as its central 
scaffold, that co-ordinately regulates the metabolism of PtdIns(3,5)P2 (Botelho et al., 
2008; Jin et al., 2008). 
PtdIns(3,5)P2 was the only PPIn that it attacked (Rudge et al., 2004), even though its 
catalytic site is very similar to that of the relatively non-specific PPIn phosphatase 
Sac1p (Hughes et al., 2000a). Fig4p includes a canonical CX5R catalytic motif and 
has an extensive C-terminal coiled-coil domain that mediates its interaction with 
Vac14p: deletion or inactivation of Vac14p or removal of the C-terminal segment of 
Fig4p renders it completely cytosolic, as does deletion of FAB1 (Rudge et al., 2004). 
Surprisingly, inactivation of this PtdIns(3,5)P2 5-phosphatase, in yeast or in animal 
cells, leads to a profound defect in PtdIns(3,5)P2 synthesis (Rudge et al., 2004; Chow 
et al., 2007). Recent work has unravelled this apparent conundrum b
th
 Fig4p 
 PtdIns PtdIns3P 
 Vps34p 
PtdIns 
(3,5)P2 
 PtdIns5P 
 Ymr1p? 
Endoplasmic reticulum Endosome Vacuole 
 Vps15p 
 Myotubu- 
larin 
  Fab1p  
 Vps27p 
Vac1p Vps5p 
Atg18p 
Ent3p  Ent5p 
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The multiple defects displayed by mutants deficient in PtdIns(3,5)P2 synthesis give 
clues to the function of this lipid. These include (Michell et al., 2006; Dove and 
Johnson, 2007):  
• Gross enlargement of the vacuole;  
• A defect in the ubiquitin-dependent sorting of proteins into the internal 
es of MVB that are subs ntly trafficked to the vacuole lumen;  
• Abnormal sensitivity of the cells to multiple stresses, including heating or 
alkalinization of the external medium;  
• Failure to acidify the vacuole normally.  
hese phenotypes seem to originate from independent dysfunctions in that they are 
nase function 
D2134R
 yet been identified.  
vesicl eque
T
partially separable. All of the underlying functions depend on the lipid ki
of Fab1p, as they are also displayed by cells in which wild-type Fab1p is replaced by 
a kinase-dead variant of Fab1p (fab1 ) (Gary et al., 1998).  
 
PPIns exert their effects on cellular activities primarily by serving as membrane 
binding sites for specific effector proteins, and there seems no reason for 
PtdIns(3,5)P2 to be exceptional. Proposed effectors for PtdIns(3,5)P2 include the 
PROPPIN (β-propeller(s) that binds PPIn) family of seven-bladed β-propellers 
(Svp1p/Atg18p, Hsv1p/Atg21p and Hsv2p in yeast) (Michell et al., 2006). Atg18p is 
necessary for PtdIns(3,5)P2-dependent retrieval of membranes from the vacuole to the 
late endosome (Dove et al., 2004; Michell et al., 2006). The PtdIns(3,5)P2-dependent 
functions of Hsv1p and Hsv2p remain less well defined. Proteins that may be 
implicated in PtdIns(3,5)P2-dependent MVB sorting include the epsin-like proteins 
Ent3p and Ent5p (Friant et al., 2003). No PtdIns(3,5)P2 effectors that are required for 
vacuole acidification have
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One of the principal function of PtdIns(3,5)P2 is to regulate the fission/fragmentation 
of lysosome/vacuoles both under normal conditions and in stressed cells. Changes in 
vacuole morphology – by fusion or fission – are easy to induce by hypo- or hyper-
ical microscopy, so investigation of 
. The 
itant with fragmentation of the   
e et al., 2004). The rise is transient, 
NaCl) lead to highly 
agmented vacuoles and a large PtdIns(3,5)P2 accumulation that takes up to 60 min 
intains 10% of the normal levels of 
osmotic stress and are readily seen by opt
PtdIns(3,5)P2-dependent control of vacuole morphology may help to advance our 
understanding of the molecular mechanisms of this type of membrane fission
concentration of PtdIns(3,5)P2 in yeast, and in some plant and some animal cells, 
increases in response to hyper-osmotic stress, concom
budding yeast vacuole (Dove et al., 1997; Rudg
with the degree of hypertonicity regulating the duration and magnitude of the 
PtdIns(3,5)P2 accumulation. Modest stresses (e.g. 0.4 M NaCl) cause slight vacuole 
fragmentation and provoke a modest accumulation of PtdIns(3,5)P2 that reverses 
within ~10 min, whereas more intensive stresses (e.g. 0.9M 
fr
to revert to pre-stress values (Duex, et al., 2006a; Dove et al.,  2009). The transient 
elevation in PtdIns(3,5)P2 levels likely provides some osmotic protection for the cell 
because vacuole fragmentation dramatically decreases the total vacuole volume. It is 
also possible that the increase in vacuole membrane PtdIns(3,5)P2 might regulate 
transmembrane channels to release ions, other osmolytes and water from the vacuole 
into the cytoplasm. 
 
The correlation of vacuole fragmentation and PtdIns(3,5)P2 synthesis was nicely 
demonstrated by three related fab1 mutants. A kinase-dead fab1 mutant (D2134R) 
displayed an enlarged vacuole all the time (Gary et al., 1998; Odorizzi et al., 1998); a 
fab1 mutant (G2042V/G2045V) that only ma
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PtdIns(3,5)P2 manifests some vacuole fragmentation (Gary et al., 1998; Odorizzi et 
al., 1998); and FAB1-5 – a FAB1 mutant that makes supra-normal levels of 
PtdIns(3,5)P2 – has fragmented or shrunken vacuoles (Gary et al., 2002). Any 
identification of PtdIns(3,5)P2 effector proteins that influenced this process would 
contribute to the understanding of the molecular mechanisms of vacuole 
fragmentation.  
 
The machinery for homotypic vacuole fusion is relatively well characterized 
(reviewed in Ostrowicz et al., 2008 and discussed above), but that for vacuole fission 
has only recently begun to be unravelled (Peters et al., 2004; Baars et al., 2007). This 
has allowed a new recognition that these two processes may use shared components to 
maintain the equilibrium between vacuole fusion and fission (Fig. 1.18). Vps1p, a 
dynamin-like protein that had previously been recognised as necessary for vesicle 
budding at the TGN, was the first protein to be implicated also in vacuole fission 
(Vater et al., 1992; Peters et al., 2004). It was found that Vps1p can form polymers 
and nucleate several t-SNAREs (e.g. Vam3p) together (Peters et al., 2004). At the 
priming stage of fusion, Vps1p is depolymerised and freed from the vacuole 
membrane in a process that requires Sec18p/NSF and Vam3p but not Sec17p/α-SNAP 
and the v-SNARE. This release of Vps1p liberates the t-SNAREs for initiating fusion 
and at the same time disrupts fission activity which presumably prevents futile cycles 
f fission and fusion. The idea that vacuole fusion and fission are mechanistically o
coupled was reinforced when the Mayer group, who had identified the dual roles for 
Vps1p, showed that the vacuolar V-ATPase is involved in both processes. Fusion 
requires the physical presence of the V0 subcomplex – the membrane sector of the V-
ATPase complex – but occurs in the absence of a trans-membrane H+ gradient, 
  55 
                                                                                                                                    Introduction 
whereas vacuole fission requires the establishment of a proton gradient by the V-
ATPase (Baars et al., 2007).   
 
The HOPS complex also plays central roles in both vacuole fission and fusion. This is 
because it can interconvert between two forms: the tethering complex for fusion that 
was discussed above and a slightly different CORVET (Class C Core 
vacuole/endosome tethering) complex that catalyses either vacuole fission or vacuole-
It will be important for future studies to examine whether the CORVET complex 
might be involved in the link between Fab1p activity, PtdIns(3,5)P2 concentration and 
vacuole sub-compartmentation. A link between the function of the HOPS and 
CORVET machineries and PtdIns(3,5)P2 availability is suggested by the finding that 
deletion of some CORVET and/or HOPS subunits can cause mislocalisation of 
Atg18p, Atg21p and Hsv2p (Kane, 2005). In addition, vacuole fission in yeast cells 
requires both the V-ATPase and vacuole acidification, and it has long been known that 
PtdIns(3,5)P2 is required for vacuolar acidification: fab1∆, vac7∆ and vac14∆ cells all 
have neutral vacuoles and this defect and vacuole enlargement seem to occur 
independently (Rusten et al., 2006). How PtdIns(3,5)P2 regulates vacuole 
acidification remains enigmatic so far, but is likely to involve undefined effector 
proteins regulating the V-ATPase either directly or indirectly, and that will exert 
secondary effects on vacuole fission. 
endosome fusion, or both (Peplowska et al., 2007, see Fig. 1.18). 
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regulate endo-lysosomal fusion/fission status 
The yeast vacuole normally exists as a series of discrete, but tethered, compartments whose size and 
shape depend upon growth status, osmolarity and activity of the V-ATPase, the HOPS–CORVET 
equilibrium and the activity of the Fab1p pathway. This diagram illustrates the interplay between these 
pathways and emphasizes that the interconversion of HOPS into CORVET has profound implications 
growing cells. Starvation and/or hypo-osmotic stress can cause vacuolar fusion mediated by HOPS, 
shifting the vacuole to the single enlarged organelle shown on the left. Alternatively, hyperosmotic 
fragmentation of the vacuole, as shown on th
Figure 1.18: CORVET–HOPS, the V-ATPase and the Fab1p pathway co-operate to 
for the fusion–fission equilibrium. In the centre, the vacuole is depicted as it appears in exponentially 
stress or an artificial hyperactivation of the CORVET or Fab1p pathways can result in extreme 
e right-hand side of the Figure. The casein kinase Yck3p, 
apparently restrains fusion after fission has occurred by phosphorylating a number of targets; Vps41p, a 
subunit of HOPS is one of these targets 
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1.10 Project aims 
PtdIns(3,5)P2 was first identified in budding yeast by Dr. Dove in 1997 (Dove et al., 
1997). When my Ph.D. work started in 2005, there has been a long history on 
PtdIns(3,5)P2 research by Dr. Dove’s lab. The study of PtdIns(3,5)P2 field was mainly 
targeted on two focuses: its metabolism and its cellular functions. My first project was 
aimed to the former. 
 
As detailed in Section 1.9, in S. cerevisiae, PtdIns(3,5)P2 is generated by  the lipid 
kinase Fab1p. Fab1p requires the activator proteins, Vac7p and Vac14p for normal 
activity, based largely on the genetic studies. However there was a dearth of 
biochemical and cellular evidence to elaborate this regulatory mechanism. 
PtdIns(3,5)P2 can also be degraded to PtdIns3P or PtdIns5P by inositol lipid 
phosphatases, probably by two enzymes Fig4p and Ymr1p respectively, but again 
in vitro work was lacking. One of the effectors of PtdIns(3,5)P2,  Atg18p
as also thought to have a negative feedback effect on the synthesis of PtdIns(3,5)P2, 
 
s going to construct 
ill too slim, calling more components identified. In this case, my second project was 
unched by a recent discovery that a yeast casein kinase Yck3p was required to 
much of the , 
w
but similar to all above propositions, the underlying mechanism remained to be
intensively investigated. As far as my project is concerned, I wa
endogenous level-expressed, C-terminally GFP-tagged these related proteins to 
observe their localisation patterns, combined with the standard biochemical 
techniques, in hope to answer some of above questions. 
 
In addition, PtdIns(3,5)P2 was well documented to be necessary for the hyper-osmotic 
induced vacuole fragmentation in budding yeast, but so far this stress signalling was 
st
la
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inhibit the vacuole fusion upon hyper-osmotic stress (see Section 1.8 and Chapter 4 
ents in the context of regulating vacuole fusion may produce 
seful information towards the PtdIns(3,5)P2 knowledge, alternatively at least on 
for more information). My starting point of second project was that: because 
PtdIns(3,5)P2 is required for vacuole fission whereas Yck3p is necessary to inhibit 
vacuole fusion, therefore it seems both molecules are functioning synergistically to 
control the hyper-osmotic signalling in budding yeast. The further investigation on 
Yck3p functional ev
u
Yck3p signalling itself. So, in my second project, I was going to exploit the hyper-
osmotic triggered, Yck3p-catalyzed phosphorylation of Vps41p (a subunit of tethering 
complex regulating the homotypic vacuole fusion) as a phenotype to screen some 
selective deletion mutants (ideally ~100), expecting to find some novel components 
which will be part of PtdIns(3,5)P2-involved stress pathway and Yck3p/Vps41 
pathway itself. 
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2.1 Strains, Media and Reagents  
 
 
 
rain FY833 (from ATCC), cells were used to express GST-Fig4p in 
yeast. Wild type BY4741 and BY4742 as well as deletion strains were purchased from 
EUROSCARF (Germany). S. cerevisiae strains were grown in standard Yeast extract 
–Peptone-Dextrose (YPD) or Synthetic Complete (SC) minimal media supplemented 
with essential amino acids. The budding yeast strains used in this study are listed in 
Table 2.1. 
 
The media for growth of yeast strains and other solutions are described below. Yeast 
extract, bacto peptone, bacto agar, yeast nitrogen base without amino acids and 
ammonium sulphate were obtained from Difco Laboratories. All other biochemical 
reagents were obtained from Sigma-Aldrich except as in indicated, and were of 
Biotechnological grade or better. 
 
 
Chapter 2    Materials and Methods 
 
TOP10 competent cells (Invitrogen) were used for all sub-cloning. BL21-
CodonPlus(DE3)-RIL cells (Stratagene) were used to express GST-SKIP and GST-
Ymr1p fusion proteins. BL21-star (DE3)-RIL cells (made based on the BL21- star
(DE3) E.coli strains from Invitrogen, see below for the construction strategy) were 
used to express His6-Fig4p and GST-Fig4p fusion proteins. E.coli strains were
propagated in LB broth or LB plates (containing appropriate antibiotics for plasmid
retention) following routine manipulation. 
 
S. cerevisiae st
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                           Tabl 1 S. cer  ai used i is
 
n e Ge p rc
e 2. : evisiae str ns 
noty e 
                             
Strai nam
n th  study 
Sou e 
W303
BY47  
BY47  
vps34
 
 
 
41
42
∆ 
fab1∆ 
vac14∆
vac7∆ 
atg18∆ 
ldb19∆ 
fig4∆ 
vps45∆ 
apm3∆ 
yck3∆ 
hog1∆ 
sho1∆ 
plc1∆ 
arg82∆
MA u 2; ∆2; leu2 2 -1 e2 ; can 00
MA hi ; l 0; met15 r   
MA ; his3 ; 0; lys2∆ a3
BY ; 4:: MX4 
BY ; :: 4 
BY ; 4 MX4 
BY 2; :: 4 
BY 2; 8:: X4 
BY 2; 9:: X4 
BY 2; 
BY 2; 5:: MX4 
BY 2; 3:: X4 
BY 2; :: 4 
BY 2; :: 4 
BY 2; :: 4 
BY 2; :: 4 
BY 2; 2:: MX4 
sc
sc
sc
sc
sc
sc
scarf 
scarf 
scarf 
scarf 
scarf 
scarf 
scarf 
scarf 
scarf 
scarf 
scarf 
Tα; ra3-5  trp1
Ta; s3∆1 eu2∆
Tα ∆1 leu2∆
4742 vps3 kan
4742 fab1 kanMX
4742 vac1 ::kan
474 vac7 kanMX
474 atg1 kanM
474  ldb1 kanM
474 fig4::kanMX4 
474 vps4 kan
474 apm kanM
474 yck3 kanMX
474 hog1 kanMX
474 sho1 kanMX
474 plc1 kanMX
474 arg8 kan
-3_11 ; his3 1; ad -1 1-1  
∆0; u a3∆0
0; ur ∆0  
Euro
Euro
Euro
Euro
Euro
Euro
Euro
Euro
Euro
Euro
Euro
Euro
Euro
Euro
Euro
Euro
Euro
arf 
arf 
arf 
arf 
arf 
arf 
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ipk1∆ 
kcs1∆ 
apl5∆ 
W303 (ssk2∆,ssk22∆) 
, fab1∆) 
14-GFP) 
VAC14-GFP) 
AC14-GFP) 
C14-GFP) 
+ pUG36-VAC7 
+ pUG36-VAC7 
 (VPS41-3HA) 
(VPS41-3HA) 
VPS41-3HA) 
(VPS41-3HA) 
VPS41-3HA) 
(VPS41-3HA) 
(VPS41-3HA) 
(VPS41-3HA) 
VPS41-3HA) 
ssk22∆ (VPS41-3HA) 
 fab1∆ (VPS41-kanMX6) 
VPS41-3HA) 
BY4742; ipk1::kanMX4 
BY4742; kcs1::kanMX4 
BY4742; apl5::kanMX4 
W303; ssk2::URA3, ssk22::LEU2 
1::TRP1, fab1::HIS3 
C14-GFP:HIS3MX6 
S3MX6 
MX6 
MX6  
MX6 
X6 
MX6 
3MX6 
MX6 
MX6 
PS41-3HA:HIS3MX6 
PS41-3HA:kanMX6 
MX6 
Euroscarf 
Euroscarf 
Euroscarf 
Euroscarf 
M.Gustin 
dy 
udy 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
vip1∆ BY4742; vip1::kanMX4 
W303 (hog1∆
BY4742 (VAC
vps34∆ (
fab1∆ (V
fig4∆ (VA
vps45∆ 
apm3∆ 
BY4742
yck3∆ 
fab1∆ (
vac14∆ 
fig4∆ (
atg18∆ 
ldb19∆ 
hog1∆ 
sho1∆ (
ssk2∆ 
hog1∆
plc1∆ (
W303; hog
BY4742; VA
vps34∆; VAC14-GFP:HIS3MX6 
fab1∆; VAC14-GFP:HIS3MX6 
fig4∆; VAC14-GFP:HIS3MX6 
vps45∆ 
apm3∆ 
BY4742; VPS41-3HA:HI
yck3∆; VPS41-3HA:HIS3
fab1∆; VPS41-3HA:HIS3
vac14∆; VPS41-3HA:HIS3
fig4∆; VPS41-3HA:HIS3M
atg18∆; VPS41-3HA:HIS3
ldb19∆; VPS41-3HA:HIS
hog1∆; VPS41-3HA:HIS3
sho1∆; VPS41-3HA:HIS3
W303 (ssk2∆, ssk22∆); V
W303 (hog1∆, fab1∆); V
plc1∆; VPS41-3HA:HIS3
This stu
This st
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
 62 
 
 
Materials and Methods 
 63 
 
 
 (VPS41-3HA) 
VPS41-3HA) 
VPS41-3HA) 
VPS41-3HA) 
) 
 
 
P 
S3) + pEGKT-FAB1 
S3) + pEGKT-FAB1kin- 
IS3) + pEGKT-FAB1fyve- 
IS3) + pEGKT-FAB1CCT-like- 
pEGKT-FAB1PIPKIII unique- 
14-mCHERRY:TRP1) 
S3MX6 
MX6 
MX6 
MX6 
PS41-GFP:HIS3MX6 
; VPS41 S24,26,28A-3HA:HIS3MX6 
X6 
:HIS3MX6 
3MX6 
:HIS3MX6 
P:HIS3MX6 
-∆901; lys2-801; suc2-
P1 
  
  
  
  
  
arg82∆
ipk1∆ (
kcs1∆ (
vip1∆ (
BY4742 (VPS41-GFP
yck3∆ (VPS41-GFP) 
plc1∆ (VPS41-GFP) 
arg82∆ (VPS41-GFP) 
ipk1∆ (VPS41-GFP) 
kcs1∆ (VPS41-GFP) 
vip1∆ (VPS41-GFP) 
VPS41S24,26,28A-3HA 
VPS41S44A-3HA 
VPS41S24,26,28,44A-3HA
VPS41G171R-3HA 
VPS41Q803stop codon-3HA
VPS41S24,26,28,44A-GF
fab1∆(VAC14-GFP:HI
fab1∆(VAC14-GFP:HI
fab1∆(VAC14-GFP:H
fab1∆(VAC14-GFP:H
fab1∆(VAC14-GFP:HIS3) + 
SEY6210 (FIG4-GFP:HIS3,VAC
 
arg82∆; VPS41-3HA:HI
ipk1∆; VPS41-3HA:HIS3
kcs1∆; VPS41-3HA:HIS3
vip1∆; VPS41-3HA:HIS3
BY4742; VPS41-GFP:HIS3MX6 
yck3∆; VPS41-GFP:HIS3MX6 
plc1∆; VPS41-GFP:HIS3MX6 
arg82∆; VPS41-GFP:HIS3MX6 
ipk1∆; VPS41-GFP:HIS3MX6 
kcs1∆; VPS41-GFP:HIS3MX6 
vip1∆; V
BY4742
BY4742; VPS41 S44A-3HA:HIS3M
BY4742; VPS41 S24,26,28,44A-3HA
BY4742; VPS41 G171R-3HA:HIS
BY4742; VPS41 Q803stop codon-3HA
BY4742; VPS41 S24,26,28,44A-GF
fab1∆; VAC14-GFP:HIS3MX6 
fab1∆; VAC14-GFP:HIS3MX6 
fab1∆; VAC14-GFP:HIS3MX6 
fab1∆; VAC14-GFP:HIS3MX6 
fab1∆; VAC14-GFP:HIS3MX6 
MATα; leu2-3,112; ura3-52; his3-∆200; trp1
∆9; FIG4-GFP:HIS3; VAC14-mCHERRY:TR
This study
This study
This study
This study
This study
This study  
This study  
This study  
This study  
This study  
This study  
This study  
This study  
This study  
This study  
This study  
This study  
This study 
This study 
This study 
This study 
This study 
This study 
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2.2 Media composition and solutions 
2.2.1 Luria Broth (LB)  (1L) 
Yeast Extract (0.5%, w/v), Tryptone (1.0%, w/v), NaCl (1.0%, w/v) 
2.2.3 LB agar (1L) 
LB + Bacto agar (2.0%, w/v) 
2.2.4 LB agar + 100 μg/ml Ampicillin or 34 μg/ml chloramphenicol (1L) 
LB agar + Ampicillin (100 μg/ml) or chloramphenicol (34 μg/ml) 
2.2.5 SOC medium (1L) 
E a ), 
), 
2.2.7 YPD + 0.9 M NaCl or 0.4 M NaCl  
YPD + NaCl (0.9 M or 0.4 M) 
2.2.8 YPD agar (1L) 
YPD + Bacto agar (2.0%, w/v) 
2.2.9 Amino-acid stock powder  
leucine (2. ), Serin 2.01g), Adenine (2.03g), Glycine (1.99g), Phenylalanine 
nine 
 id 2  n  the 
2.2.10 Synthetic complement (SC) + Glucose (1L) 
2.2
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Materials and Methods 
Yeast nitrogen base (w/o amino acids & w/o ammonium sulfate) (1.7g), Ammonium 
powder (1g), Tryptophan (100mg), Histidine (100mg), 
mg)  
to the addition of 20 g of 
d). The media was then autoclaved for 15 mins at 121°C, cooled 
m a 40% w/v stock) prior to use.  
 was omitted. For 
 100mg Uracil was left out.    
 M), 0.05 M EDTA (pH 8.0) 
r 
, v/v), SDS (4%, w/v), β-mercaptoethanol 
.004%, w/v) 
 running buffer 
, SDS (1%, w/v) 
r 
.22 μm filter or 
sulfate (5g), Amino acid stock 
Leucine (100mg), Lysine (100mg), Methionine (100 mg), Uracil (100
 
The pH of SC was adjusted to 5.7 with 5M NaOH, just prior 
Bacto agar (if require
and dextrose added to 2% (fro
 
To prepare selective SC medium, the corresponding amino acid
example, to make SC-Ura,
2.2.11 50x Tris-Acetate-EDTA buffer (TAE) 
Tris (2.0 M), Glacial acetic acid (0.94
2.2.12 6x DNA gel electrophoresis sample buffer 
Tris.HCl (10mM), Glycerol (50%, v/v), Bromophenol blue (0.2%, w/v) 
2.2.13 2x SDS-PAGE sample buffe
Tris.HCl (120 mM, pH 6.8), Glycerol (10%
(5%, v/v), Bromophenol blue (0
2.2.14 10x SDS-PAGE
Tris (250 mM), Glycine (2.5 M)
2.2.15 10x blot transferring buffe
Tris (250 mM), Glycine (1.87 M) 
2.2.16 Phosphate buffered saline (PBS) 
Sterile PBS (8.2 mM Na2HPO4, 1.5mM KH2PO4, 139mM NaCl, 3mM KCl) was 
prepared using PBS tablets (Oxoid) and filter sterilized via a 0
autoclaved. 
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2.3 Polymerase chain reaction (PCR) 
All PCRs were performed with Expand High Fidelity PCR system (Roche), in a 
TECHNE TC-3000 (Staffordshire, UK) thermal block cycler. Two reaction mixes 
ere prepared based on manufacturers instructions as follows: Deoxyribonucleotide 
zyme (0.75 μl) were 
ade up to 50 μl total volume with ddH2O and mixed, before mixing with the master 
ng profile was as is shown in 
ferent Tm values. The 
er sequence were 
s the Tm2 value was obtained by 
rimer that is 
early rounds of amplification: hence sequences 
temperature in order to more accurately 
get DNBA during early PCR cycles.I found 
re efficiently than PCR employing a 
ication of my target fragments. 
w
mix (200 μM of each dNTP), upstream primer (300 nM), downstream primer (300 
nM), and target DNA were mixed in one “master mix” made up to 50 μl total volume 
with ice -cold ddH2O, whilst 10x buffer (5 μl), and Expand en
m
mix 1. All PCRs were then aliquotted to 50 μl, since this was the volume that the 
thermal cycler was calibrated for. The temperature cycli
Table 2.2. A two step PCR program was used that used two dif
Tm1 was calculated by assuming that all the bases in the prim
complimentary to those on the target DNA wherea
calculating the melting temperature of only that portion of the  p
homologous to the target DNA in the 
encoding mutations or restriction sites not present in the target DNA were excluded 
from the calculation of this second melting 
reflect the  lower affinity of primers for tar
that this two step PCR program worked much mo
single measurement of Tm for amplif
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Table 2.2:  PCR cycling profile 
ast knock-in/out 
fragments were amplified from the knock-in plasmids pFA6a-3HA-HIS3MX6 and/or 
pFA6a-GFP(S65T)-HIS3MX6 and knock-out plasmids pFA6a-kanMX6 or pFA6a-
HIS3MX6 using corresponding oligos (Longtine et al., 1998). All oligos were 
synthesized by Alta Biosciences, University of Birmingham, UK and are listed in 
Table 2.3.  
94°C 94°C T －5°C 68°C 94°C T －5°C 68°C 68°C 4°C 
2.4 DNA sequencing 
The DNA sequencing was performed by the Functional Genomics and Proteomics 
Unit, University of Birmingham (Birmingham, UK). The reaction mix was prepared 
as follows: template (100 ~ 500 ng), primer (3.2 pmol), then ddH2O was added to 
total volume of 10μl. The Genomics facility then added a Terminator Reaction Mix to 
the target DNA supplied by our lab to give a final volume of 20μl. The reaction mixes 
were then amplified via PCR and the resulting chain-termination reaction resolved 
using an ABI sequencing device that separated the dye labelled fragments by capillary 
electrophoresis. The sequencing data were then analysed in Chromas (version 1.45). 
 
2.5 Plasmid construction and yeast knock-in/out fragment 
All DNA restriction enzymes and T4 DNA ligase were obtained from New England 
Biolabs, Inc (Beverly, MA). Standard molecular biology techniques were used for 
DNA manipulations. All constructs were generated by transforming into E. coli 
TOP10 competent cells and confirmed by DNA sequencing. All ye
m1 m2
4min 0.5min 1min 2min/kb 0.5min 1min 2min/kb 10min 12 hours
1 cycle 15 cycles 25 cycles 1 cycle 1 cycle 
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2.5.1 pET-15b-FIG4 & pGEX-6P-1-FIG4 
The FIG4 ORF (open reading frame) was am m original pACT2-FIG4 (a 
gif r ya m usin on es c d 
un deI and B triction enzyme sites at the 5’ and 3’, i e 
 with Nde I and BamHI, then sub-cloned into NdeI-BamHI-
y 
ST-tagged YMR1 for expression in BL21-CodonPlus(DE3)-RIL cells..  
P:HIS3) which was previously obtained from Invitrogen. The PCR 
plified fro
t of D T. Koba shi fro  Dr Dove’s lab) g olig ucleotid  that in orporate
ique N amHI res  respect vely. Th
PCR product was digested
digested pET-15b (Novagen), generating an N-terminally His6-tagged FIG4 allele for 
expression in BL21-star (DE3)-RIL cells. FIG4 was also cloned into vector pGEX-
6P-1 for expression of GST-Fig4p in BL21-star (DE3)-RIL cells. 
 
2.5.2 pGEX-6P-1-YMR1 
The cDNA of YMR1 was amplified by PCR from yeast S. cerevisiae genomic DNA 
with 5’- Xho I and 3’- Not I oligonucleotides and inserted into pGEX-6P-1 vector 
(Amersham) containing same restriction enzyme sites, generating an N-terminall
G
 
2.5.3 pEGKT-FIG4 
The pEGKT-FIG4 construct was generated by ligating PCR-duplicated FIG4 
containing unique 5’- BamH I and 3’- Hind III sites to pEGKT vector digested using 
same restriction enzymes. The resulting recombinant was expressed in yeast strain 
FY833.   
 
2.5.4 VAC14-GFP fragment and pUG36-VAC7 
VAC14-GFP fragment was amplified by PCR from genomic DNA of yeast BY4741 
(VAC14-GF
 68
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ferent S. cerevisiae null strains in 
ac14p-GFP. pUG36-VAC7 is from 
omains in either the FYVE, PIPKIII unique, CCT-like or PIPKinase 
ade by Dr Frank Cooke, UCL) were introduced into 
product was knocked into wild type and several dif
order to investigate the localisation changes of V
Dove’s lab previous work. 
 
 
2.5.5 pEGKT-FAB1 and pEGKT-FAB1 with mutation in four distinct functional 
domains individually 
In order to study which functional domain(s) of Fab1p may influence Vac14p vacuole 
membrane localisation, four constructs of pEGKT-FAB1 which have the disrupted 
functional d
domains (constructs originally m
fab1∆(VAC14-GFP:HIS3). The conserved domains being considered are defined in 
Michell et al., 2007 and the mutations were made via site-specific mutagenesis by 
overlap extension (see Section 16 in this chapter).   
 
Materials and Methods 
 70 
 
 
Table 2.3:  g e
Name  Sequence comments 
Oli os w re used in this study 
pET-15b-FIG4 
 
pGEX-6P-1-FIG4 
 
pGEX-6P-1-YMR1 
 
pEGKT-FIG4 
 
VAC14-GFP 
 
VPS41-GFP or 3HA 
 
YCK3-GFP or 3HA 
 
PLC1-Knock out 
 
IPK1-Knock out 
 
KCS1-Knock out 
 
VIP1-Knock out 
 
VPS41S-A-A (FW) 
VPS41S-A-B (RV) 
VPS41S-A-C (FW) 
VPS41S-A-D (RV)  
VPS41S-A-E (RV) 
VPS41S-A-F (FW) 
VPS41G171R (RV) 
VPS41G171R (FW) 
VPS41Q803stop codon 
TTTTTTCATATGATGAACAATGATGC G C
TTTTTTGGATCCTTATTGAAAATCA G A T A C A C
TTTTTTGGATCCATGAACAATGATG T G
TTTGTTCTCGAGTTATTGAAAATCA T A T
TTTTTTCTCGAGATGGAGTACATCA T G CT 
TTTTTTGCGGCCGCTCACTTTCTATT T ATCCAAAAA
TTTTTTGGATCCATGAACAATGATG T G
TGGGTTAAGCTTTTATTGAAAATCA T A TTT A  
ATTTGATCTTAGCTCCTGCCTCTTTG C
AAGGGTTAACTTTCAAACACATTAC
AAGCGATATTGAAATTAATGACGAC AAA G TT TAATTA
AAGTGTACACTTGCCTTGTGTATTA G AT A GAA TTAAA
TAAAATATACAAATATTGTTGTTGCT TTTTTGTT CTGTCGGA AATTAA
AAAAAAAAAGGAAAAAGAGAAAA T A G A  
TAAACGTACAACGGTAAGGTCATTC GCA TG A C TCCCCGGGTTAATT
CGTATTTATGAATATGTGTATTTGGC GAA A TCG GAA TTTAAA
AATTGTCAGAGATAAGTTCCTTTTT A A A C TCCCCGGGTTAATT
GCATCTGCCAGTACCAAAGGTGGA GAA G A T A
TTTTTATTTTTTGTATATATAAAACTAAAGC GGA AATTAA
GCGCAGCTAAAAGAATATTCATTAGTTCT CTTTGAA TTAAA
CAAAAGCATCTCGTAGCATATTAATATATT G G C G TAATTA
TTTAGTTTTGGGTTACTAAATTAAAAATTG TG T GAA C C TTTAAA
GTCTGACCTGGTTATGCAGGTCATGCTCT
CGTCGGCGATGGCATTGGCCTCATCAA  
GGCCAATGCCATCGCCGACGAGAATAATG A T A
TTAGCCTGTACCGATCACTGGAAACTGGA
TTTGTTGGTGCAGTTACATTAACGTCTTCCCTC 
AATGTAACTGCACCAACAAAAAGTGTTA G T
CTGTCCCGTCAATAGATCGCGTAGCAAAA T
GCTACGCGATCTATTGACGGGACAGTGA ATCG A 
AGATACGGACGACTCGTTCATGATAAGTC A A TCCCCGGGTTAATT
GAAGGCTTTGTCGGTCGTATTCAGAATA T A GTTTA
NdeI  
BamHI  
BamHI 
XhoI  
XhoI 
NotI 
BamHI 
HindIII 
 
 
F2 primer 
R1 primer 
F2 primer 
R1 primer 
F1 primer 
R1 primer 
F1 primer 
R1 primer 
F1 primer 
R1 primer 
F1 primer 
R1 primer 
no mutation 
S- 24,26,28 -A
S- 24,26,28 -A
no mutation 
S- 44 -A  
S- 44 -A 
G-171-R 
G-171-R 
F2 primer 
R1 primer 
AAT GAG ATACCCTT 
AGTT TAT TCTT AGA AAG ACA ATC
CAA GGA CAT 
AGT GTAT TCT TAGAAAA 
AGA TGCCAAA TAT
AAACATA CAA TTGAC 
CAA GGA CAT 
AGT GTAT TC AG AAA
ACC  
AGGGATGAGTT 
TT TG TGT TACGGATCCCCGGGT
AAT ATG TCG TA TTCGAGCTCGT
G G TCCCCGGGTT
GTA AAA ATC CTTT GAATTCGAGCTCGTTT
AC G TAT TGA GGA
CG AA GA C TTCGAGCTCG
TGA AAG AAG TCG GGA
AA AA TAT CAG GAATTCGAGCTCGTTT
TAAAAGACTC TCCCCGGGTT
ATCCTTT TTCGAGCTCGT
GCAGAAG TCC GAT CCC GGT
GG TGA CA TT GAG TCG
A 
TTGTTCGTTCGCCT
TTG TAA AAG G 
T 
GTT CATA CAC 
TAT TTCCGTCAGTG 
TT G
CTT TGA AATCGGA
AAG TCA TTAGGAATTCGAGCTC
 
A 
C 
 
AAAC
AA 
C 
AA 
AAC 
 
C 
A 
C 
AA 
AAC 
Materials and Methods 
2.6 Transformation of E.coli (Hanahan 1983) 
Plasmid DNA (0.1-10μg) was added to an aliquot of competent E.coli cells (100μl), 
incubated on ice for 30 min and heat shocked at 42°C for 45 seconds. SOC medium 
(1.0 m a ed to t l su  
min. C  
in 150 μl fresh LB medium an l of Ampicillin  
plate. Incub re at 37°C f
 
Const tion BL21 s IL 
BL21 r E.coli s s a tated  
131)   a nca s bili e  
A, s odo
E.c  
mid  
e ge  
ucin  
ns h  
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The benefits of both strains r m e y tr n e id 
from BL21-CodonPlus(DE3)-RIL, then transformi i  li 
strains. Theoretically the engineered novel strain should be able to grow in LB-agar 
medium containing Chloramphenicol but BL21 star (DE3) can not. This novel strain 
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Materials and Methods 
was designated ‘ BL21 star (DE3)-RIL’. 
 
2.8 Recombinant Protein expression and purification 
2.8.1 Expression and purification of GST-Ymr1p fusion protein 
Ymr1p was expressed in E. coli strain of BL21-CodonPlus (DE3)-RIL as a GST-
tagged full-length fusion protein. Protein expression was induced for 2 hours at 30°C 
by the addition of 1mM isopropyl-β-d-thiogalactopyranoside (IPTG) (Roche). Briefly, 
acteria from a 3-litre culture were disrupted with 1% of lysozyme and sonication in 
M EDTA 
0mM Tris-HCl, pH 
.5, 150mM NaCl, 5mM Benzamidine, 20mM Glutathione). The eluate was collected 
b
40 ml of 100 mM Hepes (pH 7.5), 150 mM NaCl, 5mM Benzamidine, 10m
as well as appropriate amount of protease inhibitor cocktail (Sigma, P8465 added 
immediately prior to use). Triton X-100 was added to 1% (v/v), and the crude lysate 
was centrifuged at 9,447 xg (8,000 rpm)(Beckman J2-MC, rotor JA18) for 15 min to 
remove insoluble material. The supernatant was decanted to a fresh high-speed tube 
for an additional high-speed centrifugation at 64,230 xg (25,000 rpm) (Beckman L-70 
ultracentrifuge, rotor Type 70 Ti) to remove the remaining insoluble materials. 
Proteins were then isolated from the resulting cleared lysates by the addition of 2 ml 
of equilibrated Glutathione sepharose 4B (Amersham biosciences, prepared in 1:1 
slurry with lysis buffer) and incubated for 2 h at 4°C. Resins were then washed twice 
with lysis buffer with detergent and twice with lysis buffer without detergent. The 
fusion protein was eluted from resin with 2ml of elution buffer (5
8
in 4 x 0.5 ml fractions. DTT (dithiothreitol) and glycerol were then added to 1 mM 
and 50% (v/v), respectively, and the protein was stored at -80°C until use. 
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2.8.2 Expression and purification of GST-Fig4p fusion protein 
xpression of GST-Fig4p was accomplished as for GST-Ymr1p with the following 
1-Star (DE3)-RIL. 
d the lysis buffer 
. The cell 
spension was lysed by addition of 1mg/ml lysozyme and cells were incubated for 
0 min at 4°C to give the enzyme time to work. Cells were then sonicated for 5 x 15s, 
E
modifications: the expression system is E. coli strain of BL2
Induction was carried out with 1mM IPTG for 2 hours at 28°C an
was 50 mM Bis-tris (pH 6.5), 150 mM NaCl, 5mM Benzamidine, 1mM EDTA. The 
rest of the protocol was as above. 
 
2.8.3 Expression and purification of GST-SKIP fusion protein 
The protocol was similar to that as described in Section 2.8.1 save for the following 
modifications: The protein expression was induced at 16°C overnight by the addition 
of IPTG to a final concentration of 0.1mM. The lysis buffer and washing buffer were 
50 mM Tris (pH:7.5), 2 mM EDTA, 10 mM Benzamidine, 10 μg/ml Trypsin Inhibitor 
(Soyabean), and PMSF (phenylmethanesulfonyl fluoride) and DTT were present at 
final concentration of 1mM (added before immediately use). The Elution buffer was 
50mM Tris (pH: 8.0), 500mM NaCl, 20 mM Glutathione.  
 
2.8.4 Expression and purification of His-Fig4p fusion protein  
Recombinant plasmid of pET-15b-FIG4 was transformed into E. coli strain BL21-star 
(DE3)-RIL for generating His6-Fig4p fusion protein. Briefly, protein expression was 
induced at 18 °C overnight by addition of 0.1mM IPTG. Cell pellets from a one litre 
culture were resuspended in 30ml of lysis buffer containing: 50mM Tris-HCl (pH: 
8.0), 300mM NaCl and 20mM Imidazole, one EDTA-free protease inhibitor cocktail 
tablet was added (Roche, Cat number: 11873580001) just prior to use
su
3
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and then Triton X-100 was added to 1% and crude lysate was centrifuged at 9,447 xg 
ith detergent and twice with lysis buffer without 
etergent. The fusion protein was eluted from Ni-NTA resin with 2ml of elution 
le. The eluate was 
ed as 
llows: 200 ml of SC-URA- media, containing 2% dextrose was inoculated with the 
 cells/ml). Then this 
for 10 min at 4°C. The supernatant was decanted into a fresh tube and subjected to 
additional 64,230 xg centrifugation for 20 min at 4°C. The resulting cleared lysate 
was incubated with 2ml of pre-equilibriated Ni-NTA agarose (Qiagen, prepared in a 
1:1 slurry with lysis buffer) for 2 hour at 4°C with gentle agitation. Resin was then 
washed twice with lysis buffer w
d
buffer: 50mM Tris-HCl, pH 7.5, 150mM NaCl, 200mM Imidazo
collected in 4 x 0.5 ml fractions. DTT and glycerol were then added to 1mM and 50% 
(v/v), respectively, and the protein was stored at -80°C until use.  
         
2.8.5 Expression and purification of GST-Fig4p fusion protein from budding 
yeast S. cerevisiae 
The yeast strain FY833 was transformed with pEGKT-FIG4 according to the standard 
yeast transformation protocol. Cell culture and protein induction were perform
fo
above strain and grown to late log phase (approximately 1~3 x 107
inoculum was added to 4 litres of fresh SC-URA- containing 2% raffinose and grown 
to a mid log phase (approximately 0.5~1 x 107 cells/ml) at 30°C with good aeration. 
An additional 40g of yeast extract, and  80g Bacto-peptone (solid) was then added to 
the culture and the GST-Fig4p fusion protein was induced for 4~6 hours at 30°C by 
addition of 2% galactose. The cells from 4-litre culture were harvested by 
centrifugation at 6000 xg and resuspended in 50 ml of lysis buffer: 50mM Tris 
(pH:7.5), 150mM NaCl, 1mM EDTA, 5mM Benzamidine and appropriate amount of 
Protease inhibitor cocktail (Sigma P8215)  before being disrupted in a  bead beater. To 
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the resulting total lysate was added Triton-X-100 to 1% (v/v) and the lysate incubated 
on ice for 30 min. Debris was removed by centrifugation at 9,447 xg for 10 min, then 
the supernatant centrifuged again at 64,230 xg for 15 min. The resulting cleared lysate 
was filter through a 0.4 μm filter and then directly loaded onto Q Hi-Trap mini 
column (Pharmacia) and a 50 ml gradient from 150mM to 2M NaCl run to resolve the 
bound protein into distinct peaks. Fractions were collected at (25 x 2 ml) and analysed 
for target protein by western blotting with anti-GST antibody. The fractions 
containing fusion protein GST-Fig4p were combined and purified further using 
standard Affinity purification of the GST fusion protein as described above. 
 
2.9 SDS-PAGE (Sodium Dodecyl Sulphate-polyacrylamide Gel 
6x SDS sample buffer (58mM Tris-HCl pH 6.8, 1.6% glycerol, 5% SDS, 0.1M DTT 
and 1.2mg bromophenol blue) was added to protein samples to a final concentration 
of 1x. Samples were then vortexed and incubated at 100°C for 5 min. Proteins were 
separated by SDS-PAGE. Electrophoresis was performed at 120V for approximately 1 
hour until the bromophenol blue dye-front reached the end of the gel or until the 
desired separation of the prestained molecular weight markers was achieved. 
 
cassette and put into the blotting buffer. A blotting cassette was assembled according 
Electrophoresis)  
2.10 Western blotting 
Proteins separated by SDS-PAGE were transferred to a Hybond-ECL nitrocellulose 
membrane (Amersham Biosciences) for further analysis. The nitrocellulose 
membrane and two pieces of 3MM filter paper (Whatman) were cut to the size of the 
separating gel and pre-soaked in the blotting buffer. The gel was removed from the 
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to the manufacturer's instructions, namely in the order of a sponge, two filter papers, 
gel (rinsed with blotting buffer), a nitrocellulose membrane, two filter papers and 
sponge, from black (cathode) to the white (anode). The assembled blotting cassette 
and an ice block for cooling were inserted into the transfer tank with blotting buffer, 
the transfer was performed at 400 mA for 1 hour. 
 
2.11 Immunochemical protein detection by Enhanced 
Chemiluminescence (ECL) 
After protein transfer had completed, the nitrocellulose membrane was rinsed with 
buffer (5% skimmed milk powder dissolved 
king, the membrane was placed in a heat-sealed bag with 5 ml 
min per 
ash) in washing buffer and bound antibodies were detected by ECL detection 
nces). ECL solution A and B were mixed 1:1 immediately 
TM
distilled water and incubated in blocking 
in PBST containing 0.1% Tween 20 in PBS) for 1 h at RT or at 4°C overnight on a 
shaker. Following bloc
primary antibody (diluted in blocking buffer), incubated for 1 h at RT with shaking. 
The membrane was then washed six times (5 min per wash) in PBST washing buffer. 
The membrane was incubated with an appropriate horseradish peroxidise-conjugated 
secondary antibody in an appropriate dilution on a shaker for 1 hour at RT. A list of 
the primary and secondary antibodies with appropriate dilutions used in this study is  
shown in Table 2.4. The membrane was then washed at least six times (5 
w
reagent (Amersham Bioscie
prior to adding to the membrane. Excess reagent was removed and the membrane was 
wrapped in Saran wrap. Chemiluminescence was detected by Gel Documentation 
System, Fluor-S  Multimager (Bio-Rad). Different exposure times were used 
depending on the intensity of the protein bands. 
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Table 2.4 
Protein detected Primary antibody Secondary antibody 
Vps41p-3HA 
 
HA.11 from mouse, 
1:1000 
 
 
IgG (H+L), 
Invitrogen, 
1:1000 
 
 
Monoclonal Antibody, 
COVΛCE, 
HRP-Goat  Anti-Mouse 
Vps41p-GFP monoclonal IgG2a, IgG (H+L), 
 
GFP (B-2), mouse 
Santa Cruz Biotechnology, 
1:500 
HRP-Goat  Anti-Mouse 
Invitrogen, 
1:1000 
 
 
 
2.12 High efficiency transformation of budding yeast (Adam et al., 
1997) 
Cells sub-cultured at 5 x 106 cells/ml in YPD medium (2 ml) were grown at 30°C to 
2~5 x 107 cells/ml. Cells were collected, resuspended in 1ml of 100 mM lithium 
acetate (LiAc). The cell suspension was centrifuged at 1000g for 30 seconds and the 
supernatant was removed. Add the following to the cell pellet in the exact order: 240 
μl of 50% PEG, 36 μl of 1.0M LiAc, 50 μl of boiled ssDNA, 25 μl of ddH2O 
containing the DNA (~ 1ug) to be transformed, and the resulting mixture were mixed 
by vortexing vigorously until the cells were completely resuspended, then incubated 
at 30°C for 30 min followed by heat shock at 42°C for 25 min. Cells were collected 
by centrifugation at 1000 xg for 15 seconds, the supernatant was discarded and the 
cells were resuspended in 200 μl of ddH2O, plated on selective agar plates and 
incubated at 30°C for at least 36 hours. 
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2.13 Genomic DNA purification from budding yeast 
The following method is adapted entra Puregene Handbook, second 
ed ~ 48, 09/ f expo  were 
collected ended i ion  kit) 
with 1.5 μl of Lytic Enzyme Solution. The resulting mixture ed at 37°C 
for 30 min. Cells were then pelleted by centrifugation at 16,000g for 1 min and 
resuspended in 300 μl of Cell Lysis Solution plus 100 μl ecipitation 
Solution, and vortexed vigorously for 20 s at high speed, then centrifuged at 16,000g 
for 3 min. The supernatant (approx. 400 μl) was decanted into a fresh tube pre-filled 
ith 300 μl of isopropanol. Samples were then mixed well and centrifuged at 16,000g  
 then on a clean piece of absorbent paper. Then DNA pellet was washed once 
r deletion of certain ORFs, the corresponding auxotrophic marker was amplified 
om the knock-out plasmids pFA6a-kanMX6 or pFA6a-HIS3MX6 (Longtine MS, et 
from the G
ition, Qiagen, p47 2007. Briefly, 2 ml o nentially growing cells
 and resusp n 300μl of Cell Suspens Solution (provided by the
 was incubat
of Protein Pr
w
for 1 min. The supernatant was then carefully discarded and the tubes drained by 
inverting
with 300 μl of 70% ethanol and air dried for up to 10 min. Afterwards, the DNA 
pellet was then resuspended in 50 μl of DNA Hydration Solution plus 1.5 μl of RNase 
A Solution and incubated at 37°C for 30 min, then incubated at 65°C for 1 hour to 
dissolve the DNA.         
 
2.14 Disruption (Knock-out) and Epitope tagging (Knock-in) of 
budding yeast strains 
Deletion and tagging of genes in chromosome in budding yeast were done by 
homologous recombination via transforming corresponding PCR fragments into the 
desired strains.   
 
Fo
fr
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al., 1998) by PCR using primers that contained sequences for annealing to the 
formly C-terminal so as not to affect expression levels from 
e native promoter.  
genesis by overlap extension (Sambrook and 
 primers (A & B) is used to amplify the DNA that contains the 
utation site together with upstream sequences. Of which, the primer A harbours a 
template plasmid, flanked by sequences that encode regions immediately before the 
start codon and after the stop codon of the corresponding ORFs. PCR products were 
used to transform yeast strains.  
 
For the chromosomal HA and GFP tagging at 3’-terminal of target gene, the knock-in 
fragment was amplified from the plasmids pFA6a-3HA-HIS3MX6 and pFA6a-
GFP(S65T)-HIS3MX6 (Longtine et al., 1998) by PCR using oligonucleotides that 
included the sequences for annealing to the template plasmid, flanked by sequences 
complementary to the 40 nucleotides immediately before and after the stop codon of 
the target gene. PCR products were used to transform yeast strains. 
 
All putative knock out and knock-in strains were confirmed by sequencing the 
appropriate locus of genomic DNA recovered from transformed cells. All proteins to 
be over-expressed were N-terminally tagged whereas the epitope tagging in yeast 
knock-in strains was uni
th
 
2.15 Site-specific muta
Russell, 2001) 
Four primers are needed to introduce a site-specific mutation by overlap extension. 
The first pair of
m
wild-type sequence whereas primer B contains the mutation(s) to be introduced. 
Similarly, the second pair of primers (C & D) is used to amplify the DNA that 
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contains the mutation sites with downstream sequences. Of which, the primer D 
includes a wild-type sequence whereas primer C harbours the mutation(s) to be 
introduced.  
 
he two sets of primers are used in two separate amplification reactions to amplify 
A mutation. Finally, the resulting VPS41S24,26,28,44A-3HA:HIS3 
agment was transformed into BY4742 wild type strains to obtain BY4742 
 sequencing the target fragment of genomic DNA. 
T
over-lapping DNA fragments (fragment AB and CD). The mutation(s) of interest is 
located in the region of overlap and therefore in both sets of resulting amplified 
fragments. The overlapping fragments are mixed, denatured and annealed to generate 
heteroduplexes that can be extended and, in a third PCR, amplified into a full-length 
DNA using two primers that bind to the extremes of the two initial fragments (The 
overall strategy is sketched in Fig. 2.1).    
 
In this study, in order to construct BY4742 (VPS41S24,26,28,44A-3HA:HIS3), firstly, 
BY4742 (VPS41S24,26,28A-3HA:HIS3) was constructed and the genomic DNA was 
extracted. Then, the resulting genomic DNA was used as the template DNA to 
amplify the VPS41S24,26,28,44A-3HA:HIS3 knock-in fragment by using a pair of oligos 
harbouring the S-44-
fr
(VPS41S24,26,28,44A-3HA:HIS3) by growing in SC-HIS3 plate and putative mutants 
were confirmed by
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template DNA 5’ 3’ 
5’ 3’ 
 
ected Mut
 
2.16 Detection of phosphorylated Vps41-3HA by immunobloting 
3 ml of exponentially growing cells were divided into two 1.5 ml tube and harvested 
by centrifuging cells at 1000g for 0.5 minutes: one tube of cell pellet was resuspended 
in 1 ml of fresh YPD medium and the other in 1 ml of fresh YPD c
Figure 2.1: Site-dir agenesis by Overlap Extension (from Sambrook and 
Russell, 2001) 
ontaining 0.9M 
aCl, then incubated at 30°C for another 15 minutes. These two fractions of cells 
(hyper-osmotically shocked and non-shocked) were collected again by centrifuging 
and re-suspended in 200 μl of 0.1M NaOH, and incubated at RT for 5 minutes. The 
cells were again centrifuged and the supernatant discarded. The cell pellet was 
washed twice in 300 μl of ddH2O then resuspended in 50 μl of 1x SDS-PAGE loading 
N
5’ 3’ 
5’ 3’ 5’ 3’ 
5’ 3’ 
5’ 3’ 
5’ 3’ 
5’ 
5’3’ 
3’ 
B 5’
5’ 
3’ 
3’
C 
D 
5’ 
5’ 3’ 
3’ 
A 
A 
D 
5’ 
5’ 
3’ 
3’ 
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buffer and boiled for 3 minutes. Centrifugation was then carried out at maximum 
speed (13,000 xg) for 1 minute to remove the debris. The supernatant, containing the 
extracted total protein, could then be immediately analysed by the routine 
immunobloting protocol described above except the SDS-PAGE was run at 82V for 6 
hours and the Vps41-3HA was probed by anti-HA primary antibody from mouse. For 
each experiment, equal amount of samples (equivalent to 5 x 106 cells) were analysed. 
 
2.17 Quantification of immunoblot bands using ImageJ 1.42  
In order to compare the ratio of phosphorylated Vps41p to that of non phosphorylated 
Vps41p, the intensity of bands on the western blot was measured using the ImageJ 
1.42 program (National institutes of Health, Bethesda, MD). In brief, the blot picture 
was converted to 8-bit grayscale and inverted. Then the phosphorylated and/or 
nonphosporylated bands were selected by drawing a line around the boundary of the
gh such selection criteria were subjective, particularly when the 
hosphorylated band and nonphosphorylated band were not sufficiently separated to 
 this 
 
bands, largely based on good judgement about where the edges of the band were 
located. Althou
p
allow the software resolve the bands as two separate identities, the results from
selection analysis did provide us with some ideas about the trends of quantification 
change. Once the interested bands were chosen by the freehand selection tool, the 
integrated intensity of bands was obtained by the software, using the Area and Mean 
Gray Value columns multiplied together. The resulting values obtained in this way 
were then divided by one another to determine the ratio of phosphorylated to non-
phosphorylated Vps41p. 
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2.18 Immuno-purification of Vps41p-3HA from budding yeast 
300 ml of exponentially growing cells of BY4742 (VPS41-3HA:HIS3) were 
harvested and subject to the hyper-osmotic stress by incubating in YPD with 0.9M 
NaCl for 15 minutes at 30°C. Cells were pelleted again and resuspended in 10 ml of 
0.1M NaOH and incubated for 5 minutes at RT to weaken the cell-walls. Cells were 
collected by centrifugation and supernatant was discarded. In order to extract the total 
protein contents, the cells were lysed in 5 ml of lysis buffer (60mM Tris-HCl pH 6.8, 
 resulting 
urified phosphorylated Vps41-3HA bands were detected by 
oomassie staining and excised for analysis by mass spectrometry conducted in the 
unctional Genomics and Proteomics Unit, University of Birmingham, UK. 
2% SDS, 2% glycerol, 3% β-mercaptoethanol) by boiling for 3 minutes. The
extracted supernatant (approx. 5 ml) contained the total protein content and so also 
contained the phosphorylated Vps41p-3HA. The total lysates were diluted 10 times 
using binding buffer (60mM Tris-HCl pH 6.8, 150mM NaCl) and pre-cleared by 
incubating with Protein G sepharose 4 fast flow (GE Healthcare) for 2 hours to 
remove the non-specific proteins. 
 
To prepare the anti-HA antibody - conjugated protein G sepharose, 100 μl of protein 
G sepharose and 30 μl of anti-HA antibody were incubated in 500 μl binding buffer 
for 2 hours, then washed four times with 10 ml binding buffer: the resulting anti-HA 
antibody-conjugated protein G sepharose was added into 10 times diluted, pre-cleared 
50 ml total lysates and incubated for 2 hours. After incubation, the beads were washed 
four times with 4 x 10ml binding buffer and the resulting beads (with the Vps41-3HA 
now bound to the beads) were resuspended in 80 μl of 1 x SDS-PAGE loading buffer, 
followed boiling for 3 minutes. The resulting supernatants were loaded onto the SDS-
PAGE and the immuno-p
c
F
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2.19 Analysis of Vps41p phosphorylation sites by LC-CID-FT-ICR-
MS (Liquid chromatography-Collision induced dissociation-Fourier 
transform-Ion cyclotron resonance-Mass spectrometry) 
 
Sample preparation 
The excised Vps41p bands from the coomassie stained SDS-PAGE gel was first 
destained with 100 mM ammonium bicarbonate, dehydrated with 100% acetonitrile, 
reduced with 10 mM DTT at 60°C for 15 minutes and alkylated with 50mM 
Iodoacetamide for 45 minutes at room temperature in the dark. Proteolytic digestion 
was performed with Trypsin Gold (Promega, Madison, WI) in 50 mM ammonium 
bicarbonte at a ratio of 1:50 (enzyme to protein, w/w) at 37°C overnight. The digest 
was diluted in 0.1% formic acid (Fisher Scientific, Leicestershire, UK) to give a final 
concentration of 50 fmol/μl.  
  
Liquid chromatography 
The resulting digest mixture from above was injected using online Micro AS 
autosampler and Surveyor MS pump (Thermo Fisher Scientific, Germany) to a 75 μm 
(internal diameter) Integrafrit (New Objective, USA) C8 resolving column (length 10 
cm). The peptides were separated using a binary solvent system consisting of (A) 
water (J.T.Baker, Holland) and 0.1% formic acid and (B) acetonitrile (J.T.Baker, 
Holland) and 0.1% formic acid. A linear 40 min gradient increasing the composition 
of (B) from 5% to 40% was used. The Triversa Nanospray source (Advion 
Biosciences, NY) was used to spray the peptide eluted in a flow rate of ~300 nL min-1 
into the mass spectrometer. The nanoelectrospray voltage was typically +1.7 kV.  
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Mass spectrometry 
All mass spectrometry experiments were performed on a Thermo Finnigan 7-Tesla 
LTQ FT mass spectrometer (Thermo Fisher Scientific, Germany). The mass 
spectrometer alternated between a full FT-MS scan (m/z 380 – 2000) and subsequent 
CID MS/MS scans of the three most abundant ions. Survey scans were acquired in the 
ICR cell with a resolution of 100,000 at m/z 400. Precursor ions were isolated and 
subjected to CID in the linear ion trap, which the product ion was acquired with a 
resolution of 25 000 at m/z 400. Collision activation for the experiment was 
performed in the linear trap using helium gas at a collision energy normalized to 
precursor m/z of 35% and qexcite = 0.25. The width of the precursor isolation window 
was m/z 2 and only multiply charged precursor ions were selected for MS/MS. Data 
acquisition was controlled by Xcalibur 2.0 software (Thermo Fisher Scientific, 
Germany). CID MS/MS data were searched against the non-redundant NCBI database 
and the possible phosphorylation site localisation was assessed by using the 
SEQUEST algorithm within the Bioworks 3.3.1 (Thermo Electron Corp., Bremen, 
Germany). 
 
3 ml of yeast cells were grown to mid-logarithmic phase, and harvested by 
centrifugation at 700g for 1 min, then re-suspend in 150 μl fresh medium with 40 μM 
FM4-64 (Molecular Probles, Inc), incubated with shaking at 30°C for 15min, washed 
once with fresh medium, and then resuspended in 1 ml of fresh medium to chase by 
incubating at 30°C for 1 hour. 
 
2.20 Staining of cells with the lipophilic dye FM4-64 (Vida and Emr, 
1995) 
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Salt treatment of labelled cells (FM4-64) was performed by incubating cells in media 
2.21 Fluorescence microscopy 
e E
inositol lipids or GroPInsPns were resolved on a Partisphere 5-μM SAX 
olumn (240mm x 4 mm) protected by a SAX guard cartridge. To resolve GroPIns4P 
from GroPIns5P the following novel HPLC gradient was employed: A= dH2O, B= 
1.25M (NH4)2HPO4 pH 4.4 (orthophosphoric acid); 0 min, 0% B; 5 min, 0% B; 10 
 B; 55 min, 4.3% B, 95 min, 40% B; 100 min, 80% B; 105 min, 80% B; 110 
timal separation. 
containing 0.40M NaCl for 10 minutes or 60 minutes. This concentration of NaCl 
elicited similar changes in vacuole volumes as 0.9M NaCl but caused less 
perturbation of the refractive index of the medium, which led to better imaging (Duex 
et al., 2006a). Cells were viewed at room temperature on a microscope.  
 
Yeast strains were cultured to 0.5 ~ 1 X 107 cells/ml in appropriate media and 
visualized on a Nikon Eclips 600 microscope with an XF100-3 filter cube (Omega 
Optical). Images were acquired with an ORCA digital camera (Hamamatsu, Japan) 
and processed in Adobe Photoshop. Figures showed representative fields from 
multiple experiments.   
 
2.22 HPLC analysis of inositol lipids 
Deacylated 
c
min, 2%
min, 0% B. Note that this gradient relies upon a pH shift in order to resolve the two 
species of glycerophosphoinositols and that the exact elution position of these 
molecules, and their degree of resolution was variable depending upon the age of the 
column and the quality of the samples: some adjustments to the gradient were 
sometimes required to retain op
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Chapter 3   Regulation of PtdIns(3,5)P2 metabolism 
 
3.1 Introduction 
Chapter 1 introduced the fact that PtdIns(3,5)P2 is involved in the regulation of a 
variety of cellular processes, including membrane retrieval by retrograde trafficking, 
ubiquitin-dependent sorting of proteins from the TGN to vacuole via the MVB 
nd adaptation to hyperosmotic stress (reviewed 
pectively. The domain structures of proteins involved in 
tdIns(3,5)P2 metabolism are delineated in Fig. 3.1. This chapter summarises work 
designed to determine the relationships between some of these proteins. 
 
2
ay form a complex to control the 
pathway, control of vacuole acidity a
by Efe et al., 2005; Michell et al., 2006; Dove and Johnson, 2007). In S. cerevisiae, 
PtdIns(3,5)P2 is made by the sequential actions of the two lipid kinases: Vps34p and 
Fab1p, with Fab1p requiring Vac14p and Vac7p to express its PtdIns3P 5-kinase 
activity. PtdIns(3,5)P2 is dephosphorylated to PtdIns3P and PtdIns5P, probably by 
Fig4p and Ymr1p res
P
To gain a better understanding of the machinery regulating PtdIns(3,5)P  synthesis in 
yeast, I studied the behaviour of Vac14p and Vac7p using GFP constructs. Knock-in 
strains expressing Vac14p-GFP at endogenous levels were used to examine Vac14p 
localisation in fab1Δ, fig4Δ and vps34Δ mutants. Vac14p-GFP is normally on the 
vacuole membrane but fails to localise there in these strains, suggesting that 
recruitment of Vac14p to the vacuole requires Fab1p, Fig4p and/or Vps34p (or their 
products). Furthermore, the study of Fig4p localisation revealed that Vac14p and 
Fig4p are co-residing on some micro-domains of the vacuole membrane, consist with 
the yeast two hybrid analysis that Vac14p may interact with Fig4p (Dove et al., 2002), 
also strengthening the idea that Vac14p and Fig4p m
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PtdIns what 
actor(s) is/are affecting the localisation of Vac14p in fig4Δ cells, one of the effectors 
merged: over-expressed Atg18p partially rescued the 
mislocalisation of Vac14p in fig4Δ cells, suggesting that Atg18p may also regulate 
PtdIns(3,5)P2 metabolism by influencing the distribution pattern of the Vac14p-Fig4p 
complex, and therefore of the Fab1p kinase.  
 
and Thorner, 2007) 
(3,5)P2 synthesis and turnover co-ordinately. Next, when I tried to find 
f
of PtdIns(3,5)P2, Atg18p, e
Vac7p 
Vac14p 
 
 
Figure 3.1:  Domain structure of proteins in Fab1p pathway (adapted from Strahl 
FYVE, Fab1, YGL023, Vps27, and EEA1; CCT, chaperonin containing T-complex homology region; 
HEAT, HEAT repeat motif; TM, transmembrane domain; C2, C2 domain; LKU, lipid kinase unique 
domain; GRAM, glucosyltransferase, Rab-like GTPase activator and myotubularin domain 
 
My studies of Vac7p-GFP suggest that this integral membrane protein traffics from 
the Golgi via the AP-3 pathway and never passes through the late endosome. This 
result is important because Fab1p plays critical roles in the late endosome and our 
Vps34p 
Fig4p 
0 200 (amino acids) 
Fab1p 
type I/III kinase domain  C2  HEAT 
LKU  
Ymr1p 
FYVE CCT Cys-rich domain 
TM 
lipid phosphatase domain GRAM 
PIPK kinase domain 
SAC1-like 
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data suggest that Vac7p cannot be involved in this process.  
 
In addition, our modified in vitro colorimetric phosphatase assay also demonstrates 
that the conversion of PtdIns(3,5)P2 to PtdIns3P is likely to be catalyzed by Fig4p 
whilst Ymr1p may indeed metabolise PtdIns(3,5)P2.  
 
It still remains unknown whether PtdIns5P is present in budding yeast. However, in 
the work decribed below observed the presence of a peak that co-elutes with authentic 
[1 Ins5P in the HPLC analysis, suggesting the presence of PtdIns5P in yeast 
cells. Combined with the observed ability of Ymr1p to convert PtdIns(3,5)P2 to 
P  vitro, it seems likely that budding yeast contains a very small amount of 
P . 
 
3.2 Results 
3.2.1 Vac14p fails to localise on the vacuole membrane in fab1Δ, fig4Δ and vps34Δ 
cells  
Altho c14p to  the activators of Fab1p and possibly also 
. Dove initially failed to demonstrate a direct functional interaction between 
ame with 
GFP at the 3'-end. The fusion protein was expressed as a full-length protein under the 
control of the native VAC14 promoter and is therefore likely to be expressed at near-
normal physiological levels.  
4C]GroP
tdIns5P in
tdIns5P
ugh Va  is known be one of
Fig4p, Dr
Vac14p, Fab1p and Fig4p using yeast two-hybrid method (data not shown). 
 
 I next examined Vac14p localisation in yeast. To analyse its localisation in vivo, the 
chromosomal copy of the VAC14 gene at its native locus was tagged in fr
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Vac14p-GFP localised predominantly to the vacuole membrane in wild-type BY4742 
ig. 3.2). This result is consistent with Vac14p being a peripheral membrane-
, vac7, atg18/svp1, ldb19/svp3 
nd/or vps34, all of which encode proteins that play a role in the metabolism or the 
 
physiological levels in wild type BY4742, and in fig4Δ, fab1Δ and vps34Δ cells 
WT (VAC14::VAC14-GFP)  fig4Δ (VAC14::VAC14-GFP) 
(F
associated protein that regulates the levels of PtdIns(3,5)P2 by activating Fab1p at the 
tonoplast. To determine what regulates Vac14p localisation, I expressed this fusion 
protein in yeast deletion strains lacking fab1, fig4
a
function of PtdIns(3,5)P2.  Vac14p failed to decorate the enlarged vacuoles of fab1Δ, 
fig4Δ and vps34Δ cells (Fig. 3.2), so these three proteins are required for localisation 
of Vac14p. Vac14p localisation was not affected by deletion of the effectors 
Atg18p/Svp1p or Ldb19p/Svp3p. 
 
 
Figure 3.2: Vac14-GFP expressed at physiological levels fails to localise on the 
vacuole membrane in fig4Δ, fab1Δ and vps34Δ cells. 
The VAC14 gene at its native locus was tagged in frame with GFP at the 3'-end and expressed at 
 
fab1Δ (VAC14::VAC14-GFP)  vps34Δ (VAC14::VAC14-GFP)  
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The mislocalisation phenotype of Vac14p is consistent with a recent identification of a 
Fab1p-Fig4p-Vac14p signalling complex which is tethered to vacuole membrane via 
the binding of the FYVE domain of Fab1p to PtdIns3P (Botelho et al., 2008). Since 
the Vac14p does not possess a transmembrane domain, its attachment to the vacuole 
membrane probably requires interactions with other proteins or lipids; quite possibly 
from Fab1p and Fig4p. Therefore Vac14p is mislocalised in both fab1Δ and fig4Δ 
cells. Interestingly, I also noticed that Vac14p’s localisation pattern was different 
when comparing fab1Δ / fig4Δ and vps34Δ cells. Vac14p is completely diffuse and 
cytoplasmic in the former two strains but is concentrated into distinct vesicular dots in 
latter strain. It is unknown what organelle this dot corresponds to but my data would 
em to indicate that in the absence of PtdIns3P/Vps34p, the whole Fab1p-Vac14p-
Fig4p signalling complex is re-distributed to a subcellular compartment that these 
proteins are not normally resident in. 
 
Unexpectedly, although Vac14p localisation is not obviously different comparing wild 
type and ed Atg18p can lisation 
of Vac14p in fig4Δ (Fig. 3.3). This observation is interesting considering that Atg18p 
was proposed to have a negative feedback effect on PtdIns(3,5)P2 generation whilst it 
was found to be a specific effector of PtdIns(3,5)P2 required for membrane retrival 
from vacuole (Dove et al., 2004). This result is possible evidence for the above 
propos ffect may be ac14p-
ig4p complex’s proper localisation. 
se
 atg18Δ cells, over-express  partially rescue the misloca
al that Atg18p’s feedback e  achieved by affecting the V
F
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Figure 3.3: Over-expressed Atg18p partially r
fig4Δ (VAC14:VAC14-GFP) 
 with pEGKT 
fig4Δ (VAC14:VAC14-GFP)  
with pEGKT-FIG4 
fig4Δ (VAC14:VAC14-GFP) 
 with pEGKT-ATG18 
fig4Δ (VAC14:VAC14-GFP)
escues the mislocalisation of Vac14p 
in fig4Δ cells 
he constructs pEGKT-ATG18 was introduced into fig4Δ (VAC14:VAC14-GFP) and induced to over-
negative controls, respectively 
served domains being considered are defined in 
ichell et al., 2006. Fluorescence microscopy showed that Fab1p mutated in its 
YVE domain (in conserved Cys residues, so as to lose its ability to bind PtdIns3P) 
r in the PIPKinase domain (to yield a catalytically inactive protein) retained an 
T
express by addition of 2% Galactose. Introduction of pEGKT-FIG4 and pEGKT were positive and 
 
3.2.2 Both the CCT-like and PIPKIII-unique domains of Fab1p are required for 
Vac14p to localise to the vacuole membrane 
To address which domain(s) of Fab1p might mediate the interaction with Vac14p, I 
introduced constructs harboring FAB1 with mutations in various functional domains 
into fab1Δ (VAC14:VAC14-GFP) cells to see which of the Fab1p variants could 
support Vac14p localisation. The con
M
F
o
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ability to partially correct the mis-localisation of Vac14p in fab1-null cells. By 
contrast, no Vac14p-GFP was associated with the vacuole in cells that expressed 
Fab1p in which a conserved central Gly residue in the CCT-like domain was mutated, 
and most of the Vac14p-GFP was not vacuole-associated in cells harbouring Fab1p 
carrying mutations in conserved Cys residues in the PIPKIII-unique region of the 
protein (Fig.
 
 
Constructs containing differential FAB1 variants were introduced into fab1Δ (VAC14:VAC14-GFP) to 
 
(Fab1p mutated on PIPkinase domain) (Fab1p mutated on FYVE domain) 
 3.4).  
(Fab1p)
Figure 3.4: Vac14p-GFP distribution in fab1Δ introduced constructs harboring 
FAB1 with mutations in various functional domains 
identify what domain(s) of Fab1p may regulate Vac14 loading onto vacuole membranes. A construct 
containing wild type FAB1 was positive control 
(Fab1p mutated on CCT-like domain) (Fab1p mutated on PIPKIII-unique domain) 
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The finding that Vac14p also failed to localise on the vacuole in fig4Δ and vps34Δ 
cells seems to lend weight to the possibility that Fab1p alone is not enough to recruit 
Vac14p to vacuole. It is therefore quite possible that additional proteins are required to 
mediate Vac14p localisation other than Fab1p. The above proteins are likely 
candidates.  
 
In the respect of Fig4p, it was shown to be a specific PtdIns(3,5)P2 5-phosphatase in 
vitro and proposed to be able to convert PtdIns(3,5)P2 to PtdIns3P in vivo (Rudge et 
al., 2004). Fig4p localises on the vacuole membrane in wild type but not in fab1Δ 
cells, which is reminiscent of the localisation defects of Vac14p in the same mutant. 
Like Vac14p, Fig4p has no trans-membrane domain, so the same questions about 
Vac14p localisation apply to Fig4p. How can Fig4p be recruited to vacuole 
membrane? Is it Fab1p alone that achieves this or does it require additional proteins? 
To address this question, I constructed strains expressing both Fig4p-GFP and 
Vac14p-mCHERRY from their own promoters by doing standard yeast knock-ins. 
Micr ation cro-
domains of the vacuole membrane in wild-type cells (Fig. 3.5). This observation 
further supported the idea that Vac14p and Fig4p may form a complex and might be 
mutually dependent on each other for vacuole membrane loading. I tried to investigate 
the Fig4p localisation pattern in various deletion mutants as I have successfully done 
fo ve l 
d images of Fig4p localisation 
brighter signal. 
oscopy clearly showed the co-localis of Vac14p and Fig4p in some mi
r Vac14p, but the Fig4p-GFP construct ga very weak fluorescence signals in al
strains tested except for wild type, possibly because of the instability of Fig4p-GFP. 
Thus to date I have not yet managed to get any goo
except for in wild-type cells e.g. those displayed in Fig. 3.5. If time allowed I would 
construct a Fig4p-3XGFP construct as this should produce a 
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et 
al., 1997). The fact that Vac7p enters the vacuole in apm3Δ cells is most readily 
Fig4-GFP Vac14-mCHERRY Merged DIC 
Figure 3.5: Co-localisation of Vac14p and Fig4p in micro-domains of the vacuole 
membrane A strain of BY4742 expressing VAC14:VAC14-mCHERRY and FIG4:FIG4-GFP, was 
constructed and visualized by light microscopy and fluorescence. Merged images were then produced 
in Photoshop. 
 
 
3.2.3 Vac7p traffics to the vacuole membrane via the AP-3 pathway  
I examined the localisation of Vac7p, an activator of Fab1p that seems to be confined 
to some yeasts. The over-expressed fusion protein yEGFP-Vac7p resides on the 
vacuole membrane in wild type cells, together with Fab1p, Vac14p and Fig4p. Unlike 
the other members of the Fab1p pathway, Vac7p is an integral membrane protein, and 
I therefore determined by what route Vac7p travels to the vacuole membrane from the 
Golgi.  
 
By examining the localisation of Vac7p in several deletion mutants defective for 
essential participants in trafficking pathways to the vacuole, it was found that Vac7p 
resides on the vacuole membrane in vps45Δ cells but goes into the vacuole lumen in 
apm3Δ cells (Fig. 3.6). Vps45p is essential for protein traffic through the late 
endosome-dependent CPY pathway, and Apm3p is needed for the AP-3-dependent 
direct Golgi-to-vacuole pathway (Bryant et al., 1998; Stepp et al., 1997; Cowles 
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explained if Vac7p is shunted into the CPY pathway by bulk flow when a lack of 
Apm3p ina he A ce Vac7p has entered the CPY pathway, it 
probably lacks the negative sorting information required to keep it out of the 
intraluminal vesicles of the MVB and so travels to the vacuole lumen. This result, as 
well as the lack of effect of VPS34 deletion on Vac7p localisation, strongly suggests 
that Vac7p is normally delivered to vacuole membrane via the AP-3 pathway. It has 
2  
nthesis on the vacuole membrane whereas the Vac14p-Fig4p complex may do this 
b predominantly on endosomal compartments. 
.6: GFP-Vac7p fails to localise on the vacuole membrane in apm3Δ but not 
ps45Δ 
pUG36-VAC7 was introduced into apm3Δ and vps45Δ cells. GFP-Vac7p expression was repressed by 
ctivates t P-3 pathway. On
been observed that the Vac14p-Fig4p complex regulates PtdIns(3,5)P2 synthesis and 
turnover independently of Vac7p (Duex et al., 2006b). Our discovery of an AP-3 
dependent Vac7p trafficking pathway suggests that Vac7p may control PtdIns(3,5)P
sy
jo
 
 
Figure 3
apm3Δ with pUG36-VAC7  vps45Δ with pUG36-VAC7  
v
addition of 0.8mM of Methionine 
 
3.2.4 PtdIns5P is present in live yeast  
It has not been clear whether yeast normally contains PtdIns5P, because most HPLC 
analyses of PPIn do not distinguish between PtdIns4P and PtdIns5P. I have however, 
now devised an anion-exchange HPLC method that resolves the deacylation products 
of all three of the natural PtdInsP isomers. Figure 3.7 shows an HPLC trace of 
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deacylated lipids extracted from wild-type cells. This HPLC gradient can resolve 
GroPIns4P and GroPIns5P by virtue of a pH shift from 3.8 to 4.4 that allows these 
two isomers to be separated. 
 
Fig. 3.7 clearly shows the presence of a peak that co-elutes with authentic 
[14C]GroPIns5P. This authentic standard was made by HPLC purifying  
GroPIns(3,5)P2  from [14C]inositol radiolabelled yeast that had been subjected to a 
0.9M NaCl stress for 10-15 minutes, followed by immediate methanol quenching. 
The resulting [14C]GroPIns(3,5)P2 was desalted using Dowex resin and eluted in 1.0 
M TEAB (tetraethylammonium bicarbonate) a volatile buffer that was removed in 
vacuo using a Speed-vap low pressure drying device. Dried desalted 
C]GroPIns(3,5)P2 was then incubated with washed erythrocyte membranes (3-4 mg 
protein) at pH 7.5 in 1 ml of 12.5 mM HEPES/KOH/1 mM EGTA/5 mM EDTA for 
4 h, see Dove et al., 1997). This treatment reproducibly removes the 3-phosphate 
from the inositol ring whilst leaving the 5-phosphate intact (the 5-phosphatase activity 
requires Mg2+ for activity).  
 
ation, but the behaviour of Ins(1,2)P2 and Ins(1,6)P2, the 
comparator InsP2 isomers makes it unlikely that the deacylation products of the other 
possible but unknown PtdInsP isomers (PtdIns2P and PtdIns6P) would elute in this 
position. Its full characterisation must await the discovery of a treatment that 
increases the level of this inositide in cells.  
 
[14
The small quantity of [3H]GroPIns5P indicates the likely presence of its parent lipid 
(PtdIns5P) in yeast cells. So far I have been unable to obtain enough of this material 
for formal chemical identific
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3
cells and resolved using a novel HPLC gradient. Note the extra peak that co-elutes 
with authentic [14C] GroPIns5P 
 
Figure 3.7 HPLC analysis of [ H] inositol labelled lipids extracted from wild-type 
Ymr1p and Fig4p from E. coli  
If PtdIns5P does exist in budding yeast, Ymr1p might be a factor to generate it by 3- 
possibility, I had to gain a better understanding of the substrate specificity of Ymr1p. 
experiment, I had to first obtain a reasonable amount of purified Ymr1p by 
. Therefore, I expressed GST-tagged 
Ymr1p in bacteria and purified the full length GST-fusion protein (Fig. 3.8). I then set 
p  a colorimetric phosphatase assay using malachite green and the purified Ymr1p 
3.2.5 Purification of yeast 
dephosphorylating PtdIns(3,5)P2 in vivo as discussed in Chapter 1.  To examine this 
To do this, I resolved to examine its catalytic activity by employing a malachite 
green-based colorimetric phosphatase assay. However, in order to set up this 
overexpressing the recombinant Ymr1p in E.coli
u
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but time precluded me from doing anythiug other than the most preliminary of 
characterisations of this enzyme. 
 
Whilst I was characterizing Ymr1p, I was also interested in investigating another 
enzyme, Fig4p, the proposed PtdIns(3,5)P2 5-phosphatase (Rudge et al., 2004) by 
utilising this same colorimetric assay. But unlike the Ymr1p purification, work on 
Fig4p presented a challenge as it appeared to be unstable in bacteria. Following the 
published method (Rudge et al., 2004) using a His6-tagged bacterial expression 
system, I just obtained a truncated protein. Similar results were obtained when the 
protein was expressed in P. pastoris. Expression in S. cerevisiae, using a construct 
where Fig4p was tagged as an N-terminal GST-fusion, showed that the enzyme could 
ade full length but the yield was low. It was then decided to return to the bacterial 
 colorimetric assay showed that it can degrade 
P2 but not PtdIns3P or PtdIns(4,5)P2, a detailed characterization was 
be m
system and try to express GST-Fig4p in the same way as Ymr1p. This yielded some 
protein, although the yield was still less than the other proteins (Fig. 3.8). The first 
assay of purified GST-Fig4p by
PtdIns(3,5)
beyond the scope of this study. 
 
       99  
Regulation of PtdIns(3,5)P2 metabolism 
 
The annotated bands were assumed to be the bone-fide Gst-Fig4p and Gst-Ymr1p proteins based on the 
 
.3.1 Involvement of Vac14p and Vac7p in the synthesis of PtdIns(3,5)P2 by 
Fab1p 
Our Vac14p-GFP localisation data suggest that the CCT-like and PIPKIII-unique 
domains of Fab1p are necessary for Vac14p to associate with the vacuole membrane. 
The most likely interpretation is that they directly bind to one another, but our method 
would not have distinguished whether intermediary proteins are involved.  
 
To address the details of the Fab1p:Vac14p interaction, I made constructs that would   
 
Figure 3.8: GST-Ymr1p (105.3 KDa) and GST-Fig4p (126.9 KDa) fusion proteins 
purified from E. coli and resolved by SDS-PAGE  
expected molecular weight firstly, and being purified to do mass spectrometry for the futher verification 
and confirmation 
 
3.3 Discussion 
This Chapter has described studies of the regulation of PtdIns(3,5)P2 metabolism in 
yeast, notably the roles of Vac14p and Vac7p in its synthesis and its possible 
metabolism to PtdIns5P in vivo via the myotubularin like protein, Ymr1p.  
   
Marker GST-Fig4p GST-Ymr1p 
75 KDa 
100 KDa 
150 KDa 
GST-Ymr1p 
GST-Fig4p 
3
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attach a CAAX mo  C A is an aliphatic residue, X is any amino 
acid, see Hancock 2003; Strahl et al., 2005) that directs prenylation and results in any 
target proteins so-tagged becoming resident at the plasma membrane.  I then 
constructed fluorescently tagged constructs containing each of the four isolated 
functional domains of Fab1p with yEGFP at the 5-termini and a CAAX motif at the 3-
terminus. The aim was to introduce these constructs into fab1Δ (VAC14:VAC14-2X 
mCHERRY) or fab1Δ (FIG4:FIG4-2X mCHERRY) strains in which either Vac14p or 
Fig4p would be tagged with mCherry, and so determine whether any of the Fab1p 
embrane-directed FYVE domain 
olecule.  
elho et al., 
08). Our results are in general agreement with the conclusions of that study, though 
14p and this was confirmed in the above work. 
3.3.2 Myotubularin type 3-phosphatases of Ymr1p  
Ymr1p is the sole member of the m
tif (where  is Cysteine, 
domains could recruit either Vac14p or Fig4p to the plasma membrane. Unfortunately, 
I only obtained cells expressing the plasma m
construct, probably because the chosen constructs were not stable in the absence of 
the rest of the Fab1p m
 
Nevertheless, the recent description of the isolation of a protein complex comprising 
Fab1p, Vac14p and Fig4p used this strategy to recruit Vac14p to the vacuole 
membrane using a CCT domain tagged to a trans-membrane domain (Bot
20
our work was obviously at a much earlier stage. In particular, I found that Atg18p can 
bind Vac
 
yotubularin-related phosphatase family present in 
yeast (Parrish et al., 2004). Myotubularins were originally identified as a family of 
presumed protein tyrosine phosphatases (Taylor et al., 2000a; Clague and Lorenzo, 
2005). They were of note because mutations in genes encoding at least two of the 
myotubularins resulted in certain types of the human genetic disease X-linked 
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myotubular myopathy (a defect in the MTM1 gene) or Charcot-Marie Tooth disease 
(linked to mutations in MTMR2) (Sarnat, 1990; Berger et al., 2002). Subsequently, it 
emerged that they could hydrolyse PtdIns3P and later it was also found that they 
could hydrolyse PtdIns(3,5)P2 (Wishart and Dixon, 2002; Clague and Lorenzo, 2005). 
Hence, it is likely that defects in the metabolism of one of these lipids underlie the 
two genetic diseases described above (see below for more evidence). 
 
Mutations in the gene encoding mammalian Fig4p have recently been shown to 
underlie a previously undefined genetic neuropathy that bears striking similarity with 
the Charcot-Marie Tooth disease caused by disruption of the myotubularin MTMR2 
described above (Chow et al., 2007). Since the only common substrate of both these 
phosphatases is PtdIns(3,5)P2, it seems likely that defective metabolism of this lipid 
sults in at least 3 neurological and musclo-skeletal diseases in humans. 
r et al., 2000a). This suggests 
dundancy amongst yeast lipid phosphatases 
given that budding yeast can express several Sac1p-like proteins, as well as a PTEN-
like phosphatase (Tep1p), which are also thought to play a role in regulating PtdIns3P 
levels (Hughes et al., 2000a). However, recent work has suggested that the 
mammalian enzymes can all hydrolyse PtdIns(3,5)P2 (Clague and Lorenzo, 2005). 
Prior to our work, it was not known if this was also a property of the yeast Ymr1p 
re
 
Ymr1p likely functions in cytoplasm to vacuole transport (CVT) pathway and in the 
maintenance of the architecture of the endosomal system, possibly by regulating the 
localisation and levels of PtdIns3P (Parrish et al., 2004). However, the ymr1 null 
mutant strain has no obvious phenotypes and its functions only emerge when other 
PPIn phosphatases are simultaneously inactivated (Taylo
a nonessential function or possible re
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protein, indeed the enzyme had never been expressed and examined in vitro. It is also 
not known if any of the other proteins in the CVT or Vps34p pathways are adaptors 
for this phosphatase. The significance of myotubularin mediated degradation of 
PtdIns(3,5)P2 is that it gives rise to another PPIn signal: PtdIns5P, that may have its 
own functions in cell regulation. Since PtdIns5P has never before been described in 
yeast, I was particularly interested in the possible presence of this lipid in S. 
erevisiae. This is because the route of synthesis of PtdIns5P is not well established in 
s(4,5)P2 , in 
ly described 3-phosphatase  activity in vivo (Taylor et al., 2000a; 
c
any system but in yeast it would be a relatively trivial matter to establish, as long as I 
have an assay for this lipid.  
 
In my current study, I first demonstrated that bacterially expressed GST-Ymr1p is 
active, and the preliminary colorimentric phosphatase assay suggested it can also 
specifically degrade PtdIns3P and PtdIns(3,5)P2 but not PtdIns4P or PtdIn
line with its previous
Pendaries et al., 2003). In addition, the detection of PtdIns5P from intact cells by our 
HPLC analysis further supports the proposal that Ymr1p may be a bona fide 
PtdIns(3,5)P2 3-phosphatase in budding yeast. 
 
If time allowed I would exploit the observation that pH shifts allow separation of 
PtdIns4P and PtdIns5P by HPLC to optimize an HPLC method to separate PtdIns5P 
from PtdIns3P and PtdIns4P. I would then have liked to have looked at the role of 
Fab1p and Ymr1p in production of PtdIns5P, by radiolabelling fab1 and ymr1 
knockout strains. I would also have liked to try to find stresses (e.g. hyper-osmotic, 
oxidative, UV, alkalinsation etc) that elevate the levels of the putative PtdIns5P.  
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Having identified a possible novel inositol lipid in yeast, an important experiment 
would be to confirm that this is indeed PtdIns5P using the periodate oxidation 
method. Putative GroPIns5P will be HPLC purified, desalted and oxidised by 
periodate. This opens the inositol ring wherever there are two adjacent free hydroxyls, 
yielding a polyol-phosphate. If I dephosphorylate the polyol-phosphate and identify 
the resulting polyol (PtdIns5P should result in the formation of Xylitol), then this will 
tell us what the original compound was. This would typically be done with [3H]lipid 
as well as an authentic [14C]PtdIns5P standard to account for losses and to ensure that 
the reaction proceeds in the control. It will then be necessary to identify the resulting 
H]polyol by HPLC co-chromatography with authentic standards.     
)P2 degradation after stress.  
[3
 
I would also have liked to have dual label yeast undergoing hyper-osmotic stress with 
[3H]inositol to isotopic equilibrium and pulse-chase them with [32P]orthophosphate. 
This would allow me to measure turnover rates of PtdIns(3,5)P2 so that I can 
determine if Fab1p is activated or Fig4p is inhibited by hyper-osmotic stress (or both).  
Looking at the same cells using our new HPLC gradient may also allow us to 
determine if Ymr1p plays any role in PtdIns(3,5
       104  
A novel osmotic stress pathway 
Chapter 4: A Novel Osmotic Stress Pathway Mediated by 
 
4.1 Introduction 
Stress signalling occurs in response to changes in the extracellular environment and 
allows cells to survive by making appropriate adjustments to their metabolism and 
physiology. In budding yeast, one response to hyper-osmotic stress is activation of the 
Fab1p lipid kinase to produce PtdIns(3,5)P2, a lipid required for membrane fission 
and other events. Hypo-osmotic stress, however, activates Plc1p, a p
Inositol Polyphosphates and Vps41p in S. cerevisiae 
hospholipase C 
that cleaves the PtdIns(4,5)P2 to generate water-soluble inositol polyphosphates, 
 unable to 
generate inositol pyrophosphates. This has led others to suggest that Plc1p is activated 
by any event that causes plasma membrane deformation and this includes all osmotic 
imbalances (Cooper et al., 1999). 
 
It is therefore possible that PPIns and their derived IPs are involved in the responses 
of cells to all osmotic stresses. The exact role of inositides in stress adaptation is still 
largely obscure but may involve the regulation of vacuolar membrane dynamics via 
fusion and fission. Indeed, many mutants with defective IPs metabolism display 
including bisdiphosphoinositol tetrakisphosphate (which can be abbreviated either as 
(PP)2-IP4 or IP8), a ‘high energy’ inositol pyrophosphate. Plc1p is required for vacuole 
fusion in vitro (Jun et al, 2004), suggesting that IP8 may be required for hypo-osmotic 
stress-induced vacuole fusion. However, I also noticed that Plc1p and IPs are 
important in the response to hyper-osmotic stress since plc1Δ mutants cannot grow in 
hyperosmotic media. The same is true of arg82Δ and kcs1Δ mutants that are
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ab o 
vacuolar hom
 
al stresses makes it an excellent model 
 phenomena because it is relatively large and its size and shape 
ing complex that is required for homotypic vacuole 
sion, might be one target of Yck3p-mediated phosphorylation. It was suggested that 
errant vacuole morphology, although the molecular mechanism linking IPs t
eostasis was undefined at the time I began this work.  
The response of the yeast vacuole to extern
system to study such
can be recorded by light microscopy. As discussed in Chapter 1, hypo- and hyper-
osmotic stresses can provoke fusion and fission of vacuolar subcompartments, so 
allowing novel components of fusion/fission pathways to be identified by genetic 
screens.  
 
A simple way to examine how cells sense and adapt to hyperosmotic stress is to add 
NaCl to the medium. Wild-type vacuoles become fragmented within 10 min and this 
fragmentation can be maintained for one hour or more (Duex et al., 2006a; Dove and 
Johnson, 2007). In an original screen using this technique, it was found that when a 
yeast casein kinase Yck3p is deleted, cells still exhibit the hyper-osmotically driven 
and PtdIns(3,5)P2-dependent vacuole fragmentation, but that this fragmentation is not 
maintained and the vacuoles quickly re-fuse (LaGrassa and Ungermann, 2005). 
Yck3p therefore seems to be required to maintain vacuoles in the fragmented state 
after PtdIns(3,5)P2 levels have returned to basal. This study suggested that Vps41p, an 
important part of the HOPS tether
fu
phosphorylation of Vps41p might block the tethering together of vacuole 
subcompartments and so ‘freeze’ vacuoles in the fragmented state upon hyper-osmotic 
stress, but there was no direct evidence on this question when my study was initiated.    
My starting point was the idea that Vps41p phosphorylation might be controlled by 
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the same upstream signalling pathway that activates Fab1p: both processes are 
activated by hyperosmotic stress, and it seemed possible that the control of the two 
rocesses might be integrated.  
that is under the influence of Plc1p-catalyzed generation of inositol 
yrophosphate(s). The phosphorylation sites on Vps41p were characterized by FT-
2
p
 
An immunoblot method was developed to detect Vps41p phosphorylation in vivo, and 
was used to rule out the possibility that hyper-osmotically activated Vps41p 
phosphorylation lies directly downstream of either the Hog1p or Fab1p/PtdIns(3,5)P2 
pathway. Instead, our data suggest that Vps41p may lie on a novel osmotic stress 
pathway 
p
ICR mass spectrometry and their phosphorylation was shown to be required for 
Yck3p-mediated inhibition of vacuole fusion in salt-stressed cells.  As a result of these 
studies, I propose a model in which Fab1p and Vps41p might lie on two parallel rapid 
response pathways to high extracellular osmotic potential whilst the Hog1p pathway 
mediates long-term adaptation.  
 
4.2 Results 
4.2.1 Vps41p is phosphorylated by Yck3p upon hyper-osmotic stress  
In a screen of deletion strains whose vacuole fusion/fission fails to response properly 
to external hyper-osmotic stress, Ungermann and his colleagues (2005) observed that 
Vps41p, a subunit of HOPS complex which governs the homotypic vacuole fusion 
procedure, is phosphorylated by the casein kinase Yck3p upon hyper-osmotic stress. 
They suggested that this phosphorylated Vps41p might inhibit vacuole membrane 
fusion and therefore cause the hyper-osmotically induced vacuole fragmentation that 
had been triggered by Fab1p/PtdIns(3,5)P  to persist. 
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This suggested to us that phosphorylation of Vps41p by Yck3p is a part of a yeast 
hyper-osmotic signalling pathway. These results provoked us to ask whether I could 
use phosphorylation of Vps41p by Yck3p as a selective screen of yeast null mutants 
deally ~100), with which to identify novel components of the Fab1p salt stress 
tal yeast proteins, subjected them to SDS-PAGE 
paration and analysed these by western blot analysis using anti-HA antibody. This 
 routinely available techniques, and the key simplification was that I 
 
ed that this method 
(i
pathway. In the original study, phosphorylation of Vps41p was identified by isolating 
vacuole fractions, incubating these with or without ATP under standard fusion 
conditions, resolving proteins by SDS-PAGE, and detecting Vps41p by 
immunoblotting: phosphorylated Vps41p migrates more slowly than the non-
phosphorylated form (LaGrassa and Ungermann, 2005). The complexity of this 
method is not appropriate for large scale screens.  
 
I therefore developed a simpler in vivo method by which to identify hyper-osmotically 
induced Vps41p phosphorylation. I constructed a C-terminally 3×HA-tagged Vps41p 
construct that could be integrated into the yeast chromosome and expressed at 
endogenous levels, extracted to
se
only employed
used a 0.1M NaOH-based cell lysis method to extract total cell protein: this involves
no cell breakage protocol and removed the need for phosphatase inhibitors and ice-
based handling of samples (see chapter 2 for a full description).  
 
By using this rapid and convenient method, I could readily detect phosphorylated 
Vps41p in cells subjected to hyper-osmotic stress (0.9M NaCl for 15 min) in vivo, and 
confirmed that this hypertonically activated phosphorylation of Vps41p is dependent 
on the casein kinase Yck3p (Fig. 4.1). These data both confirm
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works robustly and demonstrated for the first time that this pathway is active in vivo.  
 
 
 
Figure 4.1: Vps41p is phosphorylated upon hyper-osmotic stress via Yck3p 
Wild type and yck3∆ cells expressing Vps41-3HA at endo
phase and then subjected to hyper-osmotic stress (0.9M NaCl, 15
genous levels were grown to exponential 
 min) or mock treated. Cells were then 
tracted by treatment with NaOH and boiled in SDS sample buffer and then immunoblotted with Anti-
HA antibody. The slightly retarded band was believed to be phosphorylated Vps41p based on previous 
 
Next, I examined the time-course for this response and the effects of varying 
osmolarity. Stress-induced Vps41p phosphorylation was extremely rapid, starting 
within less than one minute, and was sustained for at least one hour (Fig. 4.2). The 
quantification demonstartes that the phosphorylation of Vps41p attained its maximum 
level during the first five minutes of stress applicattion, and this level was then 
sustained for around 30 minuts, and afterwards began to decrease. When compared 
with the change in the steady-state level of PtdIns(3,5)P2 upon hyper-osmotic stress 
(see Section 1.9), it was intriguing to note that the kinetics of both responses were 
similar, supporting our proposal that both PtdIns(3,5)P  and Vps41p were sequentially 
and synergistically controlling the hyperosmotic stress adaptation of budding yeast 
cells (see Section 4.3.4 and Fig. 4.19).        
 
ex
studies (LaGrassa and Ungermann, 2005), and was also identified to be phosphorylated Vps41p in our 
later mass spectrometry results 
2
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Figure 4.2: Time course of hyper-osmotically induced Vps41p phosphorylation 
Top: Immunoblot identification of hyperosmotic induced Vps41p phosphorylation over time. 
15 min and samples of equal volumes removed at each indicated time interval. Cells were immediately 
Vps41p (Vps41p) over time. The band intensity of all bands in the top blot were quantified by ImageJ 
 
d phosphorylation if the time point for 
mpling was changed (data not shown). This seemed appropriate for a short-term 
BY4742(VPS41:VPS41-3HA) cells were grown to exponential phase in YPD, and then 5M NaCl stock 
solution added to a final concentration of 0.9M NaCl. Cells were grown on in this hypertonic media for 
killed by addition of two volumes of methanol (this was done in order to control the time interval: 
controls indicate that this killling method does not affect the final result) and then subjected to SDS-
PAGE/immunoblot analysis 
Bottom: The change of ratio between phosphorylated Vps41p (P-Vps41p) and non-phosphorylated 
(1.42) and the ratio of P-Vps41p and Vps41p calculated from the resulting two absolute intensity 
values (see Section 2.17)     
 
In addition, the hyperosmotic induced Vps41p phosphorylation was sensitive to the 
hypertonic application, being able to respond to 0.8M NaCl shock (Fig. 4.3), even 
lower osmolarities (0.2M NaCl) provoke
sa
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response to stress: it was quick, fairly sensitive and prolonged, allowing the cells to 
survive a sudden external stress and buy time for the activation of a long-term 
response such as the Hog1p pathway. Like the rapid synthesis of PtdIns(3,5)P2, 
phosphorylation of Vps41p appeared to behave appropriately for a rapid physiological 
esponse to external salt stress. 
 
r
 
Figure 4.3: Osmolarity course of hyper-osmotic induced Vps41p phosphorylation 
equal 
 in some key deletion strains, to determine which pathways 
ight activate this phosphorylation or facilitate its cellular functions downstream. I 
BY4742(VPS41:VPS41-3HA) cells were grown to exponential phase in YPD and divided into 5 
volumes, and then 5M NaCl stock solution added to the indicated final concentrations of NaCl. Cells 
were then grown on in this hypertonic media for a further 15min and then subjected to immunoblot 
analysis 
 
 
4.2.2 Hypertonically induced Vps41p phosphorylation is independent of 
PtdIns(3,5)P2 synthesis by Fab1p and of activation of the Hog1p pathway  
After verifying that our screening method worked, I next examined the in vivo 
Vps41p phosphorylation
m
concentrated our first efforts on mutants that compromise known hyper-osmotic stress 
response pathways, particularly the Fab1p and Hog1p signalling systems.  
 
The Fab1p PtdIns3P 5-kinase lipid kinase is activated upon salt stress, but the osmotic 
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sensor that lies upstream of Fab1p is unknown. When I examined the Vps41p 
phosphorylation response in several deletion strains which block the activation of 
Fab1p, none of them had any obvious effect on Vps41p phosphorylation (Fig. 4.4). 
These ineffective mutations included inactivation of Fab1p itself, of the Fab1p 
scaffold/activator Vac14p, of the dual functional Fab1p activator and PtdIns(3,5)P2 
hosphatase Fig4p, and of two putative PtdIns(3,5)P2 effectors Svp1p/Atg18p and 
Svp3p/Ldb19p.  
 
It was noted that although Vps41p phosphorylation still occurred in the above 
mutants, the quantification analysis demonstrated that the mutants (fab1∆, ∆vac14 
and fig4∆) deficient in PtdIns(3,5)P2 synthesis had significantly less phosphorylated 
Vps41p after hyper-osmotic stress compared with those displaying a supranormal 
level of PtdIns(3,5)P (svp1∆ and svp3∆) (Fig. 4.4). This phenotype may suggest that 
rylation although it does not completely abolish it. This subtle modulation of 
ps41p is reasonable when considering the common roles of Vps41p and Fab1p in 
ducing and maintaining vacuole fragmentation upon hyperosmotic stress.   
 
 
 
 
 
 
p
2 
an absence of PtdIns(3,5)P2 could to some extent influence the Vps41p 
phospho
V
in
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Figure 4.4: Hyperosmotic induced Vps41p phosphorylation is not downstream of 
e Fab1 pathway 
op: Immunoblot idenfication of hyperosmotic induced Vps41p phosphorylation in null mutants 
which compromised the Fab1p pathway. Cells with the indicated mutations and bearing a VPS41-3HA 
nock-in were shocked for 15 min with 0.9M NaCl and then killed and proteins extracted and subjected 
 SDS-PAGE and immunoblotting 
Bottom: Comparison of the amounts of phosphorylated Vps41p (P-Vps41p) in Fab1p pathway 
disrupted null mutants. The band intensities of the top blot were quantified by ImageJ (1.42) and the 
ratio of P-Vps41p and Vps41p was calculated from the resulting two absolute intensity values (see 
Section 2.17).  
th
T
k
to
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Another hyper-osmotic response system is the Hog1p MAPK pathway. Yeast Hog1p 
is the functional homologue of mammalian p38 family of MAPKs. MAPK pathways 
are three tier protein kinase pathways that frequently end in regulation of the activities 
of nuclear transcription factors (O’Rourke et al., 2002). In Yeast, the Hog1p MAPK 
can be activated by two upstream branches that are initiated by plasma membrane 
sensor proteins: Sho1p and Sln1p (Fig. 4.5). Activation of Hog1p causes rapid 
translocation of phosphorylated Hog1p from the cytoplasm to the nucleus where it 
activates the expression of genes responsible for increasing the synthesis of glycerol, 
which then accumulates in the stressed yeast. The Hog1p pathway is the major 
mechanism for long-term adaption of yeast to high osmolarity. 
 
 
Figure 4.5: Yeast hyper-osmotic pathway II: Hog1p MAPK pathway (from 
osphotransfer in the Sln1–Ypd1–Ssk1 system occurs in constant 
ed protein kinase (MAPK) kinase kinase. 
O’Rourke et al., 2002) 
Two upstream branches of the HOG pathway can each activate Pbs2p and Hog1p. (a) The Sln1p 
branch is composed of a phosphor-relay system that regulates the activity of the two partially redundant 
MAPKKKs, Ssk2p and Ssk22p. Ph
osmotic conditions to keep Ssk1p inactive. (b) The Sho1 branch uses a novel four membrane-spanning 
domain protein to recruit Pbs2p to the membrane through an SH3-polyproline interaction, after which 
the MAPKKK Ste11p is phosphorylated by Ste20p. Hog, high osmolarity glycerol; MAPKKK, 
mitogen-activat
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When I investigated Vps41p phosphorylation in several null mutants that lacked 
either Hog1p or the upstream effector Sho1p, phosphorylation was unchanged, either 
by eye or when the bands were quantified using ImageJ, indicating that Vps41p 
phosphorylation is not downstream of activation of the Hog1p pathway, or of any 
other pathways that respond to Sho1p activation (Fig. 4.6). 
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igure 4.6: Hyper-osmotic induced Vps41p phosphorylation is not downstream of 
e Hog1p pathway 
op: Immunoblot analysis of Vps41p phosphorylaltion in mutants deficient for Hog1p pathway. The 
ove blot shows Vps41p phosphorylation in the indicated deletion strains (W303 genetic background 
for top panel, BY4742 for bottom panel). Cells were given a hyper-osmotic stress for 15 min and then 
killed and proteins extracted and resolved on an SDS-PAGE gel and immuno-blotted with anti-HA. 
Bottom: Comparison of the amounts of phosphorylated Vps41p (P-Vps41p) in Hog1p pathway 
disrupted null mutants. The band intensites from the top blot were quantified using ImageJ (1.42) and 
the ratio of P-Vps41p and Vps41p was calculated from the resulting two absolute intensity values so 
obtained  (see Section 2.17)     
 
F
th
T
ab
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In order to rule out the unlikely possibility that the Fab1p and the Hog1p pathways 
might be redundant regulators of Yck3p, I examined Vps41p phosphorylation in 
hog1∆fab1∆ double mutants in which both pathways were simultaneously inactivated. 
Vps41p phosphorylation still occurred in this mutant (Fig. 4.7).  
 
It therefore seems that hypertonically activated Vps41p phosphorylation is 
independent of the Fab1p and Hog1p pathways, so it may reflect the activation of a 
previously uncharacterized osmotic response pathway. The next question was whether 
I could identify other components of this novel pathway. 
 
 
Figure 4.7: Vps41p phosphorylation occurs even when both Fab1p and Hog1p 
pathways are blocked 
dding yeast (Perera et al., 2004), and the synthesis of IP8 is 
 
4.2.3 Synthesis of inositol ‘pyrophosphates’ is required for stimulation of Vps41p 
phosphorylation 
Given the evidence that PPIns influence osmotic responses, particularly the 
PtdIns(3,5)P2 pathway and the phospholipase C pathway, it seemed appropriate to test 
whether the latter might be involved in regulation of the phosphorylation of Vps41p. 
It is known that hypo-osmotic stress can activate Plc1p and as a result the 
accumulation of IP6 in bu
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selectively induced by hyper-osmotic stress in mammalian cells (Pesesse et al., 2004; 
Choi et al., 2007). Synthesis of inositol polyphosphates is catalyzed by sequential 
phosphorylations, by Arg82p, Ipk1p, Kcs1p and Vip1p, of the IP3 that is released by 
Plc1p-catalyed PtdIns(4,5)P2 hydrolysis (Fig. 4.8).  
 
 
 
Figure 4.8: Synthesis of Inositol polyphosphates in budding yeast 
hen I examined Vps41p phosphorylation in hyper-osmotically stimulated plc1∆, 
ts (Fig. 4.9).  The simplest interpretation of this result is that an IP8, 
 
W
arg82∆, ipk1∆, kcs1∆ and vip1∆ cells, no Vps41p phosphorylation was detected in 
any of these mutan
one of the terminal products of this pathway may be necessary for hypertonically 
induced Vps41p phosphorylation, and so I initiated experiments to explore this 
possibility further.  
 PIP2   IP3 
Arg82  IP4  IP5
 IP6
 IP71/3PP-IP5   IP7 
 IP8 
   DAG
 
Plc1p 
Ipk1 
I (1,4,5)P3 I (1,4,5,6)P4 I (1,3,4,5,6)P5 
  Kcs1 
Kcs1 
(PP)2-IP4
Arg82 
Vip1 
I (1,2,3,4,5,6)P6
or Vip1 
5PP-IP5
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Figure 4.9: Inositol polyphosphate synthesis affects hyper-osmotically induced 
Vps41p phosphoryl
T ed strains were grown to exponential phase and then given a hyper-osmotic shock (0.9M 
NaCl) for 15 in. Proteins were then extracted and resolved on SDS-PAGE and probed using an anti-
HA antibody 
 
4.2.4 Vps41p localisation is correlated to its phosphorylation  
To comprehend the function of Vps41p in osmotic stress conditions, I first constructed 
endogenously expressed Vps41-GFP to o  localisation pattern in c
wild type cells, Vps41-GFP is comparatively evenly distributed on the vacuole 
membrane that is in accord with its function during the vacuole membrane fusion and 
fission. In contrast, in yck3∆ cells, Vps41p is still retained on the vacuole, but there
re now a number of large bright dots accumulating on or proximal to certain micro-
It is proposed that 
ese micro-domains may be active sites of homotypic membrane fusion or some 
0).  
 
 
+ 
0.9 M NaCl/15min 
Vps41-3HA 
WT ∆kcs1
+ + + + + 
∆vip1 ∆plc1 ∆arg82 ∆ipk1 
ation 
he indicat
 m
bserve its ells. In 
 
a
domains of vacuole membrane which are absent in wild type cells. 
th
vesicular membrane fusion sites with vacuole. This differential distribution of Vps41p 
between wild type and yck3∆ enticed us to examine the Vps41p localisation in those 
inositol phosphate kinase null mutants where the Vps41p fails to be phosphorylated 
upon hyper-osmotic shock, such as plc1∆, arg82∆, ipk1∆, kcs1∆ and vip1∆. As 
expected, in all of these null strains, the Vps41p shared a similar localisation manner 
as in yck3∆ (Fig. 4.1
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d to the vacuole membrane via the AP-3 pathway (Sun, et al., 
004), whereas Vps41p is required by AP-3 pathway to form transport intermediates 
arsow et al., 2001). Both proteins play functional roles in the AP-3 pathway. 
Vps41-GFP DIC Vps41-GFP DIC 
yck3Δ  
kcs1Δ  
WT  
arg82Δ  plc1Δ  
ipk1Δ  
vip1Δ  
 
Figure 4.10: Vps41p localisation in wild type and IP null mutants 
Vps41p-GFP was expressed in wild type, yck3Δ and several IP null mutant cells via knock-in and 
grown to exponential phase. The fluorescence signals were then detected by fluorescence microscopy 
 
Since both Vps41p and Yck3p are vacuole-membrane localised proteins, they must 
take certain pathway to traffic to vacuole from Golgi. In budding yeast, there are two 
main routes leading to the yeast vacuole from Golgi. The first is called the CPY 
pathway. During this trafficking pathway, cargoes transit the late endosome or MVB 
and are only delivered to vacuole after MVB sorting. Alternatively, some cargoes can 
be conveyed directly from Golgi to vacuole by the AP-3 pathway. What pathway the 
cargoes can take depends on what sorting signals they have. In yeast, Yck3p is 
palmitoylated, then sorte
2
(D
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In addition, inositol pyrophosphates are proposed to act as phosphate donors for a 
novel pathway of protein phosphorylation (actually they act as phosphate donors to 
phosphoserines previously phosphorylated by CK2 type protein kinases, and hence 
form serine pyrophosphates on target proteins) (Bhandari et al., 2007). One of the 
substrates of inositol pyrophosphates was identified as a subunit of AP-3, nam ly 
Apl6p, although the physiological effect of this pyrophosphorylation is unknown 
(Bhandari et al., 2007). Therefore, I needed to examine whether the AP-3 pathway 
functions properly in the IP synthesis disrupted null strains to exclude th
that the failure of Vps41p phosphorylation in these mutants is an indirect consequence 
of complete disruption of the AP-3 pathway. 
 
In yeast cells, Sna4p can be used to examine the functional status of the AP-3
. In wild type cells, the tetraspanin type membrane protein Sna4p is delivered 
it 
contains a cryptic MVB sorting signal that directs it into the vacuole if the protein 
enters this compartment. Similar to wild type, the trafficking of Sna4p displays wild-
type localisation in plc1∆ and kcs1∆ cells (Fig. 4.11, similar results were obtained 
with arg82∆, ipk1∆ and vip1∆ mutants (data are not shown)). So I can rule out the 
possibility that the phosphorylation and localisation defects of Vps41p in any of the IP 
synthesis blockade null strains results simply from gross disruption of the AP-3 
pathway. So far the available data thus suggests that Vps41p localisation is correlated 
to its phosphorylation state, and that inositol pyrophosphates influence Vps41p 
phosphorylation through Yck3p in some fashion. 
 
e
e possibility 
 
pathway
to the vacuole outer membrane via the AP-3 pathway (Reggiori and Pelham, 2001). 
However, in AP-3 blocked apl5∆ cells, the Sna4p is mis-sorted into vacuole because 
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confirm that AP-3 pathway is working properly in IP null mutants. Cells were grown to exponential 
 
Sna4-GFP DIC 
WT   
apl5Δ   
plc1Δ   
kcs1Δ   
 
Figure 4.11: The AP-3 pathway functions properly in plc1∆ and kcs1∆ 
Endogenous levels of Sna4p-GFP were expressed in wild type, apl5∆, plc1∆ and kcs1∆ by knock-in to 
phase and visualised by fluorescence microscopy 
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In addition to being affected by IPs, deletion of VPS41 itself seems in turn to affect 
synthesis of IPs and PPIns. A n in Table 4.1, PtdIns4P, PtdIns(3,5)P2,  
PtdIns(4,5)P2 and IP6 levels (and presumably inositol pyrophosphates like IP7 and IP8, 
though I did not measure these latter two molecules directly) are drastically reduced 
in a vps41Δ strain. Indeed the lack of IP6 is almost as profound as that found in plc1Δ 
mutants, as is the effect on PtdIns(4,5)P2 levels, since deletion of PLC1 reduces the 
levels of this lipid in some strain backgrounds for unknown reasons. This may suggest 
that Vps41p may feedback regulate synthesis of IP6, much as Svp1p/Atg18p affects 
synthesis of Ptd 2. This suggests some bidirectional regulatory links between 
Vps41p and Plc1p. 
 
Table 4.1: inositol lipids and IP6 levels in [3H]Inositol radiolabelled cells 
Cells were grown in media lacking inositol but containing radiolabel (3H myo-inositol) for 5-6 
generations and then lipids and InsPs extracted and quantified by anion exchange HPLC. Peak areas 
were calculated by using the integration function in the Flo-one software. Counts in fferent strains 
ere then standardized to total counts using Excel. The above are representative results of one 
riment that was repeated 3 times 
efore attempting to investigate the upstream control of Vps41p phosphorylation, I 
solved to identify the exact Vps41p phosphorylation sites. Therefore, I immuno-
urified Vps41p from total cellular lyates (Fig. 4.12). Note that phosphorylated 
s show
Ins(3,5)P
Strain  ---> Wild-type basal Wildtype salt
Inositol lipid
PtdIns 3403000 3410102 3498579 3479290
PtdIns3P 92602 69266 95447 84270
PtdIns4P 64789 57799 19838 25418
PtdIns(3,5)P2 7863 27141 697 8901
PtdIns(4,5)P2 39370 43315 11949 9745
InsP6 6800 10500 150 250
vps41Δ basal vps41Δ salt
di
w
expe
 
4.2.5 Identification of the Vps41p phosphorylation sites 
B
re
p
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Vps41p can be detected by immunoblot but cannot be observed by coomassie 
staining, largely due to the low abundance or stiochiometry of phosphorylated Vps41p 
and to the poor sensitivity of coomassie statining. Inadequate separation from non-
phosphorylated Vps41p was also probably partially to blame as well, as SDS-PAGE 
separations were sometimes variable. In order to identify the phosphorylation sites by 
FT-ICR mass spectrometry, therefore, I excised the Vps41p bands including the 
phosphorylated and non-phosphorylated Vps41p in the SDS gel (framed by the red 
rectangular in Fig. 4.12) based on the expected molecular weight of Vps41-3HA 
(approx. 120KDa) for the analysis by FT-ICR mass spectrometry. A list of the 
individual peptides were identified with reference to individual MS spectra given in 
Table 4.2 by searching against the non-redundant NCBI database together with the 
predic . The 
distri
ma
 
 
phosphorylation modifications in certain peptides by observing its loss from the 
 modification sites because any labile 
mical and cellular experiments testing, the CID-MS 
data were analysed by the SEQUEST algorithm. As shown in the Table 4.2, the 
 
ted phosporylation site localisation assessed by the SEQUEST algorithm
bution of all identified pepties in the full Vps41p sequences was depicted 
nually in Fig. 4.13.    
The CID-FT-ICR mass spectrometry method is able to identify the presence of the
parent ion, but can not tell the exact
modification is lost during the fragmentation (see Section 4.3.3 for more discussion). 
In order to obtain some ideas of where the phosphorylation may occur which will 
facilitate the subcequent bioche
software inferred that at least one phosphorlations may occur on the four serines
within the peptide sequence 20- TIDES*NS*IS*DENNVDNKREDVNVTS*PTK -47 
but it can not tell which one(s) is/are the bone fide phosphorylation site(s).          
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Figure 4.12: Immuno-purification of Vps41p 
Approximately 300ml of BY4742 (VPS41:VPS41-3HA) cells were grown to early exponential phase 
15 min at 30 °C. Then total cell lysates were extracted based on the method described in section 2.17 
and Vps41p (both phosphorylated- and non-phosphorylated versions) was immuno-precipitated by
anti-HA antibody - conjugated protein G sepharose, and detected by coomassie staining on an SDS-
PAGE gel 
in YPD media and subject to hyper-osmotic stress by further incuabating in YPD with 0.9M NaCl for 
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(Asterisks in peptides indicate sites of phosphorylation assigned by SQUEST, the ptide in whole protein sequence were added manually) 
 
 
Peptide Mass (m/  Fragmentation type E-value Coverage 
20- TIDESNS*ISDENNVDNKR -37 2129.898 3 CID 3.62E-06 0.16 
20- TIDES*NSISDENNVDNKR -37 2129.898 3 CID 4.04E-05 0.18 
20- TIDESNSISDENNVDNKR -37 2049.931 3 CID 6.14E-08 0.41 
20- TIDESNSISDENNVDNK -36 1893.830 2 CID 2.30E-07 0.38 
654- IEAASEPTASSKEEGSNITYR -674 2240.067 3 CID 3.90E-09 0.44 
20- TIDESNSIS*DENNVDNKREDVNVTSPTK -47 3200.422 4 CID 1.43E-05 0.17 
20- TIDESNSISDENNVDNKREDVNVTS*PTK -47 3200.422 4 CID 1.43E-05 0.19 
20- TIDESNSISDENNVDNKREDVNVTSPTK -47 3120.456 4 CID 3.69E-07 0.19 
48- SVSCISQAENGVASR -62 1564.738 2 CID 3.80E-07 0.60 
823- HNNYNVESAIEVCSSK -838 1850.833 3 CID 5.93E-06 0.52 
211- MFVSGGMAGDVVLSQR -226 1685.798 2 CID 1.94E-06 0.53 
935- HIVQENSLSLEVR – 947 1523.817 2 CID 7.09E-10 0.63 
469- LSINDYHLGK -478 1159.610 2 CID 1.18E-05 0.18 
156- SSILCINTDGK -166 1207.598 2 CID 2.38E-07 0.44 
675- TELVHLYLKENK -686 1486.8264 3 CID 1.90E-04 0.59 
901- AILTCSDETSEIYLK -915 1742.851 2 CID 7.24E-11 0.57 
675- TELVHLYLK -683 1115.645 2 CID 2.84E-05 0.47 
483- TTPEYYLISSNDAIR -497 1742.859 3 CID 9.60E-05 0.34 
948- DNILVIINDETKK -960 1514.842 2 CID 1.98E-08 0.33 
285- SQLLNIPFPSR -295 1271.7106 2 CID 3.62E-06 0.38 
919- GMSDDLQIDNLQDIIK -934 1833.889 2 CID 1.46E-07 0.53 
948- DNILVIINDETK -959 1386.747 2 CID 2.15E-06 0.49 
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-3HA), abbreviated as: vps41S44A,  vps41S24,26,28A, vps41S24,26,28,44A and vps41G171R 
as 
but then these vacuoles immediately re-fused indicating that phosphorylation o
Vps41p may indeed be the means by which Yck3p blocks homotypic vacuole fusion 
during osmotic stress (Fig. 4.15 & 4.16). The localisation of this Vps41p variant, the 
Vps41S24,26,28,44A  allele, also displayed the characteristic ∆yck3-like dot morphology in 
some but not all cells (Fig. 4.17). These data reinforce the mass spectrometry results 
indicating that Serines 24, 26, 28 and 44 are likely bona fide phosphorylation sites. 
 
Figure 4.14: Response of Vps41p mutants to hyper-osmotic Stress 
The site-specific mutagenesis method described in section 2.15 was used to construct three vps41
mutants in the genomic DNA of BY4742: BY4742 (VPS41:VPS41S44A-3HA), BY4742
(VPS41:VPS41S24,26,28A-3HA), BY4742 (VPS41:VPS41S24,26,28,44A-3HA) and BY4742
PS41G171R
0.9 M NaCl/15min 
Vps41-3HA 
VPS41 
++++
vps41S44Avps41S24,26,28Avps41S24,26,28,44A 
+ 
vps41G171R 
(VPS41:V
 
 
 
 
analysed as described in section 2.16 with the wild type Vps41p acting as a positive control. 
 
 
respectively. The hyper-osmotic stress induced Vps41p phosphorylation status for each variant w
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Figure 4.16: a. The vacuole number per cell in wild type, yck3∆ and vps41 A 
upon salt stress; b. The percentage of cells containing fragmented vacuoles in wild 
type, y ∆ and vps41S24,26,28,44A upon salt stress  
Wild ty Y4742), yck3∆ and vps41S24,26,28,44A were stained with FM4-64, exposed to hy c 
stress (YPD+0.4M NaCl) for the indicated times (10 or 60min), then vacuole morphology d 
as either average vacuole number in each cell (a) or percentage of cells with fragment
according to LaGrassa & Ungermann (2005) (b). Error bars indicate mean ± SD. At least 8  
experiments were co  an nted each con tatistical sig s 
denoted by asterisks.  ≤ 0.0 *, P ≤ 0.
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igure 4.17: Vps41S24,26,28,44A localisation similar to Vps41p in yck3∆  
ells of the indicated genotypes, bearing a VPS41-GFP knock-in (expressing Vps41-GFP at 
ndogenous levels) were grown to exponential phase and the localisation of Vps41p established by 
luorescence microscopy using a 100 x objective. 
mation of transport 
esicles at the Golgi complex in the AP-3 pathway (Rehling et al., 1999). It was later 
etermined, by the same lab, that Vps41p exerts this function by homo-
erization and interaction with AP-3 through two distinct domains (Darsow et 
l., 2001): an N-terminal Apl5p binding domain and C-terminal multimerization 
omain. In order to delineate the relationship between these two domains and the 
at the genomic level by knock-in: 
g of the kinase Yck3p in this mutant. I have 
 far succeeded in constructing the vps41I832T allel that compromises the Vps41p 
  
F
C
e
f
 
 
It was reported previously that Vps41p is required for the for
v
d
oligom
a
d
phosphorylation domain that I just identified (Fig. 4.18), I tried to re-create the two 
vps41 variants described in Darsow et al, 2001, 
vps41G171R and vps41I832T cripple the Apl5p binding domain and multimerization 
domains respectively. I constructed the vps41G171R mutant and the immunoblot result 
demonstrated that this Vps41p variant failed to be phosphorylated upon salt stress 
(Fig. 4.14), probably due to the mis-sortin
not so
Vps41-GFP DIC
WT 
Vps41-GFP DIC 
ck3∆ y
DIC Vps41S24,26,28,44A-GFP
S24,26,28,44A vps41
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multimerization domain, but I expect this Vps41p variant would also display the same 
lack of ph rylation  and for h the sa as discussed 
above. 
 
 
992 
 
 as Vps41G171Rospho  muc me reason 
 
Vps41 multimerization 
domain Apl5 binding domain 
 
1 232 99 753 901 
 
G171R I832T 
 
 
Figure 4.18: Schematic domain structure of Vps41p 
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Hyperosmotic-induced 
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4.3 DISCUSSION 
Previous work indicated that Vps41p is phosphorylated by Yck3p upon hyper-osmotic 
stress in vitro. I extended this by developing a new method to detect Vps41p 
hosphorylation in vivo and succeeded in mapping the stress-induced phosphorylation 
sites of Vps41p. I used this method to test various nul ope of 
identifying upstream regulators of this pathway and ruled out both the Hog1p and 
Fab1p/PtdIns(3,5)P bination. Our data also indicate 
that Plc1p-catalyzed generation of inositol pyrophosphates may be the long-sought 
ups hough I were unable to identify the sensor system upstream of
lc1p. Radiolabelling also suggests that a bidirectional interaction is occurring 
between Vps41p and Plc1p, (or with synthesis of PPIns upstream of it). Thus I 
propose that Plc1p, through inositol pyrophosphates, may regulate the 
phosphorylation of Vps41p in response to osmotic stress. 
 
4.3.1 Detection of hyper-osmotic induced Vps41p phosphorylation by two distinct 
methods 
In the original study, Vps41p phosphorylation was detected by a complex in vitro 
method: vacuole-containing membrane fractions were isolated and then incubated 
under standard fusion conditions in the presence or absence of ATP followed by SDS-
PAGE and immuno-blotting of Vps41p. When ATP was present, Vps41p becomes 
retarded in its SDS-PAGE mobility corresponding to its increased phosphorylation 
status. However, when ATP is absent, only a single band corresponding to hypo-
phosphorylated Vps41p is observed. There are a number of disadvantages to this 
method that make it difficult to increase the throughput, as would be required for even 
a directed screen.  
p
l mutants in the h
2 pathways, either singly or in com
tream regulators, t  
P
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1). Both protocols for vacuole isolation and the in vitro vacuole fusion reaction are 
 immuno-blotting protocols. 
think this method is more physiological and rapid and will therefore lend itself to 
Vps41p were incubated together with yck3Δ vacuoles containing 
relatively complicated and not amenable for screening of large numbers of mutants.  
In addition, there are many possible artifacts associated with in vitro assays of this 
type. 
 
2). The manipulation of ATP to control the phosphorylation status of Vps41p is not 
physiological and may also introduce artifacts and could be prone to 
misinterpretation. 
 
In order to circumvent the above problems, I developed a novel method to detect 
phosphorylated Vps41p: I constructed an epitope-tagged VPS41 by knock-in (in the 
future, when anti-Vps41p sera are available, this step can be omitted), then gave the 
growing cell a hyper-osmotic stress followed by standard
I 
directed screens designed to isolate additional components of this pathway in future 
studies. 
 
4.3.2 Regulation of hyper-osmotic induced Vps41p phosphorylation 
To date, Yck3p is the only protein identified whose deletion totally abolishes Vps41p 
phosphorylation in vitro (LaGrassa and Ungermann, 2005) and in vivo (our current 
data). In the original work, Yck3p was suggested to be the direct kinase mediating 
Vps41p phosphorylation, chiefly based on the following observations: a. In the 
presence of excess Yck3p, Vps41p was constitutively phosphorylated in vivo; b. 
Yck3p and Vps41p are associated on isolated vacuoles; c. When wild type vacuoles 
containing tagged 
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untagged Vps41p, became phosphorylated in trans (LaGrassa and Ungermann, 2005).  
These data do not exclude the possibility that Yck3p is not the direct kinase but is in 
fact required for activation of the bona fide kinase in vivo or that Yck3p is required to 
constrictively phosphorylate Vps41p at a “priming site” that is required for 
ubsequent, stress-induced phosphorylation by another protein kinase (or even an 
p reaction in vitro, although such in vitro kinase assays are also 
aught with the potential for artifacts. However, the mobility of Vps41p on a gel after 
ne particular reason for being cautious about the event causing the Vps41p band-
osphates can 
s
inositol pyrophosphate, see later). Indeed casein kinases are often found in exactly 
this role as priming agents. Therefore, evidence should be obtained from the purified 
Vps41p and Yck3
fr
such an in vitro phosphorylation should at least confirm that the mobility shift 
observed after stress could be mediated by Yck3p, as this is currently uncertain. 
Fortunately, it was recently reported that both Vps41p and Yck3p have been 
successfully purified as recombinant proteins from insect cells and bacteria, 
respectively (Brett et al, 2008; Hickey et al, 2009), thus, it is very likely that this issue 
will be resolved in the near future. 
 
O
shift in response to stress is the recent discovery that inositol pyroph
donate directly one phosphate to proteins in a non-enzymatic reaction (Saiardi et al., 
2004; Bhandari et al., 2007). The available evidence suggests that proteins to be 
phosphorylated in this way must first be “primed” by being phosphorylated by CK2 
isoforms. The serine residue phosphorylated by CK2 is then apparently further 
phosphorylated by the inositol pyrophosphate directly to create a phospho-anhydride 
(or pyrophosphate) bond. Hence it is possible that the observed band shift in Vps41p 
is not a direct result of Yck3p phosphorylation but could instead be a combination of 
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phosphorylation and inositol pyrophosphate phosphate donation. Whilst this 
proposition is attractive, there are a number of objections to this model. The first is 
that Yck3p is a CK1 like enzyme and, despite the similarity in name, CK1 and CK2 
protein kinases are only very distantly related and share very little sequence homology 
or biochemical properties. CK1 isoforms form their own sub-family of protein kinase 
whilst CK2s are part of the CMGC family that includes Cyclin-dependent kinases, 
Map kinases, Glycogen synthase kinases and Cdk-like kinases (Gross and Anderson, 
1998; Meggio and Pinna, 2003). The consensus phosphorylation sequences for the 
two families of enzymes are quite different, although both prefer to phosphorylate 
serines that are present in a background of acidic amino-acids. However, all 
phosphorylations mediated by inositol pyrophosphates in yeast appear to occur in the 
presence of a priming kinase activity that can use GTP as a phosphate donor 
(Bhandari et al., 2007), indicating that the priming activity is CK2-like as this family 
of protein kinase can utilize both GTP and ATP as a substrate, whereas CK1 isoforms 
cannot (Tuazon and Traugh, 1991). So unless yeast CK1s display fundamentally 
ifferent properties to mammalian enzymes, and can use GTP, Yck3p is unlikely to be d
merely a priming kinase for inositol pyrophosphate mediated phosphorylation of 
Vps41p. 
 
In addition to the Yck3p, I propose that inositol pyrophosphates (probably IP7 and/or 
IP8) may be regulators of hyper-osmotic stress evoked Vps41p phosphorylation. Such 
a role for these molecules has been hinted at from previous studies because mutants in 
various inositol phosphate kinases display altered vacuole morphology and because 
these mutants grow very slowly or not at all in high salt for unknown reasons (Perera 
et al, 2004; Pesesse, et al., 2004; Choi et al., 2007). In addition, one of the proposed 
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targets of inositol pyrophosphate mediated phosphorylation was identified as Apl6p 
(Bhandari et al., 2007): a subunit of the AP-3 complex and therefore on the same 
pathway as Vps41p, although no functional role for this phosphorylation has yet been 
identified. Indeed I show here that ablation of inositol pyrophosphate synthesis does 
not cause a gross defect in the AP-3 pathway, since Sna4p is trafficked normally in 
plc1Δ, arg82Δ and kcs1Δ mutants (Fig. 4.11).  This was an important result because I 
then observed that hyperosmotic-activated Vps41p phosphorylation did not occur in 
single mutants of enzymes mediating the IPs synthesis pathway. If I had not done the 
earlier Sna4p experiment, it would have been easy to speculate that the failure to 
phosphorylate Vps41p was merely due to disruption of the AP-3 pathway (which 
would also result in mislocalisation of Yck3p). 
 
Our data do not allow us to determine if Plc1p and IPs are required for a constitutive 
event (e.g. priming) that is needed for the subsequent stress mediated phosphorylation 
of Vps41p or whether inositides directly control the phosphorylation in response to 
stress. There have been reports that IP levels are increased by the application of 
osmotic stresses (both hyper and hypo osmotic stresses) but the changes are relatively 
modest (3-5 fold) although these are whole cell measurements and it is unclear how 
uch of basal and stimulated IP production is nuclear and whether nuclear pools can m
access the cytoplasm (Perera et al., 2004; Choi K, et al., 2005; Choi JH, et al., 2007). 
If, for example, basal IP production in S. cerevisiae is substantially nuclear, as would 
be inferred by the number of constitutive nuclear cell functions that seem to require 
IPs, then it is possible that stimulated levels of some inositol pyrophosphates might be 
increased 10-fold by stress and this might be enough to act as a second-messenger 
type switch if the affinities of the relevant inositol phosphate targets was in the 
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appropriate range. However, this remains speculation until these direct targets are 
identified and their affinities measured (see Chapter 5 for a more extensive 
discussion). 
 
The mechanism of IP-mediated control of Vps41p phosphorylation is similarly 
unclear. There are reports that IPs, particularly IP4, can regulate casein kinase activity 
in animal cells, through binding to the regulatory β-subunit of these enzymes, but this 
report again identified the CK2 family as the targets of IPs and not CK1s like Yck3p 
(Solyakov et al., 2004). It remains possible that Yck3p is directly regulated by inositol 
pyrophosphates or it may indeed be that once Yck3p has phosphorylated Vps41p that 
the inositol pyrophosphates are then required to directly phosphorylate the same 
erines on Vps41p non-enzymatically, forming a serine pyrophosphate that is required s
to block vacuole-vacuole fusion. Our MS data did not indicate that Vps41p was 
pyrophosphorylated, but it remains possible that serine-pyrophosphate containing 
peptides were somehow not identified or destroyed during the procedure for technical 
reasons, as they are known to be much more labile than simple phosphoserine 
residues. Further experiments are required to clarify this point. 
 
Our discovery that IPs may regulate Vps41p phosphorylation, and therefore control 
vacuole fusion and fission, may provide a key to unravel the underlying mechanisms 
for the phenotypes of the IP null strains. Indeed, plc1Δ, arg82Δ and kcs1Δ mutants 
were all recently isolated in a screen for deletion mutants displaying highly aberrant 
vacuoles (Seeley et al., 2002), suggesting that IPs are indeed required for vacuole 
fusion/fission under some circumstances. This observation has also been noted in 
more directed studies of vacuole morphology in arg82Δ and kcs1Δ mutants, where 
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aberrant morphology was also reported.  
 
The discovery that levels of PtdIns4P, PtdIns(4,5)P2 and IP6 (and probably IP7 and 
8) are extremely low in vps41Δ mutants was surprising and may indicate that some IP
of the phenotypes of this strain are attributable to low Plc1p signalling. The reason for 
this effect is not clear but it is tempting to speculate that Vps41p contributes to the 
feedback regulation of steady-state levels of PPIn signals in the Plc1p pathway in 
much the same way as Svp1p/Atg18p does for the Fab1p pathway. Indeed, both 
proteins are seven bladed β−propellers and both exhibit a blade junction with a very 
similar sequence over just the area where PtdIns(3,5)P2 is reported to bind in 
Svp1p/Atg18p (Fig. 4.19) 
 
VPS41: DGxxxATGSIDGTVIIGSMDDPQNITQYDFKRPIN 
ATG18: DGxxxATAS-DKGTIIRVFDIETGDKIYQFRRGTY 
Figure 4.19: Amino-acids of the junction of blades 4 and 5 of Atg18p compared 
 
Previous studies have indicated that Vps41p might bind several inositol lipids in a 
weak and fairly nonspecific fashion but our unpublished data have not corroborated 
this so-far since Vps41p expresses poorly in bacteria and appears to produce partially 
mis-folded, albeit soluble protein, that may not display the normal properties of 
Vps41p (Heath and Dove, unpublished). The use of CCT-like chaperones in in vitro 
translation reactions might be a profitable next step to overcome this technical 
expression problem, as many β-propellers require CCTs for correct folding and these 
proteins are absent from prokaryotes. 
 
 
with the corresponding junction between two blades of Vps41p 
The AP-3 binding site of Vps41p is underlined. The PPIns binding site of Atg18p is also underlined  
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4.3.3 Identification of hyper-osmotically induced Vps41p phosphorylation sites 
 order to investigate the Vps41p phosphorylation phenomenon further, it was 
st of defects of yck3Δ cells, whereas mutants with fewer 
erine mutations displayed less severe defects as expected, further confirming that 
lation sites upon osmotic 
ss 
etry and CID enables the identification of post-translational modifications 
he Electron capture dissociation (ECD) mass 
In
imperative that the identification of the phosphorylation sites was undertaken. I 
therefore immuno-purified phosphorylated Vps41p from hyper-osmotically stimulated 
cells. Our mass spectrometry data identified the presence of phosphorylation within 
peptide of 20-TIDESNSISDENNVDNKREDVNVTSPTK-47. The SEQUEST 
algorithm analysis of the MS data suggested the four serine amino acids at 24, 26, 28 
and 44 as likely phosphorylation sites. The vps41S-A mutants harboring different 
combinations of serine-alanine transitions exhibited different degrees of 
phosphorylation of Vps41p, with the mutant harboring all four serine to alanine 
mutations phenocoping mo
s
these four serine sites are Vps41p's intrinsic phosphory
stress. 
 
The coupling of high mass accuary FT-ICR mass spectrometry and the tandem ma
spectrom
like phosphorylation. However, CID achieves peptide fragmentation by heating the 
sample to a higher Boltzmann temperature, resulting in the loss of any labile 
modification during this step and this procedure can’t locate the exact modification 
sites. In addition, the use of SEQUEST analysis on CID data just gives a low 
confidence site localization, and it is also difficult to analyse multiply and/or doubly 
phoshorylated peptides. Finally, the low stoichiometry typically associated with 
phosphorylation event means that phosphopeptides are often overlooked in data-
dependent CID analyses. However, t
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spectormetry provide an alternative to CID on the identification of exact modification 
lso reported the identification of the osmotic stress sentitive phosphorylation 
ites but mapped them to four different serine residules: S367, 368 371, 372. They 
sites (Zubarev et al., 1998). ECD is a radical-driven fragmentation technique and 
retains the labile side-chain modifications intact upon peotide backbone cleavage. 
However, ECD enables unambiguous assignment of the sites of modification, and also 
exact localization of any double phosphorylations. The downside to this technique is 
the increased sample purity and abundance required. If I had had more time, I would 
have liked to have optimized my immuno-purification method in order to get a much 
purer protein sample, and also try to enrich the phosphopeptide by use of phosphor-
specfic antibodies or chromatographic enrichment.  I would then have tried to 
determine the exact phosphorylation sites of Vps41 by ECD-FI-ICR mass 
spectrometry.   
 
After I identified these phosphorylation sites but before publishing our result, another 
group a
s
adopted a different method from us by searching available databases for CK1 (Yck3p) 
sites within the Vps41p sequence. They mutated the four serines to alanines and the 
resulting Vps41p mutants were expressed in the vps41Δ background. Membrane 
fractions were then purified from these mutants and Vps41p phosphorylation was 
detected by an ATP-dependent mobility shift on SDS-PAGE gels following an in vitro 
assay (Cabrera et al, 2009). Their data also showed no phosphorylation of Vps41p 
after these mutations were made, so how to reconcile our data with those of Cabrera et 
al.? 
 
The observed differences between our data obtained by mass spectrometry and the 
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data obtained from database searching are difficult to explain if Yck3p is the bona fide 
kinase that directly phosphorylates Vps41p in response to stress. This is, however, an 
unproven assumption, as is the assumption that Yck3p is a prototypic CK1 with the 
same consensus sequence as that found in other organisms: the exact consensus and 
substrate preferences of Yck3p are untested experimentally and conclusions based 
purely on in silico analysis are often highly questionable. Indeed, Yck3p is a fairly 
divergent member of the CK1 family and could easily display unusual substrate 
specificity.  In  addition, since Vps41p is a β-propeller, making mutations and then 
drawing conclusions based solely on the mutants in in vitro kinase assays is dangerous 
as subtle changes in amino-acid sequence can drastically affect the structure of the 
propeller and can make interpretation difficult, especially when the expected result is 
 negative one: i.e. no phosphorylation. Our mutants are in an area of the propeller, 
to the same analysis. If this were to be true, then our Vps41p mutants still blocks 
hosphorylation, although the effect could be indirect (e.g that our sites are “priming” 
a
close to the N-terminus, where point mutations would not be expected to affect the 
gross structure of the whole propeller. Cabrera’s mutations (2009), in contrast, are 
deep in the propeller, though it is difficult to evaluate the effect, these mutations might 
have without a proper 3-D model of this protein. 
 
In contrast, our identification of the phosphorylations sites has been validated by both 
subsequent immuno-blot examination of phosphorylation of Vps41p in vivo, and by 
examination of vacuole morphology in response to stress. This further strengthens the 
possibility that Ser 24, 26, 28 44 are phosphorylated in vivo, though it is possible that 
they are constitutively phosphorylated as I did not subject Vps41p from unstressed 
cells 
p
phosphorylation sites). Since our phosphorylation sites and those described by 
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Cabrera (2009) are very distant in the primary amino-acid sequence, it seems unlikely 
that one set of sites is the “priming” site for the other, unless these sequences are 
closely apposed in the 3-dimensional structure.  
 
Intriguingly, our phosphorylation sites do not conform to the consensus for CK1 and 
this suggests that I have identified the sites phosphorylated by a novel kinase, and not 
those directly attacked by Yck3p, unless this enzyme has an atypical consensus 
phosphorylation sequence. On balance, this might infer that the sites of Cabrera et al. 
are those phosphorylated by Yck3p and that these act as priming sites for our 
phosphorylations, which are responsive to hyper-osmotic stress. This would imply 
that the Yck3p phosphorylations are constitutive and that a second unidentified kinase 
mediates the phosphorylations I have uncovered. If this were the case, then it will be 
important to determine which of these kinases is downstream of Plc1p and the inositol 
phosphates. Finally, ECD mass spectrometry should be used to map the 
phosphorylation sites unequivocally.  
 
4.3.4 Three hyper-osmotic pathways in the budding yeast 
In budding yeast, two pathways have previously been known to respond to 
extracellular hyper-osmotic stress. One is called Hog1p MAPK pathway, which is 
centered on three tiers of protein kinases whose sequential phosphorylations 
eventually influence transcription factors to synthesize increased levels of glycerol 
that maintain the osmotic balance of the cells under hyper-osmotic conditions. The 
other is called Fab1p pathway, which is responsible for the generation of the 
phospholipid PtdIns(3,5)P2 and appears to regulate vacuole fission and possibly 
vacuole acidity in response to stress. In this case, it is suggested that efflux of ions, 
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osmolytes and water from vacuole to cytoplasm results in a short term benefit to the 
cell in the face of intense dehydration. It is also possible that the regulated reduction 
in vacuole membrane area makes the rupture of this organelle much less likely during 
smotic imbalances. It has been demonstrated that Fab1p and Hog1p pathways work 
ps41p come into operation much earlier than 
og1p by controlling vacuole fission and inhibiting re-fusion respectively. These two 
rm adaptation to stress. 
o
independently under hyper-osmotic stress and it now appears that Vps41p is similarly 
independent. It is still possible that Fab1p and Yck3p share a common upstream 
activator but that the pathway diverges before it reaches these two proteins, but I 
consider this unlikely because of the fact that Plc1p appears to control Vps41p 
phosphorylation. 
 
Although the PtdIns(3,5)P2 accumulation and Vps41p phosphorylation have a lot in 
common upon osmotic stress, I failed to demonstrate any form of co-regulation. Our 
final model is depicted in (Fig. 4.20): upon hyper-osmotic stress, three pathways, 
Fab1p, Vps41p and Hog1p are activated almost at the same time but they take effect 
in a defined sequence. Fab1p and V
H
pathways are therefore responsible for a rapid but short-te
Hog1p is then required for long-term adaptation and for the resumption of growth and 
cell division. 
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Figure 4.20: Model of hyper-osmotic stress pathways in budding yeast  
yper-osmotic stress first activates the Fab1p pathway and the resulting PtdIns(3,5)P2 fragments the 
vacuole to prevent immediate rupture. Plc1p is also activated and the resulting IP8 promotes 
hosphorylation of Vps41p, which blocks fusion and keeps the vacuoles in a fragmented state after 
vels of PtdIns(3,5)P2 return to normal after 10-60 mins of stress (the exact time is determined by the 
tensity of the osmotic stress). The Hog1p pathway then has time to activate gene transcription and 
levate cytoplasmic levels of glycerol, resulting in a restoration of water balance with the external 
medium
H
p
le
in
e
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Chapter 5: General discussion and future work 
5.1 Myotubularins: what is their real function? 
Following the successful purification of Ymr1p from bacteria, I also tried to examine 
its substrate preference using a malachite green-based colorimetric phosphatase assay. 
The premilinary observation showed that this enzyme can utilize PtdIns3P and 
PtdIns(3,5)P2 but not PtdIns4P or PtdIns(4,5)P2 as substrates. Since the assay is not 
yet optimized it is not possible to say what the preferred substrate is, although under 
present conditions it appears to prefer PtdIns3P. Therefore, optimizing this 
colorimetric assay in order to convince the above observation would be a major 
concern in my future work. 
 
I am interested in the study of the substrate specificity of Ymr1p because of the 
confusion surrounding the role of the myotubularin family of enzymes in animal cells. 
I had hoped to identify a myotubularin that would not attack PtdIns(3,5)P2 because 
this would have been a valuable tool for expressing in animal cells, to probe which 
substrate(s) of myotubularins is/are important in various pathological processes. It is 
known that the mammalian enzymes (e.g. MTM1 and MTMR2) will degrade both 
PtdIns3P and PtdIns(3,5)P2 (Clague and Lorenzo, 2005). In the case of the latter lipid, 
myotubularins may form PtdIns5P: indeed this is the only widely accepted route to 
this novel inositol lipid. 
 of Charcot-Marie-Tooth (CMT) like neuropathies, particularly CMT4 (Bolino 
 
 
As indicated in Chapter 1, myotubularins are inactivated in a number of human 
genetic diseases, including the muscle disease, X-linked myotubular myopathy and a 
number
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et al., 200 foldings 
yelin sheath coating the affected nerve cells causes a severe reduction in the 
e aberrant morphology of 
Schwann cells (the cells responsible for forming the myelin sheath), which have 
MTMR2, a myotubularin inactivated in CMT4B, antagonizes the action of the 
et al
 
Intriguingly mutations in mammalian Fig4p, the enzyme that degrades PtdIns(3,5)P2, 
T, known as CMT4J (Chow et al., 2007). This 
inactivation that causes CMT4B because Fig4p is not known to associate with 
PtdIns(3,5)P in all organisms tested because this enzyme is an essential part of the 
conformation, partnered with Vac14p (Duex et al., 2006a). Hence if I compare what 
happens to inositol lipid  myotubularin null and fig4-/- null strains some patterns 
      Gene inactivated 
FIG4 myotubularin 
0; Berger et al., 2002). In the case of these latter diseases, gross out
of the m
speed of the action potential. This appears to result from th
excessive plasma membrane area (Bolino et al., 2004). One recent study suggests that 
exocyst complex that delivers a membrane cargo to the plasma membrane for 
secretion (Bolis ., 2009). 
This implies that myotubularins might be regulating endocytosis somehow. 
can also give rise to a form of CM
result suggests that it is alterations in inositol lipids caused by myotubularin/Fig4p 
myotubularins. Somewhat non-intuitively, FIG4 mutations reduce the levels of 
2 
complex that correctly localises the Fab1p lipid kinase and keeps it in an active 
s in
begin to appear as following table. 
Lipid 
PtdIns3P increased increased 
PtdIns(3,5)P2 30-40% increased 
PtdIns5P ~20% ~20% or less 
 
This suggests that either too much PtdIns3P or too little PtdIns5P is responsible for 
the CMT4 type phenotype and results in excess exocytosis or a reduction in 
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compensatory endocytosis. Since PtdIns3P has a well defined set of functions in 
various cellular processes that all tend to send membrane away from the cell surface 
and towards to the lysosome/vacuole (e.g. autophagy, the Cvt pathway, protein sorting 
to the lysosome/vacuole and MVB sorting) (see Section 1.6.1), I would suggest that 
too much PtdIns3P would be unlikely to result in the delivery of more membrane to 
the cell surface, indeed, the opposite might be expected.  
 
In contrast, very little is known about PtdIns5P and it putative functions, making 
lterations in the metabolism of this lipid the prime candidate for the cause of CMT4 
P is present at the 
TGN, late endo s acuo ell as the nucleus of 
animal but not yeast c
 
So PtdIns(3,5)P2 could indeed be made close to the cell surface, and there is already 
evidence that it can influence cell surface trafficking. For example, the increased cell 
a
type neuropathies. Yet if PtdIns5P synthesis occurs via myotubularins from 
PtdIns(3,5)P2, how does this get to the cell surface: after all Fab1p/PIKfyve are 
implicated in events at or around the late endosome in animal cells: deep within the 
cell (Shisheva, 2008). However, our ideas of where PtdIns(3,5)P2  is actually made in 
a cell are vague because none of the effectors so far identified have provided us with a 
probe that is suitable for live cell imaging. In effect, I am only guessing where this 
lipid is made from the effects that I observe on phenotypes. A priori, PtdIns(3,5)P2 
(and consequently PtdIns5P) could be made anywhere that PtdIns3P is present in the 
cell. The distribution of PtdIns3P was recently defined by using a tandem FYVE 
domain construct linked to immuno-gold to probe ultrathin sections of fixed cells 
under EM (Gillooly, et al., 2000). The results suggest that PtdIns3
some/MVB and lyso omal/v lar surface, as w
ells. 
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surface residency of a number of ion and nutrient channels in response to various 
agents requires PIKfyve (the mammalian Fab1p) (Klaus et al., 2009a and b), and there 
is evidence in yeast for a requirement for Fab1p in the trafficking of Chs3p, a chitin 
synthase that cycles between the cell wall/plasma membrane and the Snc1p positive 
recycling endosome (Phelan et al., 2006).  
 
This suggests that increased PtdIns(3,5)P2  is required for exocytosis somehow and it 
t function of PPIns is not just to regulate the direction and 
n/off nature of membrane trafficking, but that these lipids balance membrane flow 
is tempting to speculate that PtdIns5P then balances the membrane delivered to the 
plasma membrane by stimulating endocytosis, either directly or possibly via type II 
PtdIns5P 4-kinases. I favour the view that PtdIns5P itself may be the regulator of 
endocytosis because I have shown here that Ymr1p can indeed make this lipid and 
that it is present in yeast cells, despite the absence of a type II PtdInsP kinase, though 
this is not well supported at present. 
 
 In regard to possible endocytic functions for PtdIns5P: it is notable that several 
bacterial pathogens produce extracellular enzymes (e.g IpgD) that they inject into 
cells to produce PtdIns5P (Niebuhr et al., 2002). Could this be to facilitate their 
uptake into cells via endocytosis: clearly further research is needed but it is an 
attractive hypothesis? 
  
Indeed it fits in with a larger hypothesis that has been suggested in our lab a number 
of times: that one importan
o
from one organelle to the next so that there is no net gain or loss of membrane from 
one organelle to another (Dove et al., 2009). 
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To understand this idea, consider how type II PtdIns5P 4-kinases are supposed to 
work: as the last step in the complicated metabolic scheme indicated below 
PtdIns ------> PtdIns3P ------->  PtdIns(3,5)P2 ------> PtdIns5P ------> PtdIns(4,5)P2. 
This metabolism seems an absurd way to synthesize a signal until I consider that there 
may be a cell biological reason for these inter-conversions: that each transition to a 
ew PPIn may accompany a parallel transition to a new compartment/organelle. Now 
ion. All the PtdIns5P does is signal the change in 
irection and when there is no myotubularin then this flow membrane away from the 
athways leading into the vacuole utilise PtdIns3P and the only 
own pathway causing membrane to leave the vacuole is dependent on PtdIns(3,5)P2 
auses the vacuole to swell and gain 
n
what if I go further and ask if PPIns are counting molecules that ensure that organelles 
do not grow or shrink as a result of endomembrane trafficking? So one important 
function of the PtdIns(3,5)P2 to PtdIns5P transition could be to regulate plasma 
membrane area. This would mean that somehow the plasma membrane turns all 
arriving PtdIns(3,5)P2  into PtdIns5P and this then results in the same amount of 
membrane leaving the cell surface as arrived at the plasma membrane, thus 
maintaining membrane area and tens
d
plasma membrane is blocked and the plasma membrane expands, as happens in mtm2-
/- Schwann cells (Bolis et al., 2009). Clearly some mechanisms must exist to balance 
membrane entry and exit from organelles and I would like to speculate that PPIns are 
a possible candidate. In this regard it is noticeable that in yeast, nearly all the 
membrane trafficking p
kn
(Dove et al., 2004). Since this lipid couplet are also interconnected metabolically, the 
same logic could apply with a certain fraction of PtdIns3P turned into PtdIns(3,5)P2 to 
balance out the inward flow. In support of this hypothesis, increasing the levels of 
active Fab1p causes the vacuole to fragment and shrink, losing membrane area whilst 
decreasing the amount of active Fab1p c
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membrane area (Bonangelino et al., 2002). 
 
5.2 Vac7p localisation 
The idea that there might be different pools of PtdIns(3,5)P2  in cells suggested to us 
that I might be able to find components of the Fab1p machinery that were only 
involved in the regulation of one pool but not others. It was therefore gratifying when 
I found that Vac7p takes the AP-3 dependent pathway to the vacuole, suggesting that 
it cannot participate in the MVB sorting functions of Fab1p/PtdIns(3,5)P2 unless it 
traffics to back from the vacuole to the Pep12p positive endosome with the cargo. I 
think this is unlikely because Vac7p obviously lacks the negative sorting information 
required to keep it out of the forming intraluminal vesicles of the MVB and so 
sending it to the Pep12p positive endosome (which matures into the MVB) would 
result in the destruction of this protein. 
 
I therefore believe that Vac7p only regulates Fab1p on the vacuole and since Vac7p is
equired for the increase of PtdIns(3,5)P2 seen after hyper-osmotic stress (Gary et al., 
2002; Duex et al., 2006b), this suggests that most of the newly synthesized lipid is 
made on the vacuole membrane. 
 
Vac7p trafficking through the AP-3 pathway may also suggest something else: that it 
and Atg18p are connected with AP-3 dependent sorting from Golgi to vacuole. As 
shown in Chapter 4, during the comparison between Vps41p and Atg18p domain 
structure, Atg18p has a domain close to the lipid binding site that looks very like the 
AP-3 binding site of Vps41p. Although Fab1p and PtdIns(3,5)P2 are not involved in 
the regulation of AP-3 pathway, perhaps Vac7p and Atg18p are, because they are 
 
r
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binding partners for one another and because Atg18p may bind AP-3 (Efe et al., 
007). It is tempting to speculate that Atg18p might mediate membrane retrieval from 
lgi in a PtdIns(3,5)P2 independent but Vac7p dependent 
afficking in other eukaryotes in general. Our 
xpectations were not unreasonable, given the fact that much of our understanding of 
aryotes (see review in Dove et al., 2009)  
2
the vacuole back to the Go
manner. Or perhaps Vac7p and Atg18p are required for forward trafficking of proteins 
and membrane towards the vacuole. Experiments are underway in the lab to determine 
the substance of these speculations.  
 
5.3 The yeast endosomal system 
Much of the work in this thesis has focused on membrane trafficking and has used the 
budding yeast, S. cerevisiae as a model organism, for reasons that are primarily 
technical and have been elaborated earlier (see Section 1.8).  In using yeast I had the 
clear intention of discovering broad mechanistic insights into membrane trafficking 
that I might then be able to apply to tr
e
eukaryotic endomembrane biology came from studies conducted in yeast (Bowers and 
Stevens, 2005). Indeed, the Fab1p pathway, originally described by ourselves and 
others from S. cerevisiae (Odorizzi et al., 1998; Cooke et al., 1998), has proved to be 
remarkably conserved in most euk
 
Yet I quickly became aware of a problem with such an evolutionary view: the yeast 
endosomal system is seemingly similar to its mammalian counterpart and yet this 
superficial similarity may be deceptive (Dove et al., 2009 and references therein). In 
order to port observations from yeast to animals it is necessary to have a clear idea of 
which compartment in yeast corresponds to which compartment in animal cells (Ali et 
al., 2004). 
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In S. cerevisiae, there is a compartment, marked by the SNARE Snc1p that is 
immediately under the plasma membrane. This has led many to assume that this 
compartment is the yeast “early endosome” (Prescianotto-Baschong and Riezman, 
2002) though more cautious researchers have also called it the “post Golgi endosome” 
(PGE) in order to avoid this assumption (Weisman, 2003). Similarly, the endosomal 
structures lying close to the vacuolar membrane that are marked by the SNARE 
ep12p, have also been dubbed “late endosomes” by many researchers (Schimmoller 
lle is also variously referred to as the “pre-
ganelle 
a because a wealth of evidence suggests 
ecause most fungi still encode a PTEN-like enzyme (Ptn1p) that in S. 
P
and Riezman, 1993), though this organe
vacuolar endosome (PVE) or pre-vacuolar compartment (PVC) in an attempt to 
sidestep the issue (Ali et al., 2004). Even the vacuole itself has not escaped, and is 
almost universally assumed to be the yeast lysosome, mostly because of a lack of any 
other obvious compartment to fulfill this requirement. 
 
Functionally, these designations may be correct in that the vacuole undoubtedly 
performs the degradative and protein recycling functions that in animal cells are 
mediated by the much smaller and considerably more acidic lysosomes. Indeed this is 
the reason that I have used the designation vacuole/lysosome in this thesis. However, 
great care needs to be exercised before making any glib assumptions about or
identity based purely on morphological criteri
that fungi have discarded, truncated or modified a whole host of cellular functions 
during the course of their rapid evolution as micro-organisms (Galagan, et al., 2005). 
 
For example, in the field of PPIns, it seems certain that fungi once had PI3KC1s but 
have completely lost them through the course of evolution (Mitra et al., 2004). We 
know this b
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pombe at least, retains the ability to degrade PtdIns(3,4,5)P3.  This assertion is also 
given added weight because slime-moulds, which diverged from animals after fungi, 
all retain PI3KC1s and indeed make substantial quantities of PtdIns(3,4,5)P3 that 
allow them to regulate the process of chemotaxis (King and Insall, 2009). Despite 
these facts, early researchers studying inositol lipid metabolism concluded that 
PtdIns(3,4,5)P3 synthesis and the pathways it regulated never evolved in fungi based 
simply on the absence of a gene for the requisite lipid kinase (Auger et al., 1989). 
 
Similarly, S. cerevisiae probably also once had as many introns interrupting the 
coding sequences of its genes as other eukaryotes do, but that they lost them as a 
result of adaptation to their unicellular habitat (Seoighe and Wolfe, 1999). 
 
So taking anything at face value presents dangers in yeast and the identity of 
 
ubset of cargos passing through it that is quite different from that found in the early 
compartments is no exception. If I cannot trust the morphology of these organelles to 
guide as to their identity, then it seems that genomics might offer another approach. 
Recent analyses of yeast Rab GTPases paint a surprising picture of the yeast 
endocytic system that is not what might have been anticipated (Pelham, 2002). 
 
For example, the Snc1p positive “early endosome” has a Rab that is most similar to 
Rab11: the Rab GTPase that in animal cells controls entry to the recycling endosome. 
This organelle is quite distinct from a mammalian early endosome and has a disparate
s
endosome (Pelham, 2002). 
 
Similarly, the Pep12p positive organelle close the vacuole, that was assumed to be a 
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“late endosome” has a Rab GTPase, Vps21p, which is most similar to Rab5: the 
mammalian early endosomal Rab (Schimmoller and Riezman, 1993). This suggests 
that it is indeed the yeast early endosome, although some EM studies imply that it can 
mature into a Pep12p negative organelle that might be the compartment known in 
animal cells as the MVB (Ali et al., 2004). 
 
If I extend the analysis to the vacuole I find that the vacuolar Rab, Ypt7p is most 
imilar to Rab7: a mammalian Rab controlling entry to and residing on, the animal 
somes (pH 
.0)  and this contrasts strongly with the pH found in the much more acidic animal 
 if the 
acuole was indeed the late endosome or was principally derived from it (Jefferies et 
face area to volume ratio. This dynamism is particularly 
vident when I consider the response of the vacuole to osmotic perturbations. It 
s
late endosome. This strongly suggests that the yeast endocytic system may in fact be 
truncated and that yeast have no true lysosomes. This assertion is also borne out by 
the fact that the vacuole has a similar pH to that found in animal late endo
6
lysosome (pH 5.5-5.0).  
 
The vacuole as the late endosome may explain why ablation of PtdIns(3,5)P2 
synthesis in animal cells, does not appear to affect lysosomal functions in most 
organisms: the late endosome is more often distorted, as would be expected
v
al., 2008). 
 
5.4 Why does the yeast vacuole respond to osmotic stress? 
In this work I have highlighted the fact that the vacuole is a highly dynamic organelle 
in terms of its size and sur
e
responds to hypo-osmotic stress by swelling and fusing to form one large 
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compartment in a HOPS dependent fashion and to hyperosmotic stress by 
fragmenting into smaller organelles and reducing in volume in a Fab1p and CORVET 
dependent manner (see Section 1.9 and Fig. 1.18). 
 
 I have used this dynamic property to begin to dissect the mechanisms that regulate 
embrane fusion and fission: two fundamental processes that probably underlay all 
 conditions because fab1Δ cells, that completely lack 
tdIns(3,5)P2, can grow perfectly well in media containing a high concentration of 
 mutants are taken from high osmolarity to low osmolarity: many fab1Δ 
ells die when this experiment is performed (Yamamoto et al., 1995). This suggests 
consequences 
m
membrane trafficking and organelle inheritance in eukaryotes. I am not the only one 
to exploit this and a slew of studies have taken advantage of the yeast vacuole in this 
way (Peters et al., 2004; Baars et al., 2007). Yet the fact remains that very little is 
known about why the vacuole responds to osmotic insults as it does. These responses 
are presumably adaptive, although the evidence for this is rather sketchy: indeed the 
fragmentation of the vacuole carried out by the Fab1p/PtdIns(3,5)P2 pathway is 
dispensable under laboratory
P
osmolytes (Yamamoto et al., 1995).  
 
However, fab1Δ yeast do in fact give us a clue as to why yeast vacuoles respond to 
high tonicity as they do. This clue to the function of the Fab1p pathway is revealed 
when fab1Δ
c
that the true function of this pathway may be to protect cells against the 
of a return to normal osmotic conditions after a hyper-osmotic shock. Perhaps this 
occurs by packaging up the vacuole into tiny sub-compartments so that the vacuole is 
less likely to burst when normal tonicity is restored: smaller and more curved 
membrane areas are intrinsically more stable than larger ones because the surface area 
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to volume ratio dictates that a smaller compartment is subject to less pressure because 
it is enclosing a proportionately lower volume of fluid relative to a larger 
compartment (Hohmann, 2002a and b). 
 
Another likely function of the vacuole fusion and fission is to regulate vacuolar 
volume. Although simple fusion and fission of the same membrane area does not 
result in a change in total membrane area, it changes vacuolar volume to a very large 
degree. Indeed if I model the vacuole as a sphere with an arbitrary surface area of 100 
units2 and break it up into 8 smaller spheres of equal size, that together have the same 
total surface area as the original vacuole/sphere, then the total volume encompassed 
by all vacuoles decreases from ~94 units3 when it is one large organelle to only ~32 
units3 when it is divided into 8: a more than 3 fold reduction in volume. Since the 
vacuole fragments much more than this, there is a much larger volume decrease. Thus 
although the vacuole loses water at the exact same rate as the cytosol during hyper-
osmotic stress, there is still a large amount of water left after all passive water flow 
as ceased. So that when the vacuole subsequently undergoes a regulated surface area h
to volume ratio increase via the Fab1p pathway, the excess water is probably extruded 
into the cytoplasm to reduce tonicity briefly and this probably co-incides with the 
point where the aquaporins are closed and cell permeability is reduced. This may be 
viewed as an acute and immediate response that merely buys the cell a few minutes 
whilst the Hog1p pathway is activated, eventually raising the cytoplasmic osmotic 
potential by the production of glycerol (Hohmann, 2002a and b). 
 
Similarly, it is likely that during excess water influx, e.g. during hypo-osmotic stress, 
the cell acts to decrease the surface area to volume ratio of the vacuole, effectively 
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increasing vacuolar volume enormously and thus containing much of the water and 
concentrating the cytosol. It is possible the vacuole may actively transport or 
hydrolyse vacuolar contents in order to draw water inside it during these episodes of 
udden dilution and this is again likely to be an acute response (Hohmann, 2002a and 
 
The role of higher IPs appear analogous to that of the lipid PtdIns(4,5)P2: they 
regulate many processes (e.g. nuclear RNA editing, mRNA export etc) and are 
required for the non-enzymatic pyro-phosphorylation of a number of proteins (See 
section 1.7 and Bhandari et al., 2007),  but it seems likely that these events happen 
s
b). 
 
5.5 Are most higher inositol polyphosphates acting as true signals or 
are they just allosteric regulators? 
 In Chapter 4 I described a possible function for inositol pyrophosphates in the 
regulation of Vps41p phosphorylation and therefore in control of homotypic vacuole 
fusion. As alluded to in Chapter 4, I have not yet uncovered the precise molecular 
event that is regulated by these inositol pyrophosphates and this leads to an interesting 
question: are most “higher” inositol phosphates really acting as signals or second 
messengers? “Higher” IPs, for the purposes of this discussion, are those containing 
more than 5 phosphates on the inositol ring. 
 
This question arises because, despite many statements to the contrary, there is 
currently no substantiated example of a “higher” IP acting as a bona fide second 
messenger and this appears to be the case because the concentration of many of these 
molecules is always high, even in apparently unstimulated cells.  
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constitutively in many cases. PtdIns(4,5)P2 is needed to keep the actin cytoskeleton 
intact and is also an essential co-factor for a number of ion channels but again these 
appear to be constitutive functions. The advantages for this mode of regulation are 
understandable because most PtdIns(4,5)P2 is in the plasma membrane and it appears 
to be acting as a compartment maker. One could imagine that the KCNQ potassium 
hannel family, for example, that requires PtdIns(4,5)P2 for full activity, are not active 
nd bind PtdIns(4,5)P2 
e to act in the same way as PtdIns(4,5)P2: 
s compartment markers. Is it possible, for example, that the “basal” higher inositol 
 could then act as 
onstitutive “compartment markers.” 
c
when being trafficked through the ER and Golgi and only acquire full activity upon 
arriving at the plasma membrane: i.e. when they encounter a
(Loussouarn et al., 2003) This mode of regulation seems desirable and logical and 
indeed, local changes in PtdIns(4,5)P2 (e.g. during receptor stimulation) do appear to 
modulate channel activity, albeit in a subtle manner. 
 
So can I learn anything about higher IP function from the PtdIns(4,5)P2 paradigm? 
These are soluble molecules and so restricting their subcellular localisation seems 
unlikely but this would be required if they ar
a
phosphates are confined to the nucleus? At face value, this seems absurd because 
there are pores in the nuclear envelope that would make confining these soluble 
molecules unlikely. Yet there are two possible mechanisms that could both contribute 
to the maintenance of a nuclear pool of higher IPs, which
c
 
The first fact to consider is that higher IPs are not as mobile as might be expected 
through pores. Indeed, there is an old observation that IP6 can be placed in dialysis 
tubing with a 50,000 Da cutoff and yet will not diffuse out of the tubing appreciably 
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over 20 h, despite being much smaller than 50 kDa in size (Van der Kaay and Van 
haastert, 1995). The authors of this work originally suggested that a large hydration 
shell of ordered water might surround the highly charged inositides and restrict their 
diffusion through the pores of the tubing. They showed that diffusion out of the tubing 
was inversely related to charge and that if very high salt concentrations were applied 
then diffusion rate was increased: presumably because of charge suppression. If the 
same phenomenon is operating at nuclear pores, which also have a molecular weight 
cutoff of about 30 kDa, then higher IPs generated in the nucleus might be retained and 
unable to diffuse into the cytoplasm and vice-versa. 
 
If the above is combined with a second mechanism: high concentration of higher IP 
hosphatases in the cytoplasm, this could effectively separate the cell into at least two 
 
the concentration of a higher IP upon some sort 
f stimulation. Our lab is currently generating Plc1p constructs that are restricted to 
p
regions where IP signalling could occur independently of the other compartment.  
 
This situation is really a prerequisite for true “higher” IP signalling because the 
resting concentration of these molecules in cells is often already high (particularly  
IP5 and IP6 but not IP7 and IP8). Yet if all of this resting higher IP is in either the 
nucleus or the cytoplasm, then true signalling could occur in the other compartment 
because it could be almost devoid of the higher IP by the mechanisms indicated 
above. This would then provide a situation in which an inactive effector protein could 
be allosterically regulated by a rise in 
o
either the nucleus or cytoplasm to test some of the above hypotheses and to see if 
pools of spatially restricted higher inositol phosphates are really possible in vivo. 
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